
<html lang="en"     class="pb-page"  data-request-id="626b199d-a711-4c0c-ae9b-b49092a63ff8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501437v;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-3"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread" /></meta><meta name="dc.Creator" content="Yi  Shen" /></meta><meta name="dc.Creator" content="Craig A.  Zificsak" /></meta><meta name="dc.Creator" content="Jill E.  Shea" /></meta><meta name="dc.Creator" content="Xuegang  Lao" /></meta><meta name="dc.Creator" content="Oana  Bollt" /></meta><meta name="dc.Creator" content="Xiufen  Li" /></meta><meta name="dc.Creator" content="Joseph G.  Lisko" /></meta><meta name="dc.Creator" content="Jay P.  Theroff" /></meta><meta name="dc.Creator" content="Courtney L.  Scaife" /></meta><meta name="dc.Creator" content="Mark A.  Ator" /></meta><meta name="dc.Creator" content="Bruce A.  Ruggeri" /></meta><meta name="dc.Creator" content="Bruce D.  Dorsey" /></meta><meta name="dc.Creator" content="Scott K.  Kuwada" /></meta><meta name="dc.Description" content="The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile..." /></meta><meta name="Description" content="The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 26, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501437v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501437v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501437v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501437v" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501437v" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0018.jpeg" /></meta><meta property="og:description" content="The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile (1) induced cancer cell apoptosis during adhesion to normal mesothelial cells which line the peritoneum. We recently demonstrated that the sulfonylacrylonitrile portion of 1 and hydrophobic aryl substitution were essential for pro-apoptotic activity in cancer cells. Here we synthesized a diverse series of analogues of 1 in order to improve the efficacy and pharmaceutical properties. Analogues and 1 were compared in their ability to cause cancer cell death during adhesion to normal mesothelial cell monolayers. Potent analogues identified in the in vitro assay were validated and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine models of ovarian and pancreatic cancer spread and metastasis, highlighting their potential clinical use as an adjunct to surgical resection of cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501437v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501437v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501437v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501437v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501437v&amp;href=/doi/10.1021/jm501437v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1140-1158</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501127s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501350y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Shen">Yi Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Craig+A.++Zificsak">Craig A. Zificsak</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jill+E.++Shea">Jill E. Shea</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xuegang++Lao">Xuegang Lao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oana++Bollt">Oana Bollt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiufen++Li">Xiufen Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+G.++Lisko">Joseph G. Lisko</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+P.++Theroff">Jay P. Theroff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Courtney+L.++Scaife">Courtney L. Scaife</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++Ator">Mark A. Ator</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+A.++Ruggeri">Bruce A. Ruggeri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+D.++Dorsey">Bruce D. Dorsey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+K.++Kuwada">Scott K. Kuwada</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">John A. Burns School of Medicine, University of Hawaii, 651 Ilalo Street, Honolulu, Hawaii 96813, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Teva Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Surgery, University of Utah, 50 N. Medical Drive, Salt Lake City, Utah 84132, United States</span></div><div class="corresp-info"><strong>*</strong>C.A.Z. e-mail, <a href="/cdn-cgi/l/email-protection#d0b3a2b1b9b7feaab9b6b9b3a3b1bb90a4b5a6b1a0b8b1a2bdfeb3bfbd"><span class="__cf_email__" data-cfemail="690a1b08000e4713000f000a1a0802291d0c1f081901081b04470a0604">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>S.K.K. phone, +1-808-586-7476; fax, +1-808-692-1966; e-mail, <a href="/cdn-cgi/l/email-protection#30435b5b4547515451705851475159591e555445"><span class="__cf_email__" data-cfemail="ed9e8686989a8c898cad858c9a8c8484c3888998">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501437v&amp;href=/doi/10.1021%2Fjm501437v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1140–1158</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 12, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 July 2014</li><li><span class="item_label"><b>Published</b> online</span>26 January 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 February 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501437v" title="DOI URL">https://doi.org/10.1021/jm501437v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1140%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYi%2BShen%252C%2BCraig%2BA.%2BZificsak%252C%2BJill%2BE.%2BShea%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D3%26contentID%3Djm501437v%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BSulfonyl%2BAcrylonitriles%2Bas%2BNovel%2BInhibitors%2Bof%2BCancer%2BMetastasis%2Band%2BSpread%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1158%26publicationDate%3DFebruary%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501437v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1636</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501437v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Craig&quot;,&quot;last_name&quot;:&quot;A. Zificsak&quot;},{&quot;first_name&quot;:&quot;Jill&quot;,&quot;last_name&quot;:&quot;E. Shea&quot;},{&quot;first_name&quot;:&quot;Xuegang&quot;,&quot;last_name&quot;:&quot;Lao&quot;},{&quot;first_name&quot;:&quot;Oana&quot;,&quot;last_name&quot;:&quot;Bollt&quot;},{&quot;first_name&quot;:&quot;Xiufen&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;G. Lisko&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;P. Theroff&quot;},{&quot;first_name&quot;:&quot;Courtney&quot;,&quot;last_name&quot;:&quot;L. Scaife&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. Ator&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;A. Ruggeri&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;D. Dorsey&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;K. Kuwada&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;1140-1158&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501437v&quot;},&quot;abstract&quot;:&quot;The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2E)-3-[(4-tert-butylphenyl)sulfonyl]acrylonitrile (1) induced cancer cell apoptosis during adhesion to normal mesothelial cells which line the peritoneum. We recently demonstrated that the sulfonylacrylonitrile portion of 1 and hydrophobic aryl substitution were essential for pro-apoptotic activity in cancer cells. Here we synthesized a diverse series of analogues of 1 in order to improve the efficacy and pharmaceutical properties. Analogues and 1 were compared in their ability to cause cancer cell death during adhesion to normal mesothelial cell monolayers. Potent analogues identified in the in vitro assay were validated and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine models of ovarian and pancreatic cancer spread and metastasis, highlighting their potential clinical use as an adjunct to surgical resection of c&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501437v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501437v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501437v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501437v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501437v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501437v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501437v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501437v&amp;href=/doi/10.1021/jm501437v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501437v" /></input><a href="/doi/pdf/10.1021/jm501437v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501437v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501437v%26sid%3Dliteratum%253Aachs%26pmid%3D25581261%26genre%3Darticle%26aulast%3DShen%26date%3D2015%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BSulfonyl%2BAcrylonitriles%2Bas%2BNovel%2BInhibitors%2Bof%2BCancer%2BMetastasis%2Band%2BSpread%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D3%26spage%3D1140%26epage%3D1158%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jmcmar.2015.58.issue-3/20150212/jmcmar.2015.58.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The spread of intra-abdominal cancers is a vexing clinical problem for which there is no widely effective treatment. We discovered previously that (2<i>E</i>)-3-[(4-<i>tert</i>-butylphenyl)sulfonyl]acrylonitrile (<b>1</b>) induced cancer cell apoptosis during adhesion to normal mesothelial cells which line the peritoneum. We recently demonstrated that the sulfonylacrylonitrile portion of <b>1</b> and hydrophobic aryl substitution were essential for pro-apoptotic activity in cancer cells. Here we synthesized a diverse series of analogues of <b>1</b> in order to improve the efficacy and pharmaceutical properties. Analogues and <b>1</b> were compared in their ability to cause cancer cell death during adhesion to normal mesothelial cell monolayers. Potent analogues identified in the in vitro assay were validated and found to exhibit improved inhibition of intra-abdominal cancer in two clinically relevant murine models of ovarian and pancreatic cancer spread and metastasis, highlighting their potential clinical use as an adjunct to surgical resection of cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peritoneal carcinomatosis is caused by cancer cell implantation of the peritoneal lining of the abdominal cavity. The peritoneum is a thin tissue that lines the abdominal organs and abdominal wall. The mesothelial cells form a monolayer of cells on the surface of the peritoneum and produce peritoneal fluid that serves to lubricate the peritoneal surfaces, significantly reducing friction between the abdominal organs and cavity. Malignant gastrointestinal and gynecological tumors, such as advanced pancreatic cancer and ovarian cancer, commonly spread to the peritoneum.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1-6)</a> In 2013, approximately 45,220 new cases of and 38,460 deaths from pancreatic cancer occurred, and, 22,240 new cases of and 14,030 deaths from ovarian cancer occurred in the United States.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> As treatment options, surgery, radiation therapy, and chemotherapy may extend survival and/or relieve symptoms in many patients, but they seldom produce a cure for advanced cases.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">During the initial steps of peritoneal carcinomatosis, tumor cells are first shed from intra-abdominal cancers or dislodged during surgical resection, and gain access to the peritoneal cavity.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15">(10-15)</a> The successful implantation of the mesothelium is the key initial step in peritoneal carcinomatosis,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> and treatments that inhibit this step may significantly decrease recurrence and peritoneal carcinomatosis.</div><div class="NLM_p">Our previous work showed that the small molecule <b>1</b> could inhibit peritoneal carcinomatosis in a murine model.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>1</b> was found to inhibit c-FLIP (FLICE Inhibitory Protein), a key inhibitor of death receptor-mediated apoptosis, which is commonly overexpressed in cancer cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Many cancer cells express death receptors of the TNFα superfamily yet evade death receptor-mediated apoptosis through the overexpression of survival proteins such as c-FLIP.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The overexpression of death receptors by cancer cells appears to be conserved, as they have been shown to mediate cancer cell proliferation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Many normal tissues contain cells, such as mesothelial cells, that express cognate death receptor ligands.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We showed that when cancer cells adhere to mesothelial cells, the death receptor ligands expressed by mesothelial cells can activate death receptors expressed on cancer cells in a juxtacrine fashion, which results in apoptosis if <b>1</b> is present.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Thus, <b>1</b>-mediated inhibition of c-FLIP expression restores death receptor-mediated cancer cell apoptosis during their adhesion to normal human mesothelial cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">In a recent study, several analogues of <b>1</b> were synthesized to determine the role of the sulfonylacrylonitrile moiety and assess the potential of an amide replacement for the <i>tert</i>-butyl fragment of <b>1</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> While studies of these analogues pointed out the importance of the functional groups to the pro-apoptotic efficacy of <b>1</b>, few of the analogues demonstrated increased efficacy in pancreatic, ovarian, or colon cancer cells compared with the parent compound. In addition, although <b>1</b> was effective in inhibiting peritoneal carcinomatosis in preclinical models, its relative insolubility in water required the use of DMSO as a delivery vehicle, which impairs its potential clinical use. The aims of the present study were to improve the efficacy of the parent compound through structural modification strategies outlined (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and test lead analogues for efficacy in clinically relevant in vivo models of intra-abdominal cancers. The incorporation of additional polarity was a priority in the design of new analogues in the hope of increasing potency and drug-like character.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Analogues of <b>1</b>. The diagram shows the strategies for modifiying the parent compound <b>1</b> to generate more effective antimetastatic drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design</h3><div class="NLM_p last">In our preliminary report,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> analogues of <b>1</b> wherein a methyl of the <i>tert</i>-butyl group is replaced by an amide were designed and evaluated for their ability to induce apoptosis in pancreatic and ovarian cancer cells during adhesion to mesothelial cell monolayers. Secondary and tertiary amide analogues displayed comparable activity to <b>1</b> in mesothelial cell coculture assay across four pancreatic and ovarian cancer cell lines. Any modification to the sulfonyl acrylonitrile fragment resulted in reduced potency in the coculture assays, highlighting the need for a strong Michael acceptor for activity. To establish a more complete picture of the structure–activity relationship (SAR) and identify compounds with improved in vivo potency versus compound <b>1</b>, a systematic approach to modifying compound <b>1</b> was undertaken (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Modification of the <i>tert</i>-butyl or phenyl ring of <b>1</b> resulted in the synthesis of five different classes of compounds. On the basis of promising in vivo activity demonstrated in a luciferase tagged A2780 ovarian peritoneal carcinomatosis mouse model,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> additional aromatic, aliphatic, and benzylic amides were prepared to expand the Series 1 amide analogues. Bioisosteric replacement of the amide moiety in Series 1 provided the heterocyclic analogues of Series 2. Keeping the amide fragment in place and tethering the remaining geminal methyl groups of <b>1</b> into a series of cyclic products furnished Series 3. Appending the amide fragment to the phenylsulfonyl group through an ether linkage, while migrating the <i>tert</i>-butyl substituent to the <i>meta</i>-position afforded the phenoxy amide Series 4. Lastly, the phenyl ring was replaced with either a pyridine or quinoline ring to afford the Series 5 heterocyclic analogues.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">4-Bromophenyl-2-propanoic acid (<b>2</b>) served as the starting point for all of the amides of Series 1 (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Deprotonation and metalation, followed by a sulfur dioxide quench, furnished the intermediate sulfinic acid, which was converted to the arylsulfonyl acrylonitrile in modest yield. Routine coupling of aliphatic and aromatic amines with <b>3</b> furnished amides <b>4a</b>–<b>t</b> as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The Series 2 heterocyclic analogues also utilized <b>3</b> as a starting material (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>); oxadiazole analogues were prepared via a direct coupling<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with substituted thiosemicarbazides (<b>5a</b>–<b>b</b>) or via a two step coupling/dehydration with acyl hydrazines (<b>5c</b>–<b>d</b>). Amide analogues <b>4u</b>–<b>w</b> were cyclodehydrated under acidic conditions to afford the benzoxazole analogues <b>6a</b>–<b>b</b> and benzimidazole <b>6c</b>. Propargyl amide <b>4x</b> was similarly cyclized, under gold catalysis,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> to afford the methyl oxazole <b>7</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Data for <b>1</b> versus Amide Analogues from Series 1<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">efficacy of compounds by coculture assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center" char=".">SU.86</th><th class="colsep0 rowsep0" align="center" char=".">BxPC-3</th><th class="colsep0 rowsep0" align="center" char=".">A2780</th><th class="colsep0 rowsep0" align="center" char=".">SKOV3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.13 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.07 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.04 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.32 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.52 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.22 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.17 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.55 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.21 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.16 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.10 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.52 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.29 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.15 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.10 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.56 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-PhCH(CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.32 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.27 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.13 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.67 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4e</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-PhCH(CH<sub>3</sub>)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.21 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.21 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.10 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.64 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4f</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>SO<sub>2</sub>C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.09 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">0.99 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.95 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.78 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">4-H<sub>2</sub>NSO<sub>2</sub>C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.11 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">1.00 ± 0.09</td><td class="colsep0 rowsep0" align="char" char=".">1.00 ± 0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.96 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">2-MeOC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.21 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.27 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4i</b></td><td class="colsep0 rowsep0" align="left">3-MeOC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.30 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.09 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.03 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.25 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>O(CH<sub>2</sub>)<sub>2</sub>O-CH<sub>2</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.66 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">0.40 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.26 ± 0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.60 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4k</b></td><td class="colsep0 rowsep0" align="left">4-FC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.18 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.23 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.11 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.60 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4l</b></td><td class="colsep0 rowsep0" align="left">3-FC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.24 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.17 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.05 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.30 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">2-FC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.20 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.15 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.03 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.30 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4n</b></td><td class="colsep0 rowsep0" align="left">4-(pyrazol-1-yl)-C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.49 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.48 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.34 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.84 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4o</b></td><td class="colsep0 rowsep0" align="left">F<sub>2</sub>CHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.81 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.82 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.86 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">1.13 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4p</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-3-amino-caprolactam</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.97 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.82 ± 0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.84 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.85 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4q</b></td><td class="colsep0 rowsep0" align="left">PhC≡C–CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.50 ± 0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.14 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.07 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.40 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4r</b></td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.24 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.12 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.06 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.50 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4s</b></td><td class="colsep0 rowsep0" align="left">4-FC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.23 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.11 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.22 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4t</b></td><td class="colsep0 rowsep0" colspan="2" align="left">–(CH<sub>2</sub>)<sub>5</sub>–</td><td class="colsep0 rowsep0" align="char" char=".">0.51 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.25 ± 0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.08 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.51 ± 0.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The final concentration of all compounds was defined at 10 μM. Luminescence of cancer cells = living cell number. Efficacy = luminescence of cancer cells treated with analogue/luminescence of cancer cells treated with DMSO; the data are presented as a mean ± SEM, <i>n</i> = 3.</p></div></div></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt; (iv) Et<sub>3</sub>N, 43% (b) amine, EDCI, HOBT, rt, 22–67%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Heterocyclic Amide Isosteres<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RCSNHNH<sub>2</sub>, 3 equiv EDCI, DCM, rt, 11–19%, or (i) RCONHNH<sub>2</sub>, EDCI, HOBT, MeCN, rt, 4 h, (ii) dioxane, POCl<sub>3</sub>, 90 °C, 2 h, 72–76%; (b) MsOH, 1,4-dioxane, 90 °C, 24 h, 55% or AcOH, 70–105 °C, 1–3 d, 11–24%; (c) AuCl<sub>3</sub>, MeCN, 4 d, 30%.</p></p></figure><div class="NLM_p">The synthesis of the cyclic amide analogues <b>10a</b>–<b>h</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) followed the same sequence as the Series 1 amides, simply starting with the appropriately tethered cyclic carboxylic acid <b>8a</b>–<b>c</b> (X = direct bond, CH<sub>2</sub> or −CH<sub>2</sub>OCH<sub>2</sub>−). The phenoxy amide analogues of Series 4 utilized bromide <b>11</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> as a precursor to the aryl sulfonyl acrylonitrile derivatives <b>13a</b>–<b>e</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Cyclic Amide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 10–27%; (b) amine, EDCI, HOBT, MeCN or DCM, rt, 28–69%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0008.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenoxy Amide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 32%; (b) amine, EDCI, HOBT, MeCN or DCM, rt, 38–79%; (c) MsOH, 1,4-dioxane, 90 °C, 11 h, 50%.</p></p></figure><div class="NLM_p">Lastly, the phenyl ring of <b>1</b> was replaced with either a quinoline to afford <b>17</b> or a pyridine, with a pendant cyclohexyl amide, to afford <b>20</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Quinoline <b>16</b> was prepared by a Friedländer condensation of bromide <b>15</b> with pinacolone; subsequent formation of the sulfonyl acrylonitrile as earlier shown provided <b>17</b>. The reversal of the order of the amidation and sulfone formation steps was necessary to prepare pyridine <b>20</b> to avoid decomposition observed in reactions of carboxylic acid <b>18</b> with <i>n</i>-butyllithium. The reduced sulfide <b>21</b>, readily prepared from <b>1</b>, was used as a negative control, highlighting the need for the sulfone oxidation state in active analogues.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Heteroaryl Analogues and a Negative Control<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuCOCH<sub>3</sub>, KOH, water, 100 °C, 3 h, 64%; (b) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 59%; (c) cyclohexylamine, Et<sub>3</sub>N, propylphosphonic anhydride, DMF, rt, 51%; (d) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 15%; (e) 4-<i>t</i>-BuPhSH, Et<sub>3</sub>N, CHCl<sub>3</sub>, 97%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biological Evaluation of Inhibitors</h3><div class="NLM_p">Screening was conducted against two pancreatic cancer cell lines (SU.86 and BxPC-3) and two ovarian cancer cell lines (A2780 and SKOV3) that were transduced with a constitutively expressing firefly luciferase plasmid which allowed for specific bioluminescent detection of living cancer cells. The cancer cells were suspended and then allowed to adhere to human mesothelial cell monolayers in the presence of vehicle or drug. Each series of analogues was tested at a single concentration (10 μM), and efficacy was calculated as the fraction of adherent cells which remained alive as compared to vehicle (DMSO). Surviving cancer cells were quantified by firefly luciferase activity in a luminometer. In Series 1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), benzyl amide <b>4b</b> showed better potency than the phenyl (<b>4a</b>) or phenethyl (<b>4c</b>) amides, and <b>4b</b> had potency close to that of <b>1</b>. Substitution of the benzyl amide was further explored; neither stereoisomer of α-methyl benzylamide (<b>4d</b> or <b>4e</b>) showed a marked improvement in potency. Aromatic substitutions were investigated, and it was found that strongly polar fragments were not tolerated (sulfone <b>4f</b> or sulfonamide <b>4g</b>). A methoxy group at either the <i>ortho</i>- (<b>4h</b>) or <i>meta-</i> (<b>4i</b>) position provided highly potent analogues. In an attempt to aid aqueous solubility, the <i>para</i>- methoxy–ethoxy substituent was incorporated (<b>4j</b>), but potency against all four cell lines was diminished. Fluorine substitution was tolerated at all three positions (<b>4k</b>–<b>m</b>) and resulted in improved efficacy in the ovarian cell lines as compared to <b>4b</b>. A weakly basic heterocyclic substituent showed diminished activity (<b>4n</b>), as did the difluoroethyl amide (<b>4o</b>). The aminocaprolactam containing analogue <b>4p</b> was largely inactive, again pointing at the need for nonpolar substitution of the amide. The phenylpropargyl amide <b>4q</b> exhibited nearly identical activity as the amide without the acetylenic spacer. A pair of <i>N</i>-methyl benzyl amides, <b>4r</b> and <b>4s</b>, as well as the piperidine amide <b>4t</b>, showed that disubstituted amides were equally efficacious in the in vitro assay.</div><div class="NLM_p">The heterocyclic amide bioisosteres prepared in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> followed similar polarity based trends in activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Phenylamino-oxadiazole <b>5a</b> was more potent than the ethyl derivative <b>5b</b>, but both were less potent than the aryl/alkyl substituted oxadiazoles <b>5c</b> and <b>d</b>. Benzoxazoles <b>6a</b> and <b>6b</b> were among the most potent analogues from all series whereas the benzimidazole <b>6c</b> lacked potency in all cell lines. The smaller methyloxazole <b>7</b> was also active, but not as potent as the benzoxazole analogues.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biological Data for Heterocyclic Amide Isosteres from Series 2<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0011.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The final concentration of all compounds was defined at 10 μM. Luminescence of cancer cells = living cell number. Efficacy = luminescence of cancer cells treated with analogue/luminescence of cancer cells treated with DMSO; the data are presented as a mean ± SEM, <i>n</i> = 3.</p></div></div><div></div></div><div class="NLM_p">The Series 3 analogues, wherein the gem-dimethyl group of the amide analogues is tied back into a cyclic derivative, were assayed across the four cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The cyclopropane (X = direct bond, <b>10a</b>–<b>b</b>) and cyclobutane (X = CH<sub>2</sub>, <b>10c</b>–<b>e</b>) analogues were roughly equipotent with the corresponding amide analogues from Series 1. A significant drop in activity was observed for the tetrahydropyran analogues <b>10f</b>–<b>h</b> (X = CH<sub>2</sub>OCH<sub>2</sub>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biological Data for Cyclic Amide Analogues from Series 3<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0013.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">efficacy of compounds by coculture assay</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R, X</th><th class="colsep0 rowsep0" align="center" char="±">SU.86</th><th class="colsep0 rowsep0" align="center" char="±">BxPC-3</th><th class="colsep0 rowsep0" align="center" char="±">A2780</th><th class="colsep0 rowsep0" align="center" char="±">SKOV3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="center">4-fluorobenzyl X = direct bond</td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.43 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="center">cyclohexyl X = direct bond</td><td class="colsep0 rowsep0" align="char" char="±">0.34 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="center">phenyl X = CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.35 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.12 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.17 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="center">4-chlorobenzyl X = CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.36 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="center">cyclohexyl X = CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.18 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.33 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="center">phenyl X = CH<sub>2</sub>OCH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.92 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.85 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.87 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.97 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="center">4-chlorobenzyl X = CH<sub>2</sub>OCH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.66 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.71 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="center">cyclohexyl X = CH<sub>2</sub>OCH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.00 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.12 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.88 ± 0.06</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The final concentration of all compounds was defined at 10 μM. Luminescence of cancer cells = living cell number. Efficacy = luminescence of cancer cells treated with analogue/luminescence of cancer cells treated with DMSO; the data are presented as a mean ± SEM, <i>n</i> = 3.</p></div></div></div><div class="NLM_p">For the Series 4 analogues, a more dramatic change in structure was implemented (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Shifting of the <i>tert</i>-butyl group from <i>para</i> to <i>meta</i> on the aryl sulfone was paired with a glycolic ether linkage. The glycolic acid derivative <b>12</b> was inactive, as expected. The amide derivatives <b>13a</b>–<b>d</b> were potent in all four cell lines, particularly the BxPC-3 and A2780 cells. Taking a cue from the highly potent benzoxazole analogues of Series 2, the benzoxazole derivative <b>14</b> was prepared and found to be slightly less potent than the corresponding phenolic amide <b>13d</b>. For a direct comparison to <b>1</b>, <i>meta</i> derivative <b>13e</b> was synthesized and found to be equipotent.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biological Data for Cyclic Phenyl Ether Series<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0015.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0016.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">The final concentration of all compounds was defined at 10 μM. Luminescence of cancer cells = living cell number. Efficacy = luminescence of cancer cells treated with analogue/luminescence of cancer cells treated with DMSO; the data are presented as a mean ± SEM, <i>n</i> = 3.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Prepared from 3-bromo-<i>tert</i>-butylbenzene.</p></div></div><div></div></div><div class="NLM_p">Lastly, the heterocyclic derivatives <b>17</b> and <b>20</b> were assessed in the coculture assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Quinoline replacement for phenyl (<b>17</b> vs <b>1</b>) showed equivalent potency in the ovarian cell lines, but a drop in activity in the pancreatic cell lines was observed. A pyridyl-for-phenyl replacement showed midrange activity in the four cell lines and was comparable with the cyclohexyl amide analogue previously disclosed.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biological Data for Heteroaryl Series<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0017.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">The final concentration of all compounds was defined at 10 μM. Luminescence of cancer cells = living cell number. Efficacy = luminescence of cancer cells treated with analogue/luminescence of cancer cells treated with DMSO; the data are presented as a mean ± SEM, <i>n</i> = 3.</p></div></div><div></div></div><div class="NLM_p">For active analogues, <b>4b</b>, <b>5d</b>, <b>6a</b>, <b>6b</b>, <b>10e</b>, <b>13a</b>, and <b>13d</b>, in addition to <b>1</b>, a series of concentrations were used to determine the half-maximal effective concentration (EC<sub>50</sub>). All of these analogues decreased cancer cell viability in the coculture assay in the micromolar range (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Dose–Response Data for Active Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> by coculture assay<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">SU.86</th><th class="colsep0 rowsep0" align="center" char="±">BxPC-3</th><th class="colsep0 rowsep0" align="center" char="±">A2780</th><th class="colsep0 rowsep0" align="center" char="±">SKOV3</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.1 3.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="char" char="±">6.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="char" char="±">6.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">5.4 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.0</td><td class="colsep0 rowsep0" align="char" char="±">6.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are reported as the average of three separate determinations.</p></div></div></div><div class="NLM_p">As we previously showed, compound <b>1</b> rapidly and strongly induces apoptosis of cancer cells during adhesion.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The most active analogues in the coculture assay were tested for their ability to induce apoptosis of A2780 ovarian cancer cells by demonstrating increased cellular levels of cleaved PARP and cleaved caspase 3, which are indicators of apoptosis. While all of the analogues induced apoptosis to a degree, analogues <b>6b</b> and <b>13a</b> showed similar levels of apoptotic induction as compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The reduced sulfide <b>21</b> served as a negative control and showed no apoptotic effect.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Apoptotic effects of test compounds. A2780 ovarian cancer cells were suspended and allowed to adhere in the presence of vehicle (DMSO) or test compound (5 μM in DMSO) for 4 h. The cells were then collected, lysed, and normalized for total protein concentration. The lysates were used to generate immunoblots of cleaved PARP and cleaved caspase 3 which are indicators of apoptosis. An immunoblot of actin served as a loading control. A sulfide analogue (<b>21</b>), which lacked potency in the coculture assay, was used as a negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because of our previous studies showing that both the sulfone and nitrile groups are essential for the apoptotic activity of <b>1</b> on cancer cells, the ability of <b>1</b> and its analogues to bind glutathione (GSH) was examined. Active analogues <b>4k</b>, <b>4r</b>, along with <b>1</b>, strongly reduced detectable GSH levels, while two inactive analogues, <b>22</b> and <b>23</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>F), that were previously reported to be inactive compared to <b>1</b>,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> did not (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). To determine if the compounds could diminish GSH in cancer cells in vivo, <b>1</b>, <b>4k</b>, and <b>4r</b> and inactive analogues (<b>22</b>, <b>23</b>) were tested in HT29 cells. Only <b>1</b>, <b>4k</b>, and <b>4r</b> could decrease cellular GSH levels in vivo while <b>22</b> and <b>23</b> could not (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). The assay used to measure cellular glutathione levels in vivo could not distinguish if <b>1</b> and its active analogues diminished cellular glutathione levels by inhibiting its synthesis or through covalent modification. Therefore, transiently suspended HT-29 cancer cells were exposed to <b>1,</b> in the absence or presence of <i>N</i>-acetylcysteine (NAC), during coculture with mesothelial cell monolayers. NAC was able to completely inhibit the apoptotic activity of <b>1</b> on adhering HT-29 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C). Furthermore, mixing of NAC and <b>1</b> before exposure to cancer cells completely inactivated the apoptotic activity of <b>1</b> on cancer cells (not shown), indicating that <b>1</b> is more than likely binding covalently to glutathione and perhaps other thiol-containing molecules. When amide analogue <b>4b</b> was incubated with glutathione, the formation of the sulfinic acid elimination product as well as glutathione-conjugated acrylonitrile was observed. Unfortunately, attempts to identify acrylonitrile-conjugated protein from cell studies failed to identify a similar conjugate. These and our previous studies show the importance of the Michael acceptor functional acrylonitrile group to the anticancer activity of <b>1</b> and its active analogues.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>1</b> and analogues of <b>1</b> were tested for their ability to bind glutathione (GSH) in vitro (A) and in HT-29 cancer cells in vivo (B). In this assay, the sulfhydryl group of glutathione reacts with DTNB (5,5′-dithiobis-2-nitrobenzoic acid, Ellman’s reagent) and produces a yellow-colored 5-thio-2-nitrobenzoic acid (TNB). The mixed disulfide, GSTNB (between GSH and TNB) that is concomitantly produced, is reduced by glutathione reductase to recycle the GSH and produce more TNB. The rate of TNB production is directly proportional to the concentration of GSH in the sample. HT-29 cancer cells that stably expressed firefly luciferase were incubated with <b>1</b> and analogues of <b>1</b> with vehicle (H20) or 680 μM <i>N</i>-acetylcysteine (NAC) for 30 min. The HT-29 cells were then transiently suspended and cocultured on mesothelial cell monolayers for 5 h. The surviving HT-29 cells were detected by luciferase activity in a luminometer (C). Results are expressed as the mean light output and error bars represent standard errors of the mean. HT-29 cells, that stably expressed firefly luciferase, were treated with buthionine sulfoximine (BSO) for 24 h. The cells were lysed and levels of cellular GSH determined (D) as in <b>3A</b>,<b>B</b> above. The effect of 24- h preincubation of BSO on cancer cell viability was tested using the coculture model (E) as in <b>3C</b>. Structures of compounds <b>22</b> and <b>23</b> are shown (F).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine if glutathione depletion may be involved in the apoptotic mechanism of <b>1</b> and its active analogues, the apoptotic activity of buthionine-sulfoximine (BSO), an irreversible inhibitor of γ-glutamylcysteine synthetase, which is the rate-limiting enzyme for glutathione (GSH) synthesis, was tested. BSO decreased GSH levels in HT29 cells within 4 h (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D) but did not affect cancer cell viability when cocultured on mesothelial cell monolayers (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>E). These results suggested that diminution of intracellular GSH levels per se was unlikely to be involved in the apoptotic activity of <b>1</b> and its active analogues during cell adhesion.</div><div class="NLM_p">To validate the in vitro coculture assay results, an in vivo murine peritoneal carcinomatosis model was performed using A2780 and SKOV3 ovarian cancer cells. Athymic 5-week-old female nu/nu mice were randomized to intraperitoneal injection with 5 mg/kg of test compound or an equal volume of vehicle (4:1 PEG400: EtOH) 4 h before IP injection of 1.5 million A2780-luc or 2 million SKOV3-luc ovarian cancer cells (<i>n</i> = 7 for each arm). The strategy to dose prior to injection of cancer cells was designed to mimic the shedding of tumor cells during intraperitoneal surgery with concomitant use of a chemotherapeutic lavage. Dosing was continued every 3 days for 14 days total. The peritoneal tumor implants were examined weekly using a bioluminescence detection system that detects luciferase activity in the tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>1</b> and test compounds inhibit peritoneal carcinomatosis by of ovarian cancer cells. The mice were pretreated intraperitoneally (IP) with 5 mg/kg active analogue or vehicle. Four hours later, 1.5 × 10<sup>6</sup> A2780-luciferase or 2 × 10<sup>6</sup> SKOV3-luciferase ovarian cancer cells were injected into each mouse IP. The treatment with vehicle or 5 mg/kg active analogue was continued three times a week for 14 days total. The intraperitoneal tumor implants were detected and quantified using a bioluminescence imager following IP D-luciferin administration. The graphs show abdominal bioluminescent output of the mice inoculated with A2780-luc cells (A) or SKOV-3-luc (B) cells. The columns represent the average tumor burden (bioluminescence) for the mice in each treatment arm and the error bars, the standard error of the means. (C,D) Imaging data for A2780-luc cells when treated with vehicle or benzoxazole <b>6b</b> on day 14 respectively. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For A2780 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) and SKOV3 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B) ovarian cancer cells, significant inhibition of intraperitoneal implantation was observed in the groups treated with <b>1</b> and analogues <b>4b</b>, <b>6b</b>, <b>13a</b>, and <b>10e</b> compared with the control mice (<i>p</i> < 0.05), which received vehicle only. Benzoxazole <b>6b</b> showed significantly greater inhibition of peritoneal carcinomatosis than compound <b>1</b> for A2780 but not SKOV-3 ovarian cancer cells. None of the other analogues showed significantly greater inhibition of peritoneal carcinomatosis than compound <b>1</b>. Some degree of weight loss was initially observed in all mice, but this corrected over the 14-day treatment period.</div><div class="NLM_p">A selection of the active analogues was assayed in a second in vivo model of pancreatic cancer metastasis. MIA PaCa-2 cells that stably expressed red fluorescent protein (RFP) were surgically implanted in the pancreatic tail. Surgical resection of the resulting pancreatic tumor 6–8 weeks post-implantation was combined with IP treatment with analogues <b>4b</b>, <b>5d</b>, <b>6a</b>, <b>10e</b>, and <b>1</b> or vehicle (4:1 PEG400:EtOH). Animals were treated at the time of surgery and then on days 3, 5, and 7. After 8 weeks, local and metastatic recurrence was assessed via fluorescent imaging of the mice. Control mice treated with vehicle alone exhibited 67% recurrence (local in the remaining pancreas or metastatic to the peritoneum and mesenteric lymph nodes). Mice treated with <b>1</b> displayed a reduction in total recurrence to 38% of the study animals (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Benzyl amide <b>4b</b> showed a strong reduction in recurrence, with only one of 18 subjects exhibiting both local and metastatic recurrence. The remaining three analogues, phenyl oxadiazole <b>5d</b>, benzoxazole <b>6a</b>, and the cyclohexyl-cyclobutane amide <b>10e</b>, displayed in vivo activity comparable to or slightly less effective than <b>1</b>, with 40–50% recurrence either locally or metastatic.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vivo Efficacy of Select Analogues in a Pancreatic Resection Model</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">local recurrence</th><th class="colsep0 rowsep0" align="center" char=".">metastases</th><th class="colsep0 rowsep0" align="center" char=".">total recurrence</th><th class="colsep0 rowsep0" align="center" char=".">% local recurrence</th><th class="colsep0 rowsep0" align="center" char=".">% metastases</th><th class="colsep0 rowsep0" align="center" char=".">% total recurrence</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">67</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In these studies, we have shown that a variety of structural modifications to <b>1</b> are permitted while maintaining in vitro coculture efficacy. In vivo efficacy in two models of cancer spread can be improved with incorporation of a benzyl amide or benzoxazole in place of a methyl group present in <b>1</b>. Activity in the coculture assays is correlated with the overall polarity of the test compounds, and compounds sufficiently more polar than <b>1</b> to lose activity. The requirement for more hydrophobic group substitutions for efficacy is likely related to cell penetration. Overall potency of active compounds in the coculture assay as measured by EC<sub>50</sub> ranged between 2 and 8 μM, and doses of 5 mg/kg were found efficacious in two in vivo models of peritoneal carcinomatosis. Importantly, the requirement for DMSO for solubility of <b>1</b> and the active analogues of <b>1</b> was obviated by the use of polyethylene glycol and ethanol, which makes the clinical use of these drugs in humans more tenable.</div><div class="NLM_p">On the basis of the structure and presumed covalent nature of our active analogues, we performed additional glutathione binding studies. Our studies show that the activity of <b>1</b> and its active analogues against cancer cells correlates directly with their ability to bind glutathione, thus making it likely that these drugs work on cancer cells through covalent binding. While glutathione depletion has been shown to cause apoptosis in cancer cells, treatment of HT-29 cells with various concentrations of buthionine sulphoximine did not induce apoptosis when they were allowed to adhere to mesothelial cell monolayers. However, preincubation of cancer cells with N-acetylcysteine inhibited the apoptotic activity of <b>1</b>, suggesting that <b>1</b> may bind other thiol-containing molecules.</div><div class="NLM_p">Traditionally, covalent inhibitors have been shunned due to their broad reactivity (and subsequent off-target effects) and perceived toxicity in humans. However, an increasing proportion of clinically effective drugs, including carfilzomib, dimethyl fumarate, afatinib, and omeprazole, act through covalent binding of cellular targets and with acceptable safety profiles.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Covalent inhibitors allow sustained inhibition of cellular targets, affording them potential advantages vital to cancer treatment: (1) lower and less frequent dosing, (2) dissociation of pharmacokinetics and pharmacodynamics because the latter is dependent on protein resynthesis, and (3) prevention of drug resistance due to longer target suppression.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">We previously showed that <b>1</b> and its active analogues rapidly diminish cellular c-FLIP protein, an important inhibitor of death receptor-mediated caspase activation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Previous studies showed that c-FLIP protein is regulated by JNK-dependent activation of ITCH, a ubiquitin ligase, that targets c-FLIP for proteasomal degradation.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Activation of the JNK pathway by <b>1</b> suggests a potential mechanism for the inhibition of c-FLIP and a focus for future studies.</div><div class="NLM_p">The first step leading to peritoneal carcinomatosis is the shedding or dislodgement of cancer cells from intra-abdominal cancers. Peritoneal seeding by cancer cells occurs in up to 35% of patients following curative resections of pancreatic cancers.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Iatrogenic seeding is a paradoxical event in that resection is the mainstay of treatment of localized intra-abdominal cancers. In fact, the detection of intraperitoneal cancer cells during the resection of intra-abdominal cancers portends a poor survival.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32">(27-32)</a></div><div class="NLM_p">While it can be difficult to know if occult peritoneal carcinomatosis is already present by the time some patients undergo curative resection of intra-abdominal cancers, there is evidence that this condition may be due to seeding following medical interventions. The most obvious examples are cancer seeding of port-sites used to remove cancers laparoscopically from the abdominal cavity.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> In one study, patients with nonmetastatic pancreatic cancer who all underwent neoadjuvant chemoradiation had either percutaneous radiologically guided or endoscopic ultrasound guided fine needle aspirates of their pancreatic cancers.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> At the end of treatment, all patients underwent restaging with computed tomography followed by attempted surgical resection. At the time of surgery, 16.3% and 2.2% of patients who underwent percutaneous or endoscopic needle biopsies, respectively, developed peritoneal carcinomatosis. However, other studies have not reflected an increased risk of peritoneal carcinomatosis in pancreatic cancer patients who underwent or did not undergo percutaneous biopsy of their cancers.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In a large randomized controlled trial, intraperitoneal chemotherapy was shown to significantly increase patient survival following curative resection of ovarian cancer,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> suggesting that inhibition of peritoneal cancer spread may improve survival. The problem with most of these and other studies regarding this controversy is that the majority of studies are retrospective and small and show modest benefit, making their clinical import questionable. A drug that specifically and rapidly inhibited implantation of cancer cells in the peritoneum at the time of curative resection would permit randomized controlled trials to resolve the controversy of whether or not biopsies or surgical resection of intra-abdominal cancers results in peritoneal seeding.</div><div class="NLM_p">The two preclinical murine models used for these studies measured different outcomes and clinical scenarios. The ovarian cancer model simply tested the ability of the drugs to inhibit ovarian cancer cells from seeding the peritoneum. The pancreatic cancer model tested the ability of the drugs to inhibit local recurrence of pancreatic cancer at the site of resection as well as distant metastasis to lymph nodes and the liver following pancreatic cancer resection. For certain cancers such as pancreatic cancer, loco-regional recurrence after surgical cancer resection is a large clinical problem for which there is no effective therapy.</div><div class="NLM_p">All lead analogues and <b>1</b> showed significant reductions in peritoneal carcinomatosis in the ovarian cancer mouse model. One analogue, <b>6b</b>, was significantly more effective at inhibiting peritoneal carcinomatosis by A2780 ovarian cancer cells than <b>1</b>, thus achieving the primary end point of designing and synthesizing an analogue with greater potency than the parent compound.</div><div class="NLM_p">For the pancreatic cancer mouse model, <b>4b</b> emerged as the most efficacious analogue compared with vehicle and <b>1</b>. Although <b>4b</b> was significantly better at inhibiting peritoneal carcinomatosis from ovarian cancer cells than vehicle, it was not significantly more effective than <b>1</b>. These results may reflect tissue-specific differences for the various lead analogues.</div><div class="NLM_p">The mechanism by which these drugs work appears to be due to the ability of <b>1</b> to rapidly inhibit the expression of survival proteins that are overexpressed in cancer cells.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> One key intracellular protein target identified in our previous studies is c-FLIP, which is commonly overexpressed in cancer cells and capable of inhibiting death receptor-mediated apoptosis in cancer cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Investigations on how <b>1</b> and its active analogues inhibit c-FLIP are presently underway.</div><div class="NLM_p last">In summary, these results suggest that these unique agents could be administered in the immediate peri-operative period to inhibit the spread of intra-abdominal cancers following surgical resection of ovarian and pancreatic cancers. The preclinical cancer assays developed and utilized for this study may be useful in developing compounds that prevent the spread of cancer cells.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthetic Procedures and Analytical Data</h3><div class="NLM_p">All reagents and solvents were obtained from commercial sources and used as received. All final products were purified to >95% purity as determined by HPLC and LCMS. Analytical HPLC was run using a Zorbax Eclipse XDB-C8 3.5 μm 4.6 mm × 75 mm column eluting with a mixture of acetonitrile and water containing 0.1% trifluoroacetic acid with a 5 min gradient of 10–100%. LCMS results were obtained on either of two instruments. A Waters Acquity Ultra Performance LC with a Waters Aquity UPLC BEH C18 1.7 μm 2.1 mm × 50 mm column was paired with a Micromass-ZQ 2000 quadrupole mass spectrometer with electrospray ionization. Alternatively, an Agilent 1100 series HPLC with a Zorbax Eclipse XDB-C8 3.5 μm 2.1 mm × 30 mm column was paired with a Bruker Esquire 2000 mass spectrometer with electrospray ionization. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were obtained on a Bruker Avance at 400 and 100 MHz, respectively, in the solvent indicated with tetramethylsilane as an internal standard. High resolution LCMS was performed on a Waters Acquity UPLC using a Phenomenex Kinetex C18 1.7 μm 2.1 mm × 50 mm column and interfaced to a Waters Synapt G2 Q-TOF mass spectrometer using positive electrospray with Leu-enkephalin as a lock-mass standard. The mobile phases were 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) using a gradient of 2%B to 95%B in 3 min to elute the compounds. Preparative HPLC was performed on a Gilson HPLC using a Phenomenex Gemini NX 5 μm C18, 21.2 mm × 100 mm column with UV detection or a Waters HPLC using a Waters XBridge PrepC8 5 μm OBD 30 mm × 75 mm column with MS detection on a Micromass-ZQ 2000 quadrupole mass spectrometer with electrospray ionization. Gradient silica gel column chromatography was performed on a CombiFlash Companion or Rf instrument (Teledyne Isco Inc.).</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-phenyl-isobutyramide (<b>4a</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (300.0 mg, 1.074 mmol), aniline (0.098 mL, 1.07 mmol), EDCI (206 mg, 1.07 mmol) and HOBt (72.6 mg, 0.537 mmol) were dissolved in tetrahydrofuran (30 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction mixture was poured over saturated sodium bicarbonate and organics were extracted with dichloromethane/ethyl acetate. Combined extracts were then dried over sodium sulfate, filtered and concentrated. The crude reaction mixture was purified on silica gel, eluting with hexanes/ethyl acetate to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-phenyl-isobutyramide as a foam (171 mg, 45%). LCMS (ESI): 355 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.22 (s, 1H), 8.23 (d, 1H, <i>J</i> = <i>J</i> = 15.7 Hz), 7.90 (d, 2H, <i>J</i> = 7.8 Hz), 7.68 (d, 2H, <i>J</i> = 7.8 Hz), 7.57 (d, 2H, <i>J</i> = 7.7 Hz), 7.27 (m, 2H), 7.05 (m, 1H), 6.90 (d, 1H, <i>J</i> = 15.7 Hz), 1.60 (s, 6H); <sup>13</sup>C NMR: (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 173.7, 153.2, 149.2, 139.0, 135.5, 128.4, 128.2, 127.6, 123.5, 120.4, 114.6, 112.0, 47.9, 26.5.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-Benzyl-2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-isobutyramide (<b>4b</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (300.0 mg, 1.074 mmol), benzylamine (0.115 g, 1.07 mmol), EDCI (206 mg, 1.07 mmol) and HOBt (72.6 mg, 0.537 mmol) were dissolved in tetrahydrofuran (30 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction mixture was poured over saturated sodium bicarbonate and organics were extracted with dichloromethane/ethyl acetate. Combined extracts were then dried over sodium sulfate, filtered and concentrated. The crude reaction mixture was purified on silica gel, eluting with hexanes/ethyl acetate to afford N-Benzyl-2-[4-((E)-2-cyano-ethenesulfonyl)-phenyl]-isobutyramide as a white powder (173 mg, 44%). LCMS (ESI): 369 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.24 (d, 1H, <i>J</i> = 15.6 Hz), 8.06 (t, 1H, <i>J</i> = 5.6 Hz), 7.86 (d, 2H, <i>J</i> = 7.6 Hz), 7.63 (d, 2H, <i>J</i> = 7.6 Hz), 7.27 (m, 2H), 7.21 (m, 1H), 7.11 (d, 2H, <i>J</i> = 7.3 Hz), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 4.24 (d, 2H, <i>J</i> = 5.6 Hz), 1.52 (s, 6H); <sup>13</sup>C NMR: (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 174.6, 153.4, 149.2, 139.6, 135.3, 128.0, 127.9, 127.6, 126.7, 126.5, 114.5, 111.9, 46.6, 42.3, 26.3; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>S, 369.1273; found, 369.1274.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-phenethyl-isobutyramide (<b>4c</b>)</h4><div class="NLM_p last">2-[4-((E)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), phenylethylamine (33.7 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.2 mL of acetonitrile. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-phenethyl-isobutyramide as a white foam (39 mg, 38%). LCMS (ESI): 383 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.79 (d, 2H, <i>J</i> = 8.6 Hz), 7.49 (d, 2H, <i>J</i> = 8.6 Hz), 7.29–7.21 (m, 3H), 7.19 (d, 1H, <i>J</i> = 15.7 Hz), 7.07–7.02 (m, 2H), 6.55 (d, 1H, <i>J</i> = 15.7 Hz), 5.20–5.08 (m, 1H), 3.53–3.46 (m, 2H), 2.76 (t, 2H, <i>J</i> = 6.7 Hz), 1.54 (s, 6H); <sup>13</sup>C NMR: (CDCl<sub>3</sub>, 100 MHz) δ 175.2, 153.3, 148.9, 138.4, 135.6, 128.8, 128.67, 128.65, 127.9, 126.7, 113.3, 110.7, 47.4, 40.7, 35.3, 26.8; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>S, 383.1429; found, 383.1425.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-((<i>S</i>)-1-phenyl-ethyl)-isobutyramide (<b>4d</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), (<i>S</i>)-1-phenylethylamine (34.3 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.3 mL of acetonitrile. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-((<i>S</i>)-1-phenyl-ethyl)-isobutyramide as an amorphous white solid (66 mg, 64%). LCMS (ESI): 383 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.84 (d, 2H, <i>J</i> = 7.6 Hz), 7.55 (d, 2H, <i>J</i> = 7.6 Hz), 7.37–7.25 (m, 3H), 7.24–7.14 (m, 3H), 6.53 (d, 1H, <i>J</i> = 15.7 Hz), 5.59 (d, 1H, <i>J</i> = 7.1 Hz), 5.16–5.06 (m, 1H), 1.61 (s, 3H), 1.60 (s, 3H), 1.43 (d, 3H, <i>J</i> = 6.8 Hz); HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>S, 383.1429; found, 383.1430.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-((<i>R</i>)-1-phenyl-ethyl)-isobutyramide (<b>4e</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), (<i>R</i>)-1-phenylethylamine (34.2 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.3 mL of acetonitrile. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-((<i>R</i>)-1-phenyl-ethyl)-isobutyramide as an amorphous white solid (69 mg, 67%). LCMS (ESI): 383 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.84 (d, 2H, <i>J</i> = 7.3 Hz), 7.54 (d, 2H, <i>J</i> = 7.3 Hz), 7.37–7.26 (m, 3H), 7.23–7.15 (m, 3H), 6.54 (d, 1H, <i>J</i> = 15.6 Hz), 5.68 (d, 1H, <i>J</i> = 6.8 Hz), 5.16–5.06 (m, 1H), 1.62 (s, 3H), 1.60 (s, 3H), 1.44 (d, 3H, <i>J</i> = 6.8 Hz); <sup>13</sup>C NMR: (CDCl<sub>3</sub>, 100 MHz) δ 174.4, 153.5, 148.9, 142.7, 135.7, 128.9, 128.7, 127.8, 127.6, 126.0, 113.3, 110.8, 49.1, 47.4, 26.9, 21.4; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>S, 383.1429; found, 383.1429.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-methanesulfonyl-benzyl)-isobutyramide (<b>4f</b>)</h4><div class="NLM_p last">4-Methanesulfonyl-benzylamine hydrochloride (59.5 mg, 0.268 mmol) was placed in methylene chloride (10 mL) and macroporous carbonate resin (3.16 mmol/g loading, 255 mg, 0.806 mmol) was added. The reaction was stirred at room temperature for 30 min and then filtered to remove the resin. The solution was added to a vial containing 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), HOBt (18.1 mg, 0.134 mmol), and EDCI (51.5 mg, 0.268 mmol). The reaction was stirred at 40 °C overnight and was then concentrated under reduced pressure. The residue was taken up in 1.6 mL of DMSO and purified by preparative HPLC using a gradient of 10–45% acetonitrile:water both containing 0.1% TFA as the eluting solvent to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-methanesulfonyl-benzyl)-isobutyramide as a white foam (33 mg, 28%). LCMS (ESI): 447 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.87 (d, 2H, <i>J</i> = 8.4 Hz), 7.80 (d, 2H, <i>J</i> = 8.2 Hz), 7.62 (d, 2H, <i>J</i> = 8.4 Hz), 7.32 (d, 2H, <i>J</i> = 8.2 Hz), 7.22 (d, 1H, <i>J</i> = 15.6 Hz), 6.57 (d, 1H, <i>J</i> = 15.6 Hz), 5.99 (t, 1H, <i>J</i> = 5.6 Hz), 4.49 (d, 2H, <i>J</i> = 6.0 Hz), 3.03 (s, 3H), 1.66 (s, 6H).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-sulfamoyl-benzyl)-isobutyramide (<b>4g</b>)</h4><div class="NLM_p last">4-Aminomethyl-benzenesulfonamide hydrochloride (59.8 mg, 0.268 mmol) was placed in methylene chloride (10 mL) and macroporous carbonate resin (3.16 mmol/g loading, 255 mg, 0.806 mmol) was added. The reaction was stirred at room temperature for 30 min and then filtered to remove the resin. The solution was added to a vial containing 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), HOBt (18.1 mg, 0.134 mmol), and EDCI (51.5 mg, 0.268 mmol). The reaction was stirred at 40 °C overnight and then concentrated under reduced pressure. The residue was taken up in 1.6 mL of DMSO and purified by preparative HPLC using a gradient of 10–45% acetonitrile:water both containing 0.1% TFA as the eluting solvent to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-sulfamoyl- benzyl)-isobutyramide as a white foam (17 mg, 14%). LCMS = 448 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.24 (d, 1H, <i>J</i> = 15.6 Hz), 8.16 (t, 1H, <i>J</i> = 5.8 Hz), 7.88 (d, 2H, <i>J</i> = 8.4 Hz), 7.73 (d, 2H, <i>J</i> = 8.1 Hz), 7.64 (d, 2H, <i>J</i> = 8.4 Hz), 7.35–7.26 (m, 4H), 6.91 (d, 1H, <i>J</i> = 15.6 Hz), 4.28 (d, 2H, <i>J</i> = 5.8 Hz), 1.52 (s, 6H)</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-methoxy-benzyl)-isobutyramide (<b>4h</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 2-methoxy-benzylamine (34.7 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir for 2 h at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-methoxy-benzyl)-isobutyramide (48 mg, 45%) as a white lyophilate. LCMS (ESI): 399 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.81 (d, 2H, <i>J</i> = 8.7 Hz), 7.53 (d, 2H, <i>J</i> = 8.7 Hz), 7.30–7.23 (m, 1H), 7.23–7.16 (m, 2H), 6.94–6.87 (m, 1H), 6.85–6.80 (m, 1H), 6.54 (d, 1H, <i>J</i> = 15.7 Hz), 5.89–5.80 (m, 1H), 4.38 (d, 2H, <i>J</i> = 5.8 Hz), 3.69 (s, 3H), 1.58 (s, 6H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 175.0, 157.4, 153.7, 148.9, 135.5, 129.9, 129.1, 128.7, 127.9, 125.7, 120.8, 113.2, 110.7, 110.3, 55.2, 47.5, 40.4,26.8; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S, 399.1379; found, 399.1381.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(3-methoxy-benzyl)-isobutyramide (<b>4i</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 3-methoxy-benzylamine (34.7 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir for 2 h at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(3-methoxy-benzyl)-isobutyramide (40 mg, 37%) as a white lyophylate. LCMS (ESI): 399 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.85 (d, 2H, <i>J</i> = 8.6 Hz), 7.61 (d, 2H, <i>J</i> = 8.6 Hz), 7.25–7.16 (m, 2H), 6.84–6.78 (m, 1H), 6.77–6.72 (m, 1H), 6.69–6.65 (m, 1H), 6.54 (d, 1H, <i>J</i> = 15.7 Hz), 5.57–5.48 (m, 1H), 4.38 (d, 2H, <i>J</i> = 5.7 Hz), 3.77 (s, 3H), 1.64 (s, 6H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 175.1, 159.9, 153.3, 148.9, 139.5, 135.8, 129.8, 128.9, 127.9, 119.7, 113.4, 113.3, 112.8, 110.7, 55.3, 47.5, 43.9, 26.9; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S, 399.1379; found, 399.1378.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-[4-(2-methoxy-ethoxymethyl)-phenyl]-isobutyramide (<b>4j</b>)</h4><div class="NLM_p">(a) Potassium hydroxide (0.682 g, 10.3 mmol) was added to a suspension of p-nitrobenzyl bromide (2.048 g, 9.480 mmol) in 2-methoxyethanol (20 mL, 254 mmol) and the mixture was heated in a vial at 105 °C. After 90 min, the mixture was cooled to room temperature. The mixture was poured into EtOAc (100 mL) and washed with water (3 × 10 mL), brine (20 mL) and dried over sodium sulfate. Concentration in vacuo after filtration gave an oil, which was purified on ISCO (25g preload w/DCM, 80g column, 5–40% EtOAc:Hex). Pure fractions were combined and conc. to afford 1-(2-methoxy-ethoxymethyl)-4-nitro-benzene (1.245 g, 62%) as an orange oil.</div><div class="NLM_p">(b) 1-(2-Methoxy-ethoxymethyl)-4-nitro-benzene (200 mg, 0.947 mmol was dissolved in methanol (9.5 mL) and 5% platinum on carbon, sulfided (0.5%) (36.9 mg, 0.00947 mmol) was added. The reaction was hydrogenated at 50 psi for 60 min and then filtered through Celite to remove the catalyst. The filtrate was then concentrated under reduced pressure to afford 4-(2-Methoxy-ethoxymethyl)-phenylamine as a yellow oil.</div><div class="NLM_p last">(c) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 4-(2-methoxy-ethoxymethyl)-phenylamine (48.7 mg, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-[4-(2-methoxy-ethoxymethyl)-phenyl]-isobutyramide as an orange oil (57 mg, 48%). LCMS = 465 (M + Na); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.23 (s, 1H), 8.23 (d, 1H, <i>J</i> = 15.7 Hz), 7.89 (d, 2H, <i>J</i> = 8.6 Hz), 7.67 (d, 2H, <i>J</i> = 8.6 Hz), 7.54 (d, 2H, <i>J</i> = 8.6 Hz), 7.22 (d, 2H, <i>J</i> = 8.6 Hz), 6.0 (d, 1H, <i>J</i> = 15.7 Hz), 4.40 (s, 2H), 3.53–3.43 (m, 4H), 3.24 (s, 3H), 1.60 (s, 6H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-fluoro-benzyl)-isobutyramide (<b>4k</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 4-fluoro-benzylamine (30.5 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.2 mL of acetonitrile. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-fluoro-benzyl)-isobutyramide as a white foam (34 mg, 34%). LCMS (ESI): 387 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.85 (d, 2H, <i>J</i> = 7.4 Hz), 7.59 (d, 2H, <i>J</i> = 7.4 Hz), 7.30–7.24 (m, 1H), 7.20–7.10 (m, 2H), 7.04–6.95 (m, 2H), 6.55 (d, 1H, <i>J</i> = 15.6 Hz), 5.63–5.50 (m, 1H), 4.37 (d, 2H, <i>J</i> = 5.6 Hz), 1.63 (s, 6H); <sup>13</sup>C NMR: (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 171.4, 161.2 (d, <i>J</i> = 242 Hz), 149.2, 147.5, 136.0, 135.9, 131.7, 128.9, 128.4 (d, <i>J</i> = 8 Hz), 114.9 (d, <i>J</i> = 21 Hz), 114.6, 112.0, 42.1, 30.4, 15.0.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(3-fluoro-benzyl)-isobutyramide (<b>4l</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 3-fluorobenzylamine (30.6 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir for 2 h at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(3-fluoro-benzyl)-isobutyramide (17 mg, 16%) as a white lyophilate. LCMS = 387 (M + H); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.87 (d, 2H, <i>J</i> = 8.7 Hz), 7.61 (d, 2H, <i>J</i> = 8.7 Hz), 7.32–7.23 (m, 1H), 7.20 (d, 1H, <i>J</i> = 15.6 Hz), 7.00–6.91 (m, 2H), 6.84–6.78 (m, 1H), 6.55 (d, 1H, <i>J</i> = 15.6 Hz), 5.62–5.49 (m, 1H), 4.40 (d, 2H, <i>J</i> = 5.9 Hz), 1.64 (s, 6H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-fluoro-benzyl)-isobutyramide (<b>4m</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 2-fluorobenzylamine (30.6 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir for 2 h at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-fluoro-benzyl)-isobutyramide (40 mg, 38%) as a white lyophilate. LCMS = 387 (M + H); <sup>1</sup>H NMR<sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.83 (d, 2H, <i>J</i> = 8.7 Hz), 7.56 (d, 2H, <i>J</i> = 8.7 Hz), 7.31–7.22 (m, 2H), 7.19 (d, 1H, <i>J</i> = 15.6 Hz), 7.12–7.06 (m, 1H), 7.05–6.98 (m, 1H), 6.54 (d, 1H, <i>J</i> = 15.7 Hz), 5.69–5.54 (m, 1H), 4.44 (d, 2H, <i>J</i> = 5.9 Hz), 1.60 (s, 6H).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-pyrazol-1-yl-benzyl)-isobutyramide (<b>4n</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), 4-pyrazol-1-yl-benzylamine (46.5 mg, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.2 mL of acetonitrile. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-pyrazol-1-yl-benzyl)-isobutyramide trifluoroacetic acid salt as a pale-yellow solid (33 mg, 28%), mp = 47–53 °C. LCMS = 435 (M + H); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.92–7.83 (m, 3H), 7.80–7.76 (m, 1H), 7.64–7.57 (m, 4H), 7.30–7.25 (m, 2H), 7.21 (d, 1H, <i>J</i> = 15.6 Hz), 6.55 (d, 1H, <i>J</i> = 15.6 Hz), 6.52–6.47 (m, 1H), 5.73–5.63 (m, 1H), 4.44 (d, 2H, <i>J</i> = 5.7 Hz), 1.64 (s, 6H).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2,2-difluoro-ethyl)-isobutyramide (<b>4o</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (100.0 mg, 0.3580 mmol), 2,2-difluoro-ethylamine (0.0290 g, 0.358 mmol), EDCI (68.6 mg, 0.358 mmol) and HOBt (24.2 mg, 0.179 mmol) were dissolved in tetrahydrofuran (10 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction mixture was poured over saturated sodium bicarbonate and organics were extracted with dichloromethane/ethyl acetate. Combined extracts were then dried over sodium sulfate, filtered and concentrated. The crude reaction mixture was purified via preparative HPLC to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2,2-difluoro-ethyl)-isobutyramide as a white foam (40 mg, 32%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.89 (d, 2H, <i>J</i> = 7.6 Hz), 7.60 (d, 2H, <i>J</i> = 7.6 Hz), 7.23 (d, 1H, <i>J</i> = 15.7 Hz), 6.57 (d, 1H, <i>J</i> = 15.7 Hz), 5.84 (tt, 1H, <i>J</i> = 4.0, 56 Hz), 5.46 (m, 1H), 3.61 (m, 2H), 1.62 (s, 6H); <sup>13</sup>C NMR: (CDCl<sub>3</sub>, 100 MHz) δ 176.1, 152.7, 148.8, 136.1, 129.0, 127.9, 113.24, 113.20 (t, <i>J</i> = 240 Hz), 110.9, 47.6, 42.0 (t, <i>J</i> = 26 Hz), 26.9; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>17</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S, 343.0928; found, 343.0928.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-((S)-2-oxo-azepan-3-yl)-isobutyramide (<b>4p</b>)</h4><div class="NLM_p last">(<i>S</i>)-3-Amino-azepan-2-one hydrochloride (44.2 mg, 0.268 mmol) was placed in methylene chloride (10 mL) and macroporous carbonate resin (3.16 mmol/g loading, 255 mg, 0.806 mmol) was added. The reaction was stirred at room temperature for 30 min and then filtered to remove the resin. The solution was added to a vial containing 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), HOBt (18.1 mg, 0.134 mmol), and EDCI (51.5 mg, 0.268 mmol). The reaction was stirred at 40 °C overnight and was then concentrated under reduced pressure. The residue was taken up in 1.6 mL of DMSO and purified by preparative HPLC using a gradient of 10–45% acetonitrile:water both containing 0.1% TFA as the eluting solvent to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-((<i>S</i>)-2-oxo-azepan-3-yl)-isobutyramide (60 mg, 57%) as a white foam. LCMS (ESI): 390 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.90–7.84 (m, 1H), 7.86 (d, 2H, <i>J</i> = 8.5 Hz), 7.69 (d, 2H, <i>J</i> = 6.5 Hz), 7.23 (d, 1H, <i>J</i> = 6.2 Hz), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 4.41–4.30 (m, 1H), 3.23–3.10 (m, 1H), 3.10–2.97 (m, 1H), 1.93–1.82 (m, 1H), 1.82–1.69 (m, 2H), 1.69–1.55 (m, 1H), 1.51 (s, 6H), 1.41–1.26 (m, 1H), 1.25–1.10 (m, 1H).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(3-phenyl-prop-2-ynyl)-isobutyramide (<b>4q</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (0.254 g, 0.909 mmol), 3-phenyl-prop-2-ynylamine hydrochloride (0.272 g, 1.62 mmol), EDCI (0.225 g, 1.18 mmol) and HOBt (0.019 g, 0.14 mmol) were combined in acetonitrile (6.0 mL). After 1h, 4-methylmorpholine (0.100 mL, 0.909 mmol) was added, due to only trace conversion to the amide. After 4 h, the mixture was concentrated in vacuo to ∼1 mL, DMSO was added (1 mL) and the mixture was filtered. Purification of the filtrate by preparative mass-directed HPLC (25–75% acetonitrile:water, both containing 0.1% TFA) afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(3-phenyl-prop-2-ynyl)-isobutyramide (165 mg; 46%) after partial evaporation in vacuo followed by lyophilization. LCMS (ESI): <i>m</i>/<i>z</i> = 393 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.22 (d, 1H, <i>J</i> = 15.6 Hz), 8.08 (t, 1H, <i>J</i> = 5.5 Hz), 7.86 (d, 2H, <i>J</i> = 8.7 Hz), 7.64 (d, 2H, <i>J</i> = 8.7 Hz), 7.37 (m, 5H), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 4.08 (d, 2H, <i>J</i> = 5.5 Hz), 1.51 (s, 6H); HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>S, 393.1273; found, 393.1274.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-Benzyl-2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-methyl-isobutyramide (<b>4r</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), <i>N</i>-methyl-benzylamine, (34.6 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.2 mL of acetonitrile. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded <i>N</i>-Benzyl-2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-methyl-isobutyramide as a white foam (33 mg, 32%). LCMS (ESI): 383 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz, mixture of rotamers) δ 7.92–7.76 (m, 2H), 7.49 (d, 2H, <i>J</i> = 8.0 Hz), 7.40–7.01 (m, 6H), 6.55 (d, 1H, <i>J</i> = 14.7 Hz), 4.72–3.94 (m, 2H), 3.02–2.31 (m, 3H), 1.63 (s, 6H).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-fluoro-benzyl)-<i>N</i>-methyl- isobutyramide (<b>4s</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), (4-fluoro-benzyl)-methyl-amine (37.4 mg, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir for 2 h at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(4-fluoro-benzyl)-<i>N</i>-methyl- isobutyramide (24 mg, 22%) as a white lyophilate. LCMS = 401 (M + H); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.84 (d, 2H, <i>J</i> = 8.6 Hz), 7.46 (d, 2H, <i>J</i> = 8.6 Hz), 7.32–7.13 (m, 3H), 7.06–6.96 (m, 2H), 6.55 (d, 1H, <i>J</i> = 15.7 Hz), 4.68–3.79 (m, 2H), 3.00–2.24 (m, 3H), 1.61 (s, 6H).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-3-[4-(1,1-Dimethyl-2-oxo-2-piperidin-1-yl-ethyl)-benzenesulfonyl]-acrylonitrile (<b>4t</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (75.0 mg, 0.268 mmol), piperidine (26.6 μL, 0.268 mmol), EDCI (51.5 mg, 0.268 mmol) and HOBt (18.1 mg, 0.134 mmol) were dissolved in methylene chloride (7.5 mL) and the reaction mixture was allowed to stir overnight at room temperature. The reaction was concentrated under reduced pressure and the residue was taken up in 1.6 mL of DMSO. Purification by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent afforded (<i>E</i>)-3-[4-(1,1-dimethyl-2-oxo-2-piperidin-1-yl-ethyl)benzenesulfonyl]-acrylonitrile as a yellow oil (25 mg, 27%). LCMS = 347 (M + H); <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.88 (d, 2H, <i>J</i> = 8.4 Hz), 7.49 (d, 2H, <i>J</i> = 8.4 Hz), 7.22 (d, 1H, <i>J</i> = 15.6 Hz), 6.56 (d, 1H, <i>J</i> = 15.6 Hz), 3.26–2.64 (m, 3H), 1.93–1.68 (m, 1H), 1.57 (s, 6H), 1.56–1.44 (m, 4H), 1.25–0.95 (m, 2H).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>E</i>)-3-{4-[1-Methyl-1-(5-phenylamino-[1,3,4]oxadiazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile (<b>5a</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (101 mg, 0.362 mmol), EDCI (211 mg, 1.10 mmol), and 4-phenyl-3-thiosemicarbazide (65 mg, 0.39 mmol) were combined in methylene chloride (3.0 mL) and stirred overnight. The mixture was concentrated in vacuo, taken up in DMSO and purified by mass-directed HPLC (25–75% acetonitrile:water, TFA modifier). Following lyophilization, (<i>E</i>)-3-{4-[1-methyl-1-(5-phenylamino-[1,3,4]oxadiazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile trifluoroacetic acid salt (35 mg, 19%) was isolated as an off-white lyophilate. LCMS (ESI): 395 (M+H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 10.38 (s, 1H), 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.91 (d, 2H, <i>J</i> = 8.0 Hz), 7.66 (d, 2H, <i>J</i> = 8.0 Hz), 7.52 (d, 2H, <i>J</i> = 7.8 Hz), 7.32 (m, 2H), 6.98 (m, 1H), 6.92 (d, 1H, <i>J</i> = 15.6 Hz), 1.77 (s, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 163.7, 160.1, 151.9, 149.0, 138.6, 136.1, 129.0, 128.6, 127.5, 121.7, 116.8, 114.6, 112.3, 39.9, 26.9; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>O<sub>3</sub>S, 395.1178; found, 395.1179.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>E</i>)-3-{4-[1-(5-Ethylamino-[1,3,4]oxadiazol-2-yl)-1-methyl-ethyl]-benzenesulfonyl}-acrylonitrile (<b>5b</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (105 mg, 0.376 mmol), EDCI (241 mg, 1.26 mmol) and 4-ethyl-3-thiosemicarbazide (60.0 mg, 0.503 mmol) were combined in methylene chloride (3 mL) and stirred overnight. The mixture was concentrated in vacuo, taken up in DMSO and purified by mass-directed HPLC (25–75% acetonitrile:water, TFA modifier). Following lyophilization, (<i>E</i>)-3-{4-[1-(5-ethylamino-[1,3,4]oxadiazol-2-yl)-1-methyl-ethyl]-benzenesulfonyl}-acrylonitrile trifluoroacetic acid salt (19 mg, 11%) was isolated as a beige lyophilate. LCMS (ESI): 347 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>, 400 MHz) δ 7.94 (d, 2H, <i>J</i> = 8.1 Hz), 7.89 (d, 1H, <i>J</i> = 15.7 Hz), 7.66 (d, 2H, <i>J</i> = 8.1 Hz), 6.83 (d, 1H, <i>J</i> = 15.7 Hz), 6.53 (br s, 1H), 3.30 (q, 2H, <i>J</i> = 7.2 Hz), 1.76 (s, 6H), 1.20 (t, 3H, <i>J</i> = 7.2 Hz).</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>E</i>)-3-{4-[1-(5-Cyclohexyl-[1,3,4]oxadiazol-2-yl)-1-methyl-ethyl]-benzenesulfonyl}-acrylonitrile (<b>5c</b>)</h4><div class="NLM_p">(a) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (131 mg, 0.469 mmol), cyclohexanecarboxylic acid hydrazide (72.0 mg, 0.506 mmol), EDCI (119 mg, 0.621 mmol) and HOBt (7.0 mg, 0.052 mmol) were combined in acetonitrile (3.0 mL) and stirred at room temperature. After 4 h, the mixture was diluted with DMSO (0.4 mL), filtered and purified by mass-directed HPLC (25–85% acetonitrile:Water, TFA modifier) to afford Cyclohexanecarboxylic acid <i>N</i>′-{2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionyl}-hydrazide (108 mg, 57%) as a white lyophilate. LCMS (ESI): 404 (M+H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.52 (s, 1H), 9.39 (s, 1H), 8.24 (d, 1H, <i>J</i> = 15.6 Hz), 7.86 (d, 2H, <i>J</i> = 8.7 Hz), 7.73 (d, 2H, <i>J</i> = 8.7 Hz), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 2.15 (m, 1H), 1.6–1.7 (m, 5H), 1.50 (s, 6H), 1.1–1.4 (m, 5H); HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub>S, 426.1463; found, 426.1466.</div><div class="NLM_p last">(b) Cyclohexanecarboxylic acid <i>N</i>′-{2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionyl}-hydrazide (52 mg, 0.13 mmol) was dissolved in 1,4-dioxane (2.0 mL) and phosphoryl chloride (0.200 mL, 2.14 mmol) was added and the mixture was heated at 80 °C for 2h, then cooled on ice before being added to 5 g of ice. The mixture was diluted with satd. sodium bicarbonate (10 mL) and extracted with DCM (3 × 10 mL). The organic extracts were washed with 1:1 brine:satd. sodium bicarbonate (10 mL), dried over sodium sulfate, filtered and concentrated in vacuo to afford (E)-3-{4-[1-(5-Cyclohexyl-[1,3,4]oxadiazol-2-yl)-1-methyl–ethyl]-benzenesulfonyl}-acrylonitrile (38 mg, 76%) as a white foam. LCMS (ESI): 386 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.85 (d, 2H, <i>J</i> = 8.7 Hz), 7.51 (d, 2H, <i>J</i> = 8.7 Hz), 7.20 (d, 1H, <i>J</i> = 15.7 Hz), 6.55 (d, 1H, <i>J</i> = 15.7 Hz), 2.84 (tt, 1H, <i>J</i> = 3.7, 11.3 Hz), 2.03 (m, 2H), 1.84 (s, 6H), 1.79 (m, 2H), 1.71 (m, 2H), 1.24–1.40 (m, 4H).</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>E</i>)-3-{4-[1-Methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile (<b>5d</b>)</h4><div class="NLM_p">(a) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (0.262 g, 0.938 mmol), benzhydrazide (0.160 g, 1.17 mmol), EDCI (0.232 g, 1.21 mmol) and HOBt (0.019 g, 0.14 mmol) were dissolved in acetonitrile (6.0 mL) and the reaction mixture was allowed to stir at room temperature for 4h. The mixture was poured into ethyl acetate (60 mL), washed with 1 N HCl (20 mL) and brine (20 mL), dried over sodium sulfate, filtered and concentrated in vacuo. Benzoic acid <i>N</i>′-{2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionyl}-hydrazide was used in the next step without purification.</div><div class="NLM_p last">(b) Benzoic acid <i>N</i>′-{2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-2-methyl-propionyl}-hydrazide (324 mg, 0.815 mmol) was dissolved in 1,4-dioxane (12.0 mL) and phosphoryl chloride (0.50 mL, 5.36 mmol) was added and the mixture was heated at 90 °C for 2 h, then cooled to room temperature and diluted with ethyl acetate (50 mL). The mixture was washed with satd. NaHCO<sub>3</sub> (25 mL) and brine (10 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The residue was dissolved in DCM and applied to a silica gel cartridge (5 g) and purified (silica gel 24g, 0–50% ethyl acetate:hexanes) to afford a foam after concentration of product containing fractions. This foam was dissolved in acetonitrile and water, and then lyophilized to give (<i>E</i>)-3-{4-[1-methyl-1-(5-phenyl-[1,3,4]oxadiazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile as a white solid (223 mg, 72%). LCMS (ESI): <i>m</i>/<i>z</i> = 380 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.22 (d, 1H, <i>J</i> = 15.7 Hz), 7.97 (m, 2H), 7.90 (d, 2H, <i>J</i> = 8.7 Hz), 7.70 (d, 2H, <i>J</i> = 8.7 Hz), 7.55–7.65 (m, 3H), 6.91 (d, 1H, <i>J</i> = 15.7 Hz), 1.86 (s, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 170.5, 164.5, 151.6, 149.0, 136.2, 132.0, 129.4, 128.6, 127.5, 126.6, 123.3, 114.5, 112.3, 40.2, 27.1; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>S, 380.1069; found, 380.1073.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>E</i>)-3-{4-[1-Methyl-1-(5-methyl-benzoxazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile (<b>6a</b>)</h4><div class="NLM_p">(a) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (124 mg, 0.444 mmol), 2-amino-4-methyl-phenol (61.0 mg, 0.495 mmol) and HOBt (6.0 mg, 0.044 mmol) were combined in 1,2-dichloroethane (4.0 mL, 51 mmol), and EDCI (105 mg, 0.548 mmol) was added. Stir at room temperature in a vial for 2h, then the mixture was concentrated in vacuo, taken up in DMSO and purified by mass-directed HPLC to afford 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-hydroxy-5-methyl-phenyl)-isobutyramide as an oil.</div><div class="NLM_p last">(b) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-hydroxy-5-methyl-phenyl)-isobutyramide (42 mg, 0.11 mmol) was dissolved in acetic acid (2.0 mL, 35 mmol) and heated at 105 °C for 3d. The mixture was concentrated in vacuo, taken up in DMSO and purified by mass-directed HPLC (25–85% acetonitrile:water, TFA modifier) to afford (<i>E</i>)-3-{4-[1-methyl-1-(5-methyl-benzoxazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile trifluoroacetic acid salt (15 mg, 28%) as an off-white lyophilate. LCMS (ESI): 367 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.21 (d, 1H, <i>J</i> = 15.6 Hz), 7.88 (d, 2H, <i>J</i> = 8.4 Hz), 7.63 (d, 2H, <i>J</i> = 8.4 Hz), 7.56 (s, 1H), 7.52 (d, 1H, <i>J</i> = 8.3 Hz), 7.18 (d, 1H, <i>J</i> = 8.3 Hz), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 2.42 (s, 3H), 1.84 (s, 6H).</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>E</i>)-3-[4-(1-Benzoxazol-2-yl-1-methyl-ethyl)-benzenesulfonyl]-acrylonitrile (<b>6b</b>)</h4><div class="NLM_p">(a) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (0.336 g, 1.20 mmol), 2-aminophenol (0.234 g, 2.14 mmol), EDCI (0.298 g, 1.56 mmol) and HOBt (0.162 g, 1.20 mmol) were dissolved in acetonitrile (11.1 mL) and the reaction mixture was allowed to stir at room temperature for 20h. The mixture was poured into ethyl acetate (200 mL), washed with 1 N HCl (25 mL) and brine (50 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The residue was applied to a silica gel cartridge (24g) as a DCM solution and purified on silica gel (40g, 5–50% ethyl acetate:hexanes) to give 2-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-hydroxy-phenyl)-isobutyramide as an off-white solid (213 mg, 48%). LCMS (ESI): <i>m</i>/<i>z</i> = 371 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.70 (s, 1H), 8.32 (s, 1H), 8.24 (d, 1H, <i>J</i> = 15.7 Hz), 7.91 (d, 2H, <i>J</i> = 8.6 Hz), 7.77 (d, 2H, <i>J</i> = 8.6 Hz),7.70 (dd, 1H, <i>J</i> = 1.5, 8.0 Hz), 6.88–6.96 (m, 2H), 6.82 (dd, 1H, <i>J</i> = 1.5, 8.0 Hz), 6.75 (dd, 1H, <i>J</i> = 1.2 Hz, 7.5 Hz), 1.62 (s, 6H).</div><div class="NLM_p last">(b) 2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-(2-hydroxy-phenyl)-isobutyramide (99 mg, 0.27 mmol) and methanesulfonic acid (0.5 mL, 7.7 mmol) were heated in 1,4-dioxane (3.0 mL) in a vial at 90 °C for 24h. The mixture was cooled to room temperature, partitioned between ethyl acetate (60 mL) and satd. sodium bicarbonate (60 mL). After separation, the aqueous was extracted with ethyl acetate (30 mL), then the combined organics were washed with brine (50 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The residue was dissolved in DCM and applied to a silica gel cartridge (5 g) followed by purification by chromatography (silica gel 40g, 0–40% ethyl acetate:hexanes) to afford (<i>E</i>)-3-[4-(1-benzoxazol-2-yl-1-methyl–ethyl)-benzenesulfonyl]-acrylonitrile as a white solid (55% yield). LCMS (ESI): <i>m</i>/<i>z</i> = 353 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.22 (d, 1H, <i>J</i> = 15.6 Hz), 7.89 (d, 2H, <i>J</i> = 8.7 Hz), 7.78 (m, 1H), 7.66 (m, 3H), 7.38 (m, 2H), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 1.86 (s, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 170.2, 152.3, 150.4, 149.0, 140.4, 136.0, 128.5, 127.6, 125.2, 124.5, 119.8, 114.6, 112.2, 110.9, 41.9, 27.3.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>)-3-{4-[1-(1<i>H</i>-Benzimidazol-2-yl)-1-methyl-ethyl]-benzenesulfonyl}-acrylonitrile (<b>6c</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-2-methyl-propionic acid (112 mg, 0.401 mmol), 1,2-benzenediamine (51.0 mg, 0.472 mmol), EDCI (98 mg, 0.51 mmol) and HOBt (27 mg, 0.20 mmol) were combined in tetrahydrofuran (6.0 mL) and stirred at room temperature. After 1 h, methylene chloride (1.0 mL) was added to aid in solubility. After stirring overnight, acetic acid (0.65 mL, 11 mmol) was added and the mixture was heated to 70 °C until complete cyclization of the aniline-amide. The mixture was concentrated in vacuo, taken up in DMSO and purified by mass-directed HPLC to afford (<i>E</i>)-3-{4-[1-(1<i>H</i>-benzimidazol-2-yl)-1-methyl–ethyl]-benzenesulfonyl}-acrylonitrile trifluoroacetic acid salt (45 mg, 24%) as an off-white lyophilate. LCMS (ESI): 352 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.7 Hz), 7.90 (d, 2H, <i>J</i> = 8.2 Hz), 7.65 (m, 4H), 7.39 (br s, 2H), 6.91 (d, 1H, <i>J</i> = 15.7 Hz), 1.89 (s, 6H).</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>)-3-{4-[1-Methyl-1-(5-methyl-oxazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile (<b>7</b>)</h4><div class="NLM_p last">2-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-<i>N</i>-prop-2-ynyl-isobutyramide (53 mg, 0.17 mmol) and gold(III) chloride (5.0 mg, 0.016 mmol) were combined in acetonitrile-d<sub>3</sub> (1.0 mL), and the rate of isomerization was monitored by <sup>1</sup>H NMR. Once complete (4 days) the mixture was filtered and purified by mass-directed HPLC and lyophilized to afford an oil. After reconcentration from acetonitrile the residue remained an oil, which slowly turned purple. The mixture was redissolved in acetonitrile, treated with macroporous carbonate resin (3 mmol/g, 0.1 g) for 30 min and filtered to give a clear solution and purple solids which were captured on the filter. The filtrate was diluted with water and lyophilized to afford (<i>E</i>)-3-{4-[1-methyl-1-(5-methyl-oxazol-2-yl)-ethyl]-benzenesulfonyl}-acrylonitrile as an off-white wax (16 mg, 30%). LCMS (ESI): 317 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.22 (d, 1H, <i>J</i> = 15.6 Hz), 7.86 (d, 2H, <i>J</i> = 8.6 Hz), 7.54 (d, 2H, <i>J</i> = 8.6 Hz), 6.91 (d, 1H, <i>J</i> = 15.6 Hz), 6.79 (s, 1H), 2.22 (s, 3H), 1.71 (s, 6H).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic acid 4-fluoro-benzylamide (<b>10a</b>)</h4><div class="NLM_p">(a) To a solution of 1-(4-bromophenyl)cyclopropanecarboxylic acid (1.0 g, 4.15 mmol) in anhydrous THF (50 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly phenyl lithium (1.8 M in toluene, 2.77 mL, 4.98 mmol). After 5 min, to this mixture, <i>n</i>-BuLi (2.5 M in hexane, 2.2 mL, 5.4 mmol) was added. A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 10 min. The reaction mixture was then allowed to warm up to room temperature and the solvent was removed in vacuo. The sulfinate residue was dissolved in water (10 mL), acetic acid (5 mL), and MeOH (15 mL), followed by addition of 2-chloroacrylonitrile (0.54 g, 6.23 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed and the residue was diluted with 20 mL of water. The solution was adjusted to pH5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 30 mL) and dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (1.16 mL, 8.3 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine, then dried over MgSO<sub>4</sub>. The final product was purified by flash column chromatography (silica gel, dichloromethane/ethyl acetate, gradient) to give 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic acid (112 mg, 10%) as a white solid. LCMS (ESI): <i>m</i>/<i>z</i> = 232 (M-CO2H)-; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 12.59 (s, 1H), 8.24 (d, 1H, <i>J</i> = 16.6 Hz), 7.83 (d, 2H, <i>J</i> = 8.5 Hz), 7.66 (d, 2H, <i>J</i> = 8.5 Hz), 6.91 (d, 1H, <i>J</i> = 16.6 Hz), 1.51 (m, 2H), 1.22 (m, 2H).</div><div class="NLM_p last">(b) 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic acid (51 mg, 0.18 mmol), 4-fluoro-benzylamine (24.2 μL, 0.213 mmol), EDCI (42.3 mg, 0.221 mmol) and HOBt (29 mg, 0.21 mmol) were combined in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir at room temperature for 60 min. The reaction was diluted with 0.5 mL of DMSO, filtered and purified by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent to afford 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic acid 4-fluoro-benzylamide (49 mg; 69%) as a white foam. LCMS (ESI): <i>m</i>/<i>z</i> = 385 (M+H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.87 (m, 2H), 7.66 (m, 3H), 7.20 (m, 2H), 7.11 (m, 2H), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 4.18 (d, 2H, <i>J</i> = 6.0 Hz), 1.42 (dd, 2H, <i>J</i> = 4.2, 7.0 Hz), 1.08 (dd, 2H, <i>J</i> = 4.2, 7.0 Hz). LCMS = 385 (M + H); HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>18</sub>FN<sub>2</sub>O<sub>3</sub>S, 385.1022; found, 385.1024.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic Acid Cyclohexylamide (<b>10b</b>)</h4><div class="NLM_p last">1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic acid (37 mg, 0.13 mmol), cyclohexylamine (18 μL, 0.16 mmol), EDCI (32 mg, 0.17 mmol) and HOBt (23 mg, 0.17 mmol) were combined in acetonitrile (1.0 mL) and the reaction mixture was allowed to stir at room temperature for 60 min. The reaction was diluted with 0.3 mL of DMSO, filtered and purified by mass-directed HPLC using a gradient of 25–75% acetonitrile:water both containing 0.1% TFA as the eluting solvent to afford 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclopropanecarboxylic acid cyclohexylamide (26 mg; 54%) as a white foam. LCMS (ESI): <i>m</i>/<i>z</i> = 359 (M+H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.84 (m, 2H), 7.59 (m, 2H), 7.20 (d, 1H, <i>J</i> = 8.1 Hz), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 3.54 (m, 1H), 1.63 (m, 4H), 1.53 (m, 1H), 1.37 (dd, 2H, <i>J</i> = 4.4, 7.0 Hz), 1.05 (dd, 2H, <i>J</i> = 4.4, 7.0 Hz), 1.02 (m, 1H). LCMS = 359 (M + H); HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>S, 359.1429; found, 359.1423.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic Acid Phenylamide (<b>10c</b>)</h4><div class="NLM_p">(a) To a solution of 1-(4-bromophenyl)cyclobutanecarboxylic acid (5.1 g, 20 mmol) in anhydrous THF (150 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly phenyl lithium (1.8 M in toluene, 13.9 mL, 25 mmol). After 5 min, to this mixture, <i>n</i>-BuLi (2.5 M in hexane, 10.4 mL, 26 mmol) was added. A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 15 min. The reaction mixture was then allowed to warm up to room temperature and the solvent was removed in vacuo. The sulfinate residue was dissolved in water (30 mL), acetic acid (16 mL), and MeOH (40 mL), followed by addition of 2-chloroacrylonitrile (2.6 g, 30 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed and the residue was diluted with 20 mL of water. The solution was adjusted to pH5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 100 mL), dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (5.6 mL, 40 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine, dried over MgSO<sub>4</sub>. The final product was purified by flash column chromatography (silica gel, dichloromethane/ethyl acetate, gradient) to give 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid (1.52 g, 26%) as a white solid. LCMS (ESI): <i>m</i>/<i>z</i> = 246 (M-CO<sub>2</sub>H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 12.66 (s, 1H), 8.23 (d, 1H, <i>J</i> = 15.7 Hz), 7.88 (d, 2H, <i>J</i> = 8.5 Hz), 7.58 (d, 2H, <i>J</i> = 8.5 Hz), 6.91 (d, 1H, <i>J</i> = 15.7 Hz), 2.75 (m, 2H), 2.45 (m, 2H), 2.01 (m, 1H), 1.81 (m, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 175.5, 151.4, 149.1, 135.5, 128.2, 127.8, 114.6, 112.0, 52.0, 31.8, 16.1.</div><div class="NLM_p last">(b) 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid (58 mg, 0.20 mmol), HOBt (6 mg, 0.04 mmol), EDCI (51 mg, 0.27 mmol) and aniline (21 μL, 0.23 mmol) in acetonitrile (0.5 mL) were stirred in a vial at room temperature for 1h. The mixture was diluted with DMSO (0.2 mL), filtered and purified by mass-directed HPLC to afford 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid phenylamide (34 mg; 47%). LCMS (ESI): <i>m</i>/<i>z</i> = 367 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.55 (s, 1H), 8.20 (d, 1H, <i>J</i> = 15.6 Hz), 7.91 (d, 2H, <i>J</i> = 8.6 Hz), 7.77 (d, 2H, <i>J</i> = 8.7 Hz), 7.58 (m, 2H), 7.27 (m, 2H), 7.02 (m, 1H), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 2.90 (M, 2H), 2.53 (m, 2H), 1.86 (m, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 172.6, 151.6, 149.1, 139.0, 135.5, 128.5, 128.3, 127.6, 123.5, 119.9, 114.6, 112.0, 54.1, 32.2, 15.7.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic Acid 4-Chloro-benzylamide (<b>10d</b>)</h4><div class="NLM_p last">1-[4-((E)-2-Cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid (62 mg, 0.21 mmol), HOBt (6 mg, 0.04 mmol), EDCI (52 mg, 0.27 mmol) and <i>p</i>-chlorobenzylamine (31 μL, 0.25 mmol) in acetonitrile (1.0 mL) were stirred in a vial at room temperature for 4h. The mixture was concentrated in vacuo, diluted with DMSO (0.6 mL), filtered and purified by mass-directed HPLC to afford 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid 4-chloro-benzylamide (44 mg; 50%). LCMS (ESI): <i>m</i>/<i>z</i> = 367 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.37 (t, 1H, <i>J</i> = 6.0 Hz), 8.25 (d, 1H, <i>J</i> = 15.8 Hz), 7.89 (d, 2H, <i>J</i> = 8.5 Hz), 7.64 (d, 2H, <i>J</i> = 8.5 Hz), 7.28 (d, 2H, <i>J</i> = 8.5 Hz), 7.06 (d, 2H, <i>J</i> = 8.5 Hz), 6.92 (d, 1H, <i>J</i> = 15.8 Hz), 4.19 (d, 2H, <i>J</i> = 6.0 Hz), 2.78 (M, 2H), 2.43 (m, 2H), 1.84 (m, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 173.8, 152.2, 149.2, 138.7, 135.4, 131.1, 128.5, 128.13, 128.08, 127.5, 114.6, 112.0, 53.3, 41.7, 32.1, 16.0.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic Acid Cyclohexylamide (<b>10e</b>)</h4><div class="NLM_p last">1-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid (58 mg, 0.20 mmol), HOBt (6 mg, 0.04 mmol), EDCI (51 mg, 0.27 mmol) and cyclohexylamine (26 μL, 0.23 mmol) in acetonitrile (1.0 mL) were stirred in a vial at room temperature. After 5h, the mixture was poured into ethyl acetate, washed with 1 N HCl, brine, dried over sodium sulfate, filtered and conc. The residue was purified to afford 1-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-cyclobutanecarboxylic acid cyclohexylamide (32 mg; 43%). LCMS (ESI): <i>m</i>/<i>z</i> = 373 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.86 (d, 2H, <i>J</i> = 8.5 Hz), 7.64 (d, 2H, <i>J</i> = 8.5 Hz), 7.51 (d, 1H, <i>J</i> = 8.0 Hz), 6.90 (d, 1H, <i>J</i> = 15.6 Hz), 3.46 (m, 1H), 2.74 (M, 2H), 2.35 (m, 2H), 1.78 (m, 2H), 1.57 (m, 5H), 1.0–1.2 (m, 5H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 172.8, 152.6, 149.2, 135.1, 128.0, 127.4, 114.6, 111.9, 53.2, 48.1, 32.3, 32.1, 25.2, 24.8, 15.8.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic Acid Phenylamide (<b>10f</b>)</h4><div class="NLM_p">(a) To a solution of 1-(4-bromophenyl)tetrahydro-2<i>H</i>-pyran-4-carboxylic acid (2.85 g, 10 mmol) in anhydrous THF (100 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly phenyl lithium (1.8 M in toluene, 7 mL, 12.5 mmol). After 5 min, to this mixture, <i>n</i>-BuLi (2.5 M in hexane, 5.2 mL, 13 mmol) was added. A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 15 min. The reaction mixture was then allowed to warm up to room temperature and the solvent was removed in vacuo. The sulfinate residue was dissolved in water (15 mL), acetic acid (8 mL), and MeOH (20 mL), followed by addition of 2-chloroacrylonitrile (1.3 g, 15 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed and the residue was diluted with 20 mL of water. The solution was adjusted to pH5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 50 mL), dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (2.8 mL, 20 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine, dried over MgSO<sub>4</sub>. The final product was purified by flash column chromatography (silica gel, dichloromethane/ethyl acetate, gradient) to give 4-[4-((E)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid (0.87 g, 27%) as a white solid. LCMS (ESI): <i>m</i>/<i>z</i> = 276 (M-CO2H)+; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 13.00 (s, 1H), 8.23 (d, 1H, <i>J</i> = 15.7 Hz), 7.91 (d, 2H, <i>J</i> = 8.7 Hz), 7.74 (d, 2H, <i>J</i> = 8.7 Hz), 6.92 (d, 1H, <i>J</i> = 15.7 Hz), 3.82 (m, 2H), 3.48 (m, 2H), 2.40 (m, 2H), 1.88 (m, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 174.3, 150.2, 149.0, 136.1, 128.4, 127.6, 114.6, 112.2, 64.6, 48.5, 33.7.</div><div class="NLM_p last">(b) 4-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid (67 mg, 0.21 mmol), aniline (29 μL, 0.32 mmol), HOBt (7.0 mg, 0.052 mmol) and EDCI (50.0 mg, 0.261 mmol) were combiend in acetonitrile (3.0 mL) and stirred at room temperature. After 24 h, the mixture was concentrated in vacuo, dissolved in DMSO and purified by mass-directed HPLC (25–75% acetonitrile:water, 0.1% TFA) to give 4-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid phenylamide (23 mg, 28%). LCMS (ESI): <i>m</i>/<i>z</i> = 397 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.38 (s, 1H), 8.22 (d, 1H, <i>J</i> = 15.7 Hz), 7.93 (d, 2H, <i>J</i> = 8.7 Hz), 7.76 (d, 2H, <i>J</i> = 8.7 Hz), 7.54 (m, 2H), 7.28 (m, 2H), 7.06 (m, 1H), 6.91 (d, 1H, <i>J</i> = 15.7 Hz), 3.81 (m, 2H), 3.55 (m, 2H), 2.60 (m, 2H), 2.00 (m, 2H).</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic Acid 4-Chloro-benzylamide (<b>10g</b>)</h4><div class="NLM_p last">4-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid (72 mg, 0.22 mmol), <i>p</i>-chlorobenzylamine (45 μL, 0.37 mmol), HOBt (9.0 mg, 0.067 mmol) and EDCI (57 mg, 0.30 mmol) were combined in acetonitrile (6.0 mL, 110 mmol) and stirred at room temperature. After 2h, the mixture was concentrated in vacuo, dissolved in DMSO and purified by mass-directed HPLC (25–75% acetonitrile:water, 0.1% TFA) to give 4-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid 4-chloro-benzylamide (32 mg 32%). LCMS (ESI): <i>m</i>/<i>z</i> = 445 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.36 (t, 1H, <i>J</i> = 5.9 Hz), 8.26 (d, 1H, <i>J</i> = 15.6 Hz), 7.90 (d, 2H, <i>J</i> = 8.6 Hz), 7.69 (d, 2H, <i>J</i> = 8.6 Hz), 7.27 (d, 2H, <i>J</i> = 8.4 Hz), 7.03 (d, 2H, <i>J</i> = 8.4 Hz), 6.93 (d, 1H, <i>J</i> = 15.6 Hz), 4.21 (d, 2H, <i>J</i> = 5.9 Hz), 3.76 (m, 2H), 3.46 (m, 2H), 2.52 (m, 2H), 1.90 (m, 2H); HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub>S, 445.0989; found, 445.0996.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic Acid Cyclohexylamide (<b>10h</b>)</h4><div class="NLM_p last">4-[4-((<i>E</i>)-2-Cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid (61 mg, 0.19 mmol), cyclohexylamine (33 μL, 0.29 mmol), HOBt (25.6 mg, 0.190 mmol) and EDCI (46 mg, 0.24 mmol) were combined in acetonitrile (6.0 mL) and stirred at room temperature. After 4 h, the mixture was concentrated in vacuo, dissolved in DMSO and purified by mass-directed HPLC (25–75% acetonitrile:water, 0.1% TFA) to give 4-[4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenyl]-tetrahydro-pyran-4-carboxylic acid cyclohexylamide (39 mg, 51%). LCMS (ESI): <i>m</i>/<i>z</i> = 403 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.87 (d, 2H, <i>J</i> = 8.6 Hz), 7.66 (d, 2H, <i>J</i> = 8.6 Hz), 7.45 (d, 1H, 8.0 Hz), 6.91 (d, 1H, <i>J</i> = 15.7 Hz), 3.77 (m, 2H), 3.56 (m, 1H), 3.44 (m, 2H), 1.83 (m, 2H), 1.62 (m, 6H), 1.12 (m, 6H); <sup>13</sup>C NMR: (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 170.6, 152.0, 149.1, 135.6, 128.2, 127.3, 114.6, 112.1, 64.5, 48.5, 48.3, 34.0, 32.0, 25.2, 24.8;HRMS-TOF-MS-ES+ (<i><b>m/z</b></i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>4</sub>S, 403.1692; found, 403.1695.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> [2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-acetic Acid (<b>12</b>)</h4><div class="NLM_p last">To a solution of 2-(4-bromo-2-<i>tert</i>-butylphenoxy)acetic acid (2.86 g, 10 mmol) in anhydrous THF (100 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly phenyl lithium (1.8 M in toluene, 7 mL, 12.5 mmol). After 5 min, to this mixture, <i>n</i>-BuLi (2.5 M in hexane, 5.2 mL, 13 mmol) was added. A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 15 min. The reaction mixture was then allowed to warm up to room temperature and the solvent was removed in vacuo. The sulfinate residue was dissolved in water (15 mL), acetic acid (8 mL), and MeOH (20 mL), followed by addition of 2-chloroacrylonitrile (1.3 g, 15 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed and the residue was diluted with 20 mL of water. The solution was adjusted to pH5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 50 mL) and dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (2.8 mL, 20 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine, then dried over MgSO<sub>4</sub>. The final product was purified by flash column chromatography (silica gel, dichloromethane/ethyl acetate, gradient) to give [2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-acetic acid (1.03 g, 32%) as a white solid. LCMS (ESI): <i>m</i>/<i>z</i> = 322 (M-H)-; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 13.19 (s, 1H), 8.22 (d, 1H, <i>J</i> = 16.6 Hz), 7.74 (dd, 1H, <i>J</i> = 2.3, 8.7 Hz), 7.68 (d, 1H, <i>J</i> = 2.3 Hz), 7.18 (d, 1H, <i>J</i> = 8.7 Hz), 6.84 (d, 1H, <i>J</i> = 16.6 Hz), 4.90 (s, 2H), 1.40 (s, 9H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 169.3, 161.4, 149.8, 139.0, 128.6, 128.5, 126.4, 114.7, 113.3, 110.7, 64.9, 34.9, 29.0.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-cyclohexyl-acetamide (<b>13a</b>)</h4><div class="NLM_p last">[2-<i>tert</i>-Butyl-4-((E)-2-cyano-ethenesulfonyl)-phenoxy]-acetic acid (57 mg, 0.18 mmol), EDCI (41.0 mg, 0.214 mmol), HOBt (5.1 mg, 0.038 mmol) and cyclohexylamine (25 μL, 0.22 mmol) in acetonitrile (0.70 mL) was stirred at room temperature for 5h, then was filtered, rinsing the vial with DMSO (0.3 mL) and the filtrate was purified by mass-directed HPLC (25–95% acetonitrile:water, both containing 0.1% TFA) to afford 2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-cyclohexyl-acetamide (27 mg; 38%) as an off white lyophilate. LCMS (ESI): <i>m</i>/<i>z</i> = 405 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.22 (d, 1H, <i>J</i> = 15.6 Hz), 7.94 (d, 1H, <i>J</i> = 7.8 Hz), 7.74 (dd, 1H, <i>J</i> = 2.4, 7.8 Hz), 7.67 (d, 1H, <i>J</i> = 2.4 Hz), 4.67 (s, 2H), 3.60 (m, 1H), 1.6–1.8 (m, 4H), 1.55 (m, 1H), 1.38 (s, 9H), 1.1–1.3 (m, 5H).</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(3-methoxy-phenyl)-acetamide (<b>13b</b>)</h4><div class="NLM_p last">[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-acetic acid (81 mg, 0.25 mmol), EDCI (58.3 mg, 0.304 mmol), HOBt (22 mg, 0.16 mmol) and 3-methoxyaniline (35 μL, 0.31 mmol) in acetonitrile (1.0 mL) was stirred at room temperature for 5 h, then was filtered, rinsing the vial with DMSO (0.3 mL) and the filtrate was purified by preparative HPLC (25–95% acetonitrile:water, both containing 0.1% TFA) to afford 2-[2-<i>tert</i>-butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(3-methoxy-phenyl)-acetamide (41 mg; 38%) as a white lyophilate. LCMS (ESI): 429 (M+H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>,): δ 10.26 (s, 1H), 8.22 (d, 1H, <i>J</i> = 15.6 Hz), 7.77 (dd, 1H, <i>J</i> = 2.4, 8.6 Hz), 7.69 (d, 1H, <i>J</i> = 2.4 Hz), 7.30 (m, 1H), 7.23 (m, 1H), 7.17 (d, 1H, <i>J</i> = 8.8 Hz), 7.12 (m, 1H), 6.84 (d, 1H, <i>J</i> = 15.6 Hz), 6.67 (dd, 1H, <i>J</i> = 2.5, 8.2 Hz), 4.95 (s, 2H), 3.73 (s, 3H), 1.42 (s, 9H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 165.3, 161.8, 159.6, 149.8, 139.6, 139.0, 129.7, 128.7, 128.5, 126.4, 114.8, 113.3, 111.4, 110.7, 109.1, 104.9, 67.1, 55.0, 35.0, 29.1; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub>S, 429.1484; found, 429.1491.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(4-fluoro-benzyl)-acetamide (<b>13c</b>)</h4><div class="NLM_p last">[2-<i>tert</i>-Butyl-4-((E)-2-cyano-ethenesulfonyl)-phenoxy]-acetic acid (104 mg, 0.322 mmol), EDCI (77 mg, 0.40 mmol), HOBt (51 mg, 0.38 mmol) and 4-fluoro-benzylamine (45 μL, 0.40 mmol) in acetonitrile (2.0 mL) was stirred at room temperature for 1h, then was added to a silica gel preload cartridge (5 g) and chromatographed (silica gel 12g, 0–20% ethyl acetate:hexanes). Some acetonitrile eluted with product as well as some HOBt. The fraction containing product was concentrated, diluted with acetonitrile and DCM (3 mL each) and treated with macroporous carbonate resin for 1h. After filtration and concentration, the residue was dissolved in acetonitrile, diluted with water and then lyophilized to afford 2-[2-<i>tert</i>-butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(4-fluoro-benzyl)-acetamide (64 mg; 46%) as an off-white lyophilate. LCMS (ESI): 431 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>,): δ 8.63 (t, 1H, <i>J</i> = 5.9 Hz), 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.74 (dd, 1H, <i>J</i> = 2.4, 8.7 Hz), 7.68 (d, 1H, <i>J</i> = 2.4 Hz), 7.32 (m, 2H), 7.1–7.2 (m, 3H), 6.84 (d, 1H, <i>J</i> = 15.6 Hz), 4.79 (s, 2H), 4.33 (d, 2H, <i>J</i> = 5.9 Hz), 1.38 (s, 9H).</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(2-hydroxy-5-methyl-phenyl)-acetamide (<b>13d</b>)</h4><div class="NLM_p last">[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-acetic acid (186 mg, 0.575 mmol), EDCI (138 mg, 0.719 mmol), HOBt (85.5 mg, 0.633 mmol), and 2-amino-4-methyl-phenol (0.142 g, 1.15 mmol) were combined in acetonitrile (6.0 mL) and stirred in a vial for 3h. The mixture was then added to ethyl acetate (100 mL) and washed with 1 N HCl (15 mL) and brine (20 mL). The organics were dried over sodium sulfate, diluted with hexane (20 mL) and filtered through 4 mL silica gel (hexane bed), rinsing with 60 mL 1:1 ethyl acetate:hexane. The filtrate was concentrated in vacuo, dissolved in DCM and applied to a silica gel cartridge (5 g) and purified (silica gel 24g, 0–50%ethyl acetate:hexanes) to afford 2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(2-hydroxy-5-methyl-phenyl)-acetamide (0.195 g; 79%). LCMS (ESI): <i>m</i>/<i>z</i> = 429 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 9.80 (s, 1H), 9.18 (s, 1H), 8.23 (d, 1H, <i>J</i> = 15.6 Hz), 7.89 (s, 1H), 7.77 (dd, 1H, <i>J</i> = 2.4, 8.7 Hz), 7.71 (d, 1H, <i>J</i> = 2.4 Hz), 7.25 (d, 1H, <i>J</i> = 8.7 Hz), 6.84 (d, 1H, <i>J</i> = 15.6 Hz), 6.75 (m, 2H), 5.00 (s, 2H), 2.19 (s, 3H), 1.44 (s, 9H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 165.2, 161.3, 149.7, 144.5, 139.0, 128.8, 128.7, 127.6, 126.5, 125.5, 124.7, 121.1, 114.7, 114.7, 113.7, 110.8, 67.5, 34.9, 29.2, 20.5; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>25</sub>N<sub>2</sub>O<sub>5</sub>S, 429.1484; found, 429.1490.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>E</i>)-3-[3-<i>tert</i>-Butyl-4-(5-methyl-benzoxazol-2-ylmethoxy)-benzenesulfonyl]-acrylonitrile (<b>14</b>)</h4><div class="NLM_p last">2-[2-<i>tert</i>-Butyl-4-((<i>E</i>)-2-cyano-ethenesulfonyl)-phenoxy]-<i>N</i>-(2-hydroxy-5-methyl-phenyl)-acetamide (0.178 g, 0.415 mmol) was heated in 1,4-dioxane (6.0 mL) with methanesulfonic acid (1.0 mL, 15 mmol) at 90 °C for 8h. The mixture was cooled to room temperature, stirred for 48 h, then was treated with additional methanesulfonic acid (1 mL) and heated for 3h at 90 °C. The mixture was cooled and added into ethyl acetate (80 mL) and satd. NaHCO<sub>3</sub> (40 mL). The layers were separated and the organics washed with brine (20 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The residue was dissolved in DCM, applied to a silica gel cartridge (5 g) and purified (silica gel 40g, 0–40% ethyl acetate:hexanes) to afford (<i>E</i>)-3-[3-<i>tert</i>-butyl-4-(5-methyl-benzoxazol-2-ylmethoxy)-benzenesulfonyl]-acrylonitrile (86 mg; 50%). LCMS (ESI): <i>m</i>/<i>z</i> = 411 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.23 (d, 1H, <i>J</i> = 15.7 Hz), 7.80 (dd, 1H, <i>J</i> = 2.4, 8.7 Hz), 7.72 (d, 1H, <i>J</i> = 2.4 Hz), 7.64 (d, 1H, <i>J</i> = 8.4 Hz), 7.61 (m, 1H), 7.46 (d, 1H, <i>J</i> = 8.7 Hz), 7.26 (dd, 1H, <i>J</i> = 1.2, 8.4 Hz), 6.85 (d, 1H, <i>J</i> = 15.7 Hz), 5.67 (s, 2H), 2.43 (s, 3H), 1.39 (s, 9H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 161.2, 161.0, 149.7, 148.6, 140.5, 139.2, 134.3, 129.1, 128.7, 126.8, 126.5, 119.9, 114.7, 113.9, 110.9, 110.5, 62.8, 34.9, 29.0, 20.9; HRMS-TOF-MS-ES+ (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>S, 411.1379; found, 411.1382.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>E</i>)-3-(3-<i>tert</i>-Butyl-benzenesulfonyl)-acrylonitrile (<b>13e</b>)</h4><div class="NLM_p last">To a solution of 3-<i>tert</i>-butyl-bromobenzene (2.13 g, 10 mmol) in anhydrous THF (50 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly <i>n</i>-BuLi (2.5 M in hexane, 11 mmol). A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 15 min. The reaction mixture was then allowed to warm up to room temperature and the solvent was removed under reduced pressure. The sulfinate residue was dissolved in water (15 mL), acetic acid (8 mL), and MeOH (20 mL), followed by addition of 2-chloroacrylonitrile (18 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed in vacuo and the residue was diluted with 20 mL of water. The solution was adjusted to pH5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 50 mL), dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (20 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine then dried over MgSO<sub>4</sub>. The crude product was purified by flash column chromatography (silica gel, dichloromethane/ethyl acetate, gradient) to give (<i>E</i>)-3-(3-<i>tert</i>-butyl-benzenesulfonyl)-acrylonitrile (0.76 g, 31%) as a white solid. LCMS (ESI): 250 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.89 (s, 1H), 7.76 (d, 1H, <i>J</i> = 7.7 Hz), 7.70 (d, 1H, <i>J</i> = 7.9 Hz), 7.55 (m, 1H), 7.23 (d, 1H, <i>J</i> = 15.9 Hz), 6.55 (d, 1H, <i>J</i> = 15.9 Hz), 1.37 (s, 9H).</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>E</i>)-3-(2-<i>tert</i>-Butyl-quinoline-6-sulfonyl)-acrylonitrile (<b>17</b>)</h4><div class="NLM_p">(a)Potassium hydroxide (0.322 g, 5.74 mmol) and water (1.3 mL) were added to a mixture of 2-amino-5-bromo-benzaldehyde (0.933 g, 4.66 mmol) and 3,3-dimethyl-2-butanone (0.700 mL, 5.60 mmol) at room temperature. After 5 min, the mixture was heated at reflux for 3h. The mixture was diluted with water (40 mL) then extracted with DCM (40 mL, 2 × 20 mL). The organic extract was washed with brine (20 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The residue was purified (DCM load onto 24 g loading cartridge, then silica gel 40g, 0–20% ethyl acetate:hexanes) to afford 6-Bromo-2-<i>tert</i>-butyl-quinoline (0.97 g; 64%) as a yellow oil with small crystals forming.</div><div class="NLM_p last">(b)To a solution of 6-bromo-2-<i>tert</i>-butylquinoline (1 g, 3.8 mmol) in anhydrous THF (50 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly <i>n</i>-BuLi (2.5 M in hexane, 2 mL, 4.94 mmol). A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 15 min. The reaction mixture was then allowed to warm up to room temperature, the solvent was removed under reduced pressure. The sulfinate residue was dissolved in water (10 mL), acetic acid (5 mL), and MeOH (15 mL), followed by addition of 2-chloroacrylonitrile (0.54 g, 6.23 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed and the residue was diluted with 20 mL of water. The solution was adjusted to pH 5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 50 mL) and dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (1.16 mL, 8.3 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine, then dried over MgSO<sub>4</sub>. The final product was purified by flash column chromatography (silica gel, dichloromethane/ethyl acetate, gradient) to give (<i>E</i>)-3-(2-<i>tert</i>-butyl-quinoline-6-sulfonyl)-acrylonitrile (0.68 g, 59%) as a white solid. LCMS (ESI): <i>m</i>/<i>z</i> = 301 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.68 (d, 1H, <i>J</i> = 2.1 Hz), 8.61 (d, 1H, <i>J</i> = 8.8 Hz), 8.30 (d, 1H, <i>J</i> = 15.7 Hz), 8.21 (d, 1H, <i>J</i> = 8.9 H), 8.07 (dd, 1H, <i>J</i> = 2.2, 8.9 Hz), 7.92 (d, 1H, <i>J</i> = 8.8 Hz), 6.96 (d, 1H, <i>J</i> = 15.7 Hz), 1.43 (s, 9H).</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-[5-((<i>E</i>)-2-Cyano-ethenesulfonyl)-pyridin-2-yl]-<i>N</i>-cyclohexyl-isobutyramide (<b>18</b>)</h4><div class="NLM_p">(a) To a suspension of 2-(5-bromopyridin-2-yl)-2-methylpropanoic acid (1.22 g, 5 mmol) 25 in 25 mL of DMF was added triethylamine (2.1 mL, 15 mmol) and cyclohexylamine (0.86 mL, 7.5 mmol) and followed by propylphosphonic anhydride (50% solution in DMF) (8.9 mL, 15 mmol) at room temperature under nitrogen. The resulting mixture was stirred at room temperature for 2h. The mixture was concentrated in vacuo, dissolved in DCM (100 mL) and brine (50 mL), separated and the organic phase was concentrated in vacuo. The crude product was purified by flash column chromatography (silica gel, dichloromethane/acetone, gradient) to give 2-(5-bromo-pyridin-2-yl)-<i>N</i>-cyclohexylisobutyramide (0.83 g, 51%) as a white solid.</div><div class="NLM_p last">(b) To a solution of 2-(5-Bromo-pyridin-2-yl)-<i>N</i>-cyclohexyl-isobutyramide (0.8 g, 3.3 mmol) in anhydrous THF (1 00 mL) under nitrogen at −80 °C (ether/dry ice), was added slowly phenyl lithium in toluene 1.8 M (2.3 mL, 4.1 mmol). After 5 min, to this mixture, <i>n</i>-BuLi (2.5 min hexane) (1.7 mL, 4.3 mmol) was added. A cloudy suspension was slowly formed. Twenty minutes after BuLi addition, a stream of sulfur dioxide was bubbled through the mixture for 10 min. The reaction mixture was then allowed to warm up to room temperature and the solvent was removed in vacuo. The sulfinate residue was dissolved in water (10 mL), acetic acid (5 mL), and MeOH (15 mL), followed by addition of 2-chloroacrylonitrile (0.43 g, 5.0 mmol). The resulting mixture was stirred at room temperature overnight. The organic solvents were removed and the residue was diluted with 20 mL of water. The solution was adjusted to pH5–6 with satd K<sub>2</sub>HPO<sub>4</sub> aq solution, then extracted with dichloromethane (2 × 30 mL) and dried over MgSO<sub>4</sub>. After filtration, the filtrate was stirred with triethylamine (0.92 mL, 6.6 mmol) for 1 h. The solution was washed with 10% aq citric acid and brine, then dried over MgSO<sub>4</sub>. The final product was purified by flash column chromatography (silica gel, dichloromethane/Ethyl acetate, gradient) to give 2-[5-((<i>E</i>)-2-cyano-ethenesulfonyl)-pyridin-2-yl]-<i>N</i>-cyclohexylisobutyramide (182 mg, 15%) as a white solid. LCMS (ESI): <i>m</i>/<i>z</i> = 362 (M + H)<sup>+</sup>; <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 8.97 (dd, 1H, <i>J</i> = 0.6, 2.4 Hz), 8.28 (d, 1H, <i>J</i> = 15.7 Hz), 8.24 (dd, 1H, <i>J</i> = 2.4, 8.5 Hz), 7.62 (dd, 1H, <i>J</i> = 0.6, 8.5 Hz), 7.22 (d, 1H, <i>J</i> = 8.0 Hz), 6.97(d, 1H, <i>J</i> = 15.7 Hz), 3.55 (m, 1H), 1.66 (m, 4H), 1.53 (m, 1H), 1.49 (s, 6H), 1.0–1.2 (m, 5H).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Reagents for Biological Studies</h3><div class="NLM_p last"><span class="smallcaps smallerCapital">d</span>-Luciferin was purchased from Xenogen. Ketamine and xylazine HCl were purchased from the University of Utah Pharmacy. Steady-Glo Luciferase Assay kit was purchased from Promega. Buthionine-sulfoximine and N-acetylcysteine were purchased from Sigma. A glutathione assay kit (Trevigen) was used per the manufacturer’s instructions to evaluate the concentration of GSH in the cancer cell lysates with or without <b>1</b> or its analogues.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Cell Cultures and Transduction</h3><div class="NLM_p last">BxPC-3 and SU.86 pancreatic cancer cell lines were maintained in the Kuwada lab as previously described.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> SKOV3 and A2780 ovarian cancer cell lines were purchased from American Type Culture Collection. SKOV3 cells were cultured in McCoy’s 5A and A2780 cells in DMEM, both supplemented with 10% fetal bovine serum, glutamine, penicillin and streptomycin. All cells were cultured at 37 °C in a humidified incubator in a 5% CO2 atm. The cancer cell lines were transduced with a retrovirus containing pLuc-puro, a constitutive luciferase reporter (a kind gift from Dr. Stephen Lessnick, University of Utah) and selected in G418-containing media. These cells were used in all in vitro and in vivo assays. MiaPaCa-2 cells were transduced with a red fluorescent protein construct as previously described.<sup>38</sup></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Coculture Assay</h3><div class="NLM_p">An in vitro model of peritoneal tumor implantation was utilized in which pancreatic or ovarian cancer cells in suspension were allowed to adhere to confluent monolayers of mesothelial cells. Briefly, the vehicle or analogues were added to the cancer cell suspensions and then the mixture were overlaid on the mesothelial cell monolayers. After a 4 h coculture, the apoptotic cancer cells unable to adhere to the mesothelial cells were washed away from the wells, only the adherent and surviving cells were detected by bioluminescence in the presence of substrate (D-luciferin). The luminescence of cancer cells correlates with the number of surviving and adherent cancer cells present.</div><div class="NLM_p last">The effect of buthionine sulfoximine (BSO) on cancer cell viability was tested using the coculture model. HT29 cells were pretreated with H<sub>2</sub>O or various concentrations of BSO for 24 h, or, with <i>N</i>-acetylcysteine (NAC) (680 μM) for 30 min. The cancer cells were transiently suspended with trypsin then overlaid onto confluent monolayers of human mesothelial cells in 96-well plates in the presence of <b>1</b> and BSO or NAC for 5 h. The remainder of the coculture procedure was performed as described above.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Statistical Analysis</h3><div class="NLM_p last">Values are expressed as the mean ± standard error of the mean (SEM). The significance of the difference between the control and each experimental test condition was analyzed by unpaired Student’s <i>t</i> test and a value of <i>p</i> < 0.05 was considered statistically significant.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Luciferase Expressing Murine Peritoneal Carcinomatosis Model</h3><div class="NLM_p last">The animal studies were approved by and performed in accordance with the University of Hawai’i Institutional Animal Care and Use Committee. Athymic 5-week-old female <i>nu</i>/<i>nu</i> mice were randomized to intraperitoneal (IP) treatment with either <b>1</b> (5 mg/kg), test compounds (5 mg/kg) or an equal volume of vehicle (80% polyethylene glycol 400:20% ethanol) 4 h prior to IP injection of 1.5–2 × 10<sup>6</sup> suspended A2780 or SKOV3 cells. Cell viability was assessed prior to injection. The mice continued to receive vehicle or test compound (5 mg/kg) IP three times a week for 14 days total. A mixture of <span class="smallcaps smallerCapital">d</span>-luciferin (1.0 mg/20 mg mouse), ketamine HCl (2.0 mg/20 mg mouse) and xylazine HCl (0.20 mg/20 mg mouse) in PBS (pH 7.4) was injected IP just prior to bioluminescent imaging in order to anesthetize the mice and provide substrate for the luciferase expressing cancer cells. The peritoneal tumor implants were imaged with a Xenogen bioluminescent imaging system.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Red Fluorescent Protein Stably Expressing MIA PaCa-2 Cell Line in Vivo Model</h3><div class="NLM_p">All animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Utah Health Sciences Center. A total of 180 male nude mice (NCr-Nu/Nu aged 6 to 8 wk old; National Cancer Institute, Frederick, MD) were used in this experiment and maintained in a barrier facility on HEPA-filtered racks. Animals were individually identified using numbered ear tags. All experiments were conducted in a biological laminar flow hood, and all surgical procedures were conducted with strict adherence to aseptic technique.</div><div class="NLM_p last">The mice were anesthetized in an isoflurane chamber and anesthetic was continued on the operating table using a nose cone. The mice were prepped with 10% povidone-iodine on the left flank and draped in a sterile fashion. Using the Universal S3B operating microscope (Carl Zeiss, Inc., Thornwood, NY) for visualization, a small (1 cm) left subcostal incision was made, and the tail of the pancreas exteriorized gently. Then 1 × 10<sup>6</sup> pancreatic cancer cells were suspended in 0.125 mL of Extracel (Advanced BioMatrix) and loaded in a 1 mL syringe. Using a 25 gauge needle, the cells/sECM (soluble extracellular matrix) solution was injected into the tail of the pancreas. All mice were injected with MiaPaCa-2/RFP cells. Once hemostasis was confirmed, the tail of the pancreas was returned into the abdomen and the wound was closed as a single layer using interrupted 5–0 silk sutures (US Surgical, Norwalk, CT). The mice were reanesthetized at 5 weeks after injection and underwent resection surgery. Resection involved midline laparotomy with mobilization of the tumor, ligation of the mid body of the pancreas proximal to the tumor using 4–0 silk suture and pancreatic transection distal to the ligature. Intraoperative RFP imaging was performed to verify that the mice had no evidence of disease after their resection, and single layer closure performed. Necropsy was performed 8 wk following pancreatic resection or sham surgery. RFP imaging was used to identify locally recurrent and metastatic disease. Any mouse exhibiting ascites, cachexia, lethargy, or failure to thrive underwent necropsy at an earlier time point. At necropsy, laparotomy and sternotomy were performed to identify recurrent and metastatic disease. All organ sites of local recurrence and metastases were recorded.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm501437v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Craig A. Zificsak</span> - <span class="hlFld-Affiliation affiliation">Teva
Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#395a4b58505e1743505f505a4a5852794d5c4f584951584b54175a5654"><span class="__cf_email__" data-cfemail="442736252d236a3e2d222d2737252f0430213225342c2536296a272b29">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott K. Kuwada</span> - <span class="hlFld-Affiliation affiliation">John
A. Burns School of Medicine, University
of Hawaii, 651 Ilalo
Street, Honolulu, Hawaii 96813, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dba8b0b0aeacbabfba9bb3baacbab2b2f5bebfae"><span class="__cf_email__" data-cfemail="ea9981819f9d8b8e8baa828b9d8b8383c48f8e9f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Shen</span> - <span class="hlFld-Affiliation affiliation">John
A. Burns School of Medicine, University
of Hawaii, 651 Ilalo
Street, Honolulu, Hawaii 96813, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jill E. Shea</span> - <span class="hlFld-Affiliation affiliation">Department
of Surgery, University of Utah, 50 N. Medical Drive, Salt Lake City, Utah 84132, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuegang Lao</span> - <span class="hlFld-Affiliation affiliation">John
A. Burns School of Medicine, University
of Hawaii, 651 Ilalo
Street, Honolulu, Hawaii 96813, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oana Bollt</span> - <span class="hlFld-Affiliation affiliation">John
A. Burns School of Medicine, University
of Hawaii, 651 Ilalo
Street, Honolulu, Hawaii 96813, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiufen Li</span> - <span class="hlFld-Affiliation affiliation">John
A. Burns School of Medicine, University
of Hawaii, 651 Ilalo
Street, Honolulu, Hawaii 96813, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph G. Lisko</span> - <span class="hlFld-Affiliation affiliation">Teva
Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay P. Theroff</span> - <span class="hlFld-Affiliation affiliation">Teva
Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Courtney L. Scaife</span> - <span class="hlFld-Affiliation affiliation">Department
of Surgery, University of Utah, 50 N. Medical Drive, Salt Lake City, Utah 84132, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. Ator</span> - <span class="hlFld-Affiliation affiliation">Teva
Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce A. Ruggeri</span> - <span class="hlFld-Affiliation affiliation">Teva
Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce D. Dorsey</span> - <span class="hlFld-Affiliation affiliation">Teva
Branded Pharmaceutical Products R&D, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.S. and C.A.Z. contributed equally to this paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The authors have received research funding for the studies herein by Cephalon Inc. (now TEVA).<br /></br></div></li></ul></div><div class="ack" id="ACK-d2618e6309-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding for this study was provided by the Huntsman Cancer Institute, University of Utah Technology Commercialization Office, and Teva Pharmaceuticals.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> Abbreviations Used</h2><tr><td class="NLM_term">c-FLIP</td><td class="NLM_def"><p class="first last">cellular-FLICE inhibitory protein</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">ITCH</td><td class="NLM_def"><p class="first last">itchy E3 ubiquitin protein ligase</p></td></tr><tr><td class="NLM_term">RFP</td><td class="NLM_def"><p class="first last">red fluorescent protein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Vogel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalthoff, H.</span><span> </span><span class="NLM_article-title">Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas</span> <span class="citation_source-journal">Virchow’s Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">439</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs004280100476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=11561750" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2001&pages=109-117&author=I.+Vogelauthor=H.+Kalthoff&title=Disseminated+tumour+cells.+Their+detection+and+significance+for+prognosis+of+gastrointestinal+and+pancreatic+carcinomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs004280100476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004280100476%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DI.%26aulast%3DKalthoff%26aufirst%3DH.%26atitle%3DDisseminated%2520tumour%2520cells.%2520Their%2520detection%2520and%2520significance%2520for%2520prognosis%2520of%2520gastrointestinal%2520and%2520pancreatic%2520carcinomas%26jtitle%3DVirchow%25E2%2580%2599s%2520Arch.%26date%3D2001%26volume%3D439%26spage%3D109%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vogel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalthoff, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne-Bruns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, B.</span><span> </span><span class="NLM_article-title">Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma</span> <span class="citation_source-journal">Pancreatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=79-88&author=I.+Vogelauthor=H.+Kalthoffauthor=D.+Henne-Brunsauthor=B.+Kremer&title=Detection+and+prognostic+impact+of+disseminated+tumor+cells+in+pancreatic+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DI.%26aulast%3DKalthoff%26aufirst%3DH.%26aulast%3DHenne-Bruns%26aufirst%3DD.%26aulast%3DKremer%26aufirst%3DB.%26atitle%3DDetection%2520and%2520prognostic%2520impact%2520of%2520disseminated%2520tumor%2520cells%2520in%2520pancreatic%2520carcinoma%26jtitle%3DPancreatology%26date%3D2002%26volume%3D2%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pannu, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montz, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, E. K.</span><span> </span><span class="NLM_article-title">Multidetector CT of peritoneal carcinomatosis from ovarian cancer</span> <span class="citation_source-journal">Radiographics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=687-701&author=H.+K.+Pannuauthor=R.+E.+Bristowauthor=F.+J.+Montzauthor=E.+K.+Fishman&title=Multidetector+CT+of+peritoneal+carcinomatosis+from+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPannu%26aufirst%3DH.%2BK.%26aulast%3DBristow%26aufirst%3DR.%2BE.%26aulast%3DMontz%26aufirst%3DF.%2BJ.%26aulast%3DFishman%26aufirst%3DE.%2BK.%26atitle%3DMultidetector%2520CT%2520of%2520peritoneal%2520carcinomatosis%2520from%2520ovarian%2520cancer%26jtitle%3DRadiographics%26date%3D2003%26volume%3D23%26spage%3D687%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span> </span><span class="NLM_article-title">The characteristics of disseminated tumor cells in pancreatic cancer: a black box needs to be explored</span> <span class="citation_source-journal">Pancreatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><div class="note"><p class="first last">(discussion 324)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=316-324&author=D.+Suauthor=K.+Yamaguchiauthor=M.+Tanaka&title=The+characteristics+of+disseminated+tumor+cells+in+pancreatic+cancer%3A+a+black+box+needs+to+be+explored"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26atitle%3DThe%2520characteristics%2520of%2520disseminated%2520tumor%2520cells%2520in%2520pancreatic%2520cancer%253A%2520a%2520black%2520box%2520needs%2520to%2520be%2520explored%26jtitle%3DPancreatology%26date%3D2005%26volume%3D5%26spage%3D316%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Munoz-Casares, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizarraga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Iglesias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muntane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrios, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Melero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Bayon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretcha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Perez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Portilla, A.</span><span> </span><span class="NLM_article-title">Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals</span> <span class="citation_source-journal">Clin. Transl. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs12094-007-0118-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=17974526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2snltVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=652-662&author=F.+C.+Munoz-Casaresauthor=S.+Rufianauthor=M.+J.+Rubioauthor=E.+Lizarragaauthor=C.+Diaz-Iglesiasauthor=E.+Arandaauthor=R.+Ciriaauthor=J.+Muntaneauthor=P.+Barriosauthor=J.+Torres-Meleroauthor=S.+Gonzalez-Morenoauthor=L.+Gonzalez-Bayonauthor=B.+Campsauthor=P.+Bretchaauthor=J.+Farreauthor=G.+Ortega-Perezauthor=A.+Gomez-Portilla&title=Treatment+of+peritoneal+carcinomatosis+from+ovarian+cancer.+Present%2C+future+directions+and+proposals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals</span></div><div class="casAuthors">Munoz-Casares F C; Rufian S; Rubio M J; Lizarraga E; Diaz-Iglesias C; Aranda E; Ciria R; Muntane J; Barrios P; Torres-Melero J; Gonzalez-Moreno S; Gonzalez-Bayon L; Camps B; Bretcha P; Farre J; Ortega-Perez G; Gomez-Portilla A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">652-62</span>
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    </div><div class="casAbstract">Peritoneal carcinomatosis, considered years ago as a final stage of unresectable cancer, can now be managed with curative intention by means of a radical cytoreductive surgical procedure with associated peritonectomy and intraperitoneal chemotherapy, as described by Sugarbaker.  Malignant neoplasms such as mesothelioma and pseudomyxoma peritonei, ovarian and colon cancer nowadays are experiencing some new therapeutical approaches.  Higher survival rates can be reached in ovarian cancer, which is commonly diagnosed in the presence of peritoneal carcinomatosis, using an optimal cytoreductive radical surgery with intraperitoneal chemotherapy.  An actualised review of the treatment of advanced ovarian cancer and a proposal of a national multicentre protocol for the treatment of peritoneal carcinomatosis from ovarian cancer has been performed by a group of Spanish surgeons and oncologists dedicated to a therapeutical approach to this pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrveJCkX-B3gaK-_ZudimnfW6udTcc2eY3TgTcyfyQM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snltVKruw%253D%253D&md5=2fce405d19580857f70c1548cdefa22a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12094-007-0118-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-007-0118-0%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Casares%26aufirst%3DF.%2BC.%26aulast%3DRufian%26aufirst%3DS.%26aulast%3DRubio%26aufirst%3DM.%2BJ.%26aulast%3DLizarraga%26aufirst%3DE.%26aulast%3DDiaz-Iglesias%26aufirst%3DC.%26aulast%3DAranda%26aufirst%3DE.%26aulast%3DCiria%26aufirst%3DR.%26aulast%3DMuntane%26aufirst%3DJ.%26aulast%3DBarrios%26aufirst%3DP.%26aulast%3DTorres-Melero%26aufirst%3DJ.%26aulast%3DGonzalez-Moreno%26aufirst%3DS.%26aulast%3DGonzalez-Bayon%26aufirst%3DL.%26aulast%3DCamps%26aufirst%3DB.%26aulast%3DBretcha%26aufirst%3DP.%26aulast%3DFarre%26aufirst%3DJ.%26aulast%3DOrtega-Perez%26aufirst%3DG.%26aulast%3DGomez-Portilla%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520peritoneal%2520carcinomatosis%2520from%2520ovarian%2520cancer.%2520Present%252C%2520future%2520directions%2520and%2520proposals%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2007%26volume%3D9%26spage%3D652%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Davidson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trope, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih Ie, M.</span><span> </span><span class="NLM_article-title">New determinates of disease progression and outcome in metastatic ovarian carcinoma</span> <span class="citation_source-journal">Histol. Histopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=20886439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmvVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=1591-1609&author=B.+Davidsonauthor=R.+Reichauthor=C.+G.+Tropeauthor=T.+L.+Wangauthor=M.+Shih+Ie&title=New+determinates+of+disease+progression+and+outcome+in+metastatic+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New determinates of disease progression and outcome in metastatic ovarian carcinoma</span></div><div class="casAuthors">Davidson Ben; Reich Reuven; Trope Claes G; Wang Tian-Li; Shih Ie-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Histology and histopathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1591-609</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ovarian cancer is the most lethal gynecologic malignancy.  This is attributed to frequent presentation at late stage, when the tumor has metastasized, as well as to development of chemotherapy resistance along tumor progression.  Patients with advanced-stage ovarian carcinoma have widespread intraperitoneal metastases, including the formation of malignant serous effusions within the peritoneal cavity.  Pleural effusions constitute the most frequent site of distant metastasis (FIGO stage IV disease).  Unlike the majority of solid tumors, particularly at the primary site, cancer cells in effusions are not amenable to surgical removal, and failure in their eradication is one of the main causes of treatment failure.  Our research in recent years has demonstrated that a large number of cancer-associated molecules are differentially expressed in effusions compared to primary carcinomas and solid metastases.  We have additionally observed that expression of several of these molecules differs between primary diagnosis (pre-chemotherapy) and disease recurrence (post-chemotherapy) specimens, and that they are significantly associated with response to chemotherapy and patient survival.  These observations are thought to be related to disease progression, as well as to the unique microenvironment of effusions, and may have impact on the selection of targeted therapy in this cancer.  This review discusses our recent observations with respect to the biology of ovarian carcinoma cells in effusions, and focuses on the clinical role of tumor-associated molecules at this anatomic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSn0Rujn_TlTIFEOhA_Im3cfW6udTcc2ebIXJpzNIPxqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmvVeksw%253D%253D&md5=53a1d9975daf9a7837ba7d8b47cdfb63</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DB.%26aulast%3DReich%26aufirst%3DR.%26aulast%3DTrope%26aufirst%3DC.%2BG.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DShih%2BIe%26aufirst%3DM.%26atitle%3DNew%2520determinates%2520of%2520disease%2520progression%2520and%2520outcome%2520in%2520metastatic%2520ovarian%2520carcinoma%26jtitle%3DHistol.%2520Histopathol.%26date%3D2010%26volume%3D25%26spage%3D1591%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span>Cancer Facts and Figures 2013; <span class="NLM_publisher-name">American Cancer Society</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cancer+Facts+and+Figures+2013%3B+American+Cancer+Society%3A+Atlanta%2C+GA%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Facts%2520and%2520Figures%25202013%26pub%3DAmerican%2520Cancer%2520Society%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fader, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. G.</span><span> </span><span class="NLM_article-title">Role of surgery in ovarian carcinoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2873</span><span class="NLM_x">–</span> <span class="NLM_lpage">2883</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1200%2FJCO.2007.11.0932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=17617518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2svgtVWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=2873-2883&author=A.+N.+Faderauthor=P.+G.+Rose&title=Role+of+surgery+in+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of surgery in ovarian carcinoma</span></div><div class="casAuthors">Fader Amanda Nickles; Rose Peter G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2873-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Surgery plays a critical role in the optimal management of all stages of ovarian carcinoma.  In apparent early-stage ovarian cancer, a comprehensive surgical evaluation allows stratification of patients into low- and high-risk categories.  Low-risk patients may be candidates for fertility-sparing surgery and can safely avoid chemotherapy and be observed.  Treatment of patients with high-risk early- or advanced-stage ovarian cancer usually requires a combined modality approach.  Although it is well known that epithelial ovarian cancer is moderately chemosensitive, what distinguishes it most from other metastatic solid tumors is that surgical cytoreduction of tumor volume is highly correlated with prolongation of patient survival.  Procedures such as radical pelvic surgery, bowel resection, and aggressive upper abdominal surgery are commonly required to achieve optimal cytoreduction.  Women who develop recurrent disease may be eligible for a secondary cytoreductive surgery or may require a surgical intervention to palliate disease-related symptoms.  For women at high risk of ovarian cancer, prophylactic bilateral salpingo-oophorectomy significantly reduces the incidence of this disease.  The purpose of this article is to provide a comprehensive review of the surgical management of ovarian carcinoma.  The roles of primary, interval, and secondary cytoreductive surgeries; second-look procedures; and palliative surgery are reviewed.  The indications for fertility-sparing and minimally invasive surgery as well as the current guidelines for prophylactic surgery in high-risk mutation carriers are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9J6wI5hl9NEewzGPswiWOfW6udTcc2ebIXJpzNIPxqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svgtVWlug%253D%253D&md5=1d4a459c16b08893e60440537603896c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.0932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.0932%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DA.%2BN.%26aulast%3DRose%26aufirst%3DP.%2BG.%26atitle%3DRole%2520of%2520surgery%2520in%2520ovarian%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D2873%26epage%3D2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Horng, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. H.</span><span> </span><span class="NLM_article-title">Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery</span> <span class="citation_source-journal">Eur. J. Gynaecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=17375705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ns1ShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=43-44&author=H.+C.+Horngauthor=C.+C.+Yuanauthor=C.+R.+Laiauthor=P.+H.+Wang&title=Presumed+Stage+IA+primary+epithelial+ovarian+carcinoma%3A+the+role+of+complete+staging+surgery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery</span></div><div class="casAuthors">Horng H C; Yuan C C; Lai C R; Wang P H</div><div class="citationInfo"><span class="NLM_cas:title">European journal of gynaecological oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-4</span>
        ISSN:<span class="NLM_cas:issn">0392-2936</span>.
    </div><div class="casAbstract">PURPOSE:  Proper staging is warranted in any patient with primary epithelial ovarian carcinoma (PEOC), but sometimes it cannot always be performed.  The prognosis of patients with and without complete staging surgery is to be determined.  METHODS:  We retrospectively evaluated 61 patients with presumed Stage IA PEOC between January 1970 and December 1993.  Inclusion criteria were: being referred patients; no ascites; an intact ovarian tumor without extra-spillage or rupture before, during or after operation; conventional regular exploratory laparotomy without urgency; more than a 5-year follow-up, except for recurrent diseases; a detailed pathology review; and no other systemic disease.  Tumors of lower malignant potential (LMP) and cystectomy for removing tumor were excluded.  Of the 61 patients, 17 patients received a close observation (Group A), and the others (44 patients) received a re-exploratory laparotomy to complete the staging surgery (Group B).  RESULTS:  The mean follow-up time was 7.4 years, ranging between 5.4 and 11.1 years, in Group A, and 8.1 years, ranging from 5.6 to 12.7 years, in Group B.  Two patients (11.8%) in Group A and seven patients (15.9%) in Group B suffered from recurrence.  Two patients finally died of disease, and both were in Group B.  CONCLUSIONS:  Based on the observation in this study that the recurrence rate of the two groups was not statistically different, close follow-up for patients with presumed Stage IA EOC, but without complete surgical staging surgery, might be acceptable when these patients are treated with postoperative adjuvant chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCX15baGk9HX6HPRus0rAafW6udTcc2ebIXJpzNIPxqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ns1ShsQ%253D%253D&md5=909174e7d9b30ec18ff46ad85dd52c28</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorng%26aufirst%3DH.%2BC.%26aulast%3DYuan%26aufirst%3DC.%2BC.%26aulast%3DLai%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DP.%2BH.%26atitle%3DPresumed%2520Stage%2520IA%2520primary%2520epithelial%2520ovarian%2520carcinoma%253A%2520the%2520role%2520of%2520complete%2520staging%2520surgery%26jtitle%3DEur.%2520J.%2520Gynaecol.%2520Oncol.%26date%3D2007%26volume%3D28%26spage%3D43%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hase, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuranaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsunomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, H.</span><span> </span><span class="NLM_article-title">Intraperitoneal exfoliated cancer cells in patients with colorectal cancer</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2FBF02239435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=9749497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK1cvhvF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1134-1140&author=K.+Haseauthor=H.+Uenoauthor=N.+Kuranagaauthor=K.+Utsunomiyaauthor=S.+Kanabeauthor=H.+Mochizuki&title=Intraperitoneal+exfoliated+cancer+cells+in+patients+with+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Intraperitoneal exfoliated cancer cells in patients with colorectal cancer</span></div><div class="casAuthors">Hase K; Ueno H; Kuranaga N; Utsunomiya K; Kanabe S; Mochizuki H</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1134-40</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  The aims of this study were to evaluate potential predictors of exfoliated free cancer cells in the peritoneal cavity and to assess intraoperative peritoneal lavage cytology as a prognostic indicator in patients with colorectal cancer.  METHODS:  From 1985 to 1987, intraoperative peritoneal lavage cytology was performed in 140 patients with colorectal cancer.  Among them, 88 patients underwent curative resection and 52 patients had noncurative surgery.  Cytology was examined twice, i.e., immediately after opening the peritoneal cavity (precytology) and just before closing the abdomen (postcytology).  One hundred milliliters of saline was poured into the peritoneal cavity and it was retrieved by suction after irrigation.  Cytologic examination was performed after staining with Papanicolaou, Giemsa, periodic acid-Schiff, and Alcian blue stains.  RESULTS:  Among the 140 patients examined, the incidence of positive cytology in the prelavage was 15 percent, and that in the postlavage was 9 percent, although it was 16 percent in either lavage.  Among patients with curative resection, 10 percent had positive cytology.  Seven characteristics were identified as features of tumors which are prone to exfoliate cells into the peritoneal cavity: 1) macroscopic peritoneal dissemination, 2) liver metastasis, 3) more than 20 ml of ascites, 4) ulcerated tumors without definite borders, 5) invasion of the serosal surface or beyond, 6) semiannular or annular shape, and 7) moderate or marked lymphatic invasion.  In patients undergoing curative surgery, among these features, circumferential involvement was the only one correlated closely with positive cytology (P < 0.02).  Positive cytology was associated with a worse outcome.  In patients who were resected curatively, the postcytology had a stronger influence on local recurrence than the precytology; the local recurrence rate in patients with positive postcytology was higher than in those with negative postcytology, regardless of the precytology.  All patients with cancer cells in the peritoneal cavity at the end of surgery had recurrence.  CONCLUSIONS:  Seven characteristics were identified as risk factors for exfoliation of cancer cells into the peritoneal cavity in patients with colorectal cancer.  These findings may be helpful for the choice of laparoscopic surgery in this era of increasing port-site metastases after laparoscopic procedure.  The results of peritoneal lavage cytology at the end of surgery were correlated with the long-term postoperative outcome of colorectal cancer.  Thus, meticulous follow-up and possibly adjuvant chemotherapy may be beneficial for patients with free cancer cells in lavage fluid, even after curative surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwuZghxOeO7-RS7coPn-RtfW6udTcc2eaTkuMprEa3zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvhvF2htA%253D%253D&md5=6807a9faaf6b85bfd97d7b7b1d9a4e90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF02239435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02239435%26sid%3Dliteratum%253Aachs%26aulast%3DHase%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DKuranaga%26aufirst%3DN.%26aulast%3DUtsunomiya%26aufirst%3DK.%26aulast%3DKanabe%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DH.%26atitle%3DIntraperitoneal%2520exfoliated%2520cancer%2520cells%2520in%2520patients%2520with%2520colorectal%2520cancer%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1998%26volume%3D41%26spage%3D1134%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milsom, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toddy, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, V. W.</span><span> </span><span class="NLM_article-title">Does laparoscopic vs conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer?</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2FBF02237382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=9715151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK1czotVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=971-978&author=S.+H.+Kimauthor=J.+W.+Milsomauthor=T.+L.+Gramlichauthor=S.+M.+Toddyauthor=G.+I.+Shoreauthor=J.+Okudaauthor=V.+W.+Fazio&title=Does+laparoscopic+vs+conventional+surgery+increase+exfoliated+cancer+cells+in+the+peritoneal+cavity+during+resection+of+colorectal+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer?</span></div><div class="casAuthors">Kim S H; Milsom J W; Gramlich T L; Toddy S M; Shore G I; Okuda J; Fazio V W</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">971-8</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  Traumatic manipulation of cancer specimens during laparoscopic colectomy may increase exfoliation of malignant cells into the peritoneal cavity, causing an early occurrence of peritoneal carcinomatosis or port-sites recurrence.  Because of this concern, the routine use of intraperitoneal chemotherapy after laparoscopic colectomy for cancer was suggested recently.  We assessed if laparoscopic vs. conventional surgery increases exfoliated malignant cells in the peritoneal cavity during resection of colorectal cancer.  METHODS:  In a prospective, randomized fashion, 38 colorectal cancer patients undergoing an elective, curative operation were assigned to either a conventional or laparoscopic procedure between June 1996 and May 1997.  In either group (n = 19), after the abdominal cavity was entered, saline was instilled into the peritoneal cavity, and the fluid was collected (Specimen 1).  During surgery, all irrigating fluids were collected (Specimen 2).  Both specimens were assessed for malignancy using four techniques: filtration process (ThinPrep), smear, cell block, and immunochemistry using Ber-EP4.  The change in the amount of tumor cells in both specimens was compared between surgical groups.  A pilot study was performed to validate the proposed cytologic method.  RESULTS:  In the pilot study of 20 consecutive patients with colorectal cancer, postresectional peritoneal cytology was positive in six patients, including two Stage II (T3, N0, M0) patients.  The pilot study also validated that our semiquantitative scoring system can be reliably used to assess the amount of free peritoneal cancer cells.  In the main study, 16 right colectomies, 3 extended right colectomies, 17 proctosigmoidectomies, and 1 left colectomy were performed.  The T and N stages were T1 (n = 13, T2 (n = 5), T3 (n = 8), T4 (n = 11); N0 (n =22), N1 (n = 8), N2 (n = 7).  Malignant cells were not detected in any Specimens 1 or, more importantly, in Specimens 2 in either surgical group.  CONCLUSION:  When performed according to strict oncologic surgical principles, laparoscopic techniques in curative colorectal cancer surgery did not have an increased risk of intraperitoneal cancer cell spillage, compared with conventional techniques.  We hope that these results can decrease some of the concerns about tumor cell spillage and seeding during laparoscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCbkMSz9JPKTDnmmyUf5qOfW6udTcc2eaTkuMprEa3zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czotVyrsQ%253D%253D&md5=55afe715c931b7af029fe837ce503c5f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2FBF02237382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02237382%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DMilsom%26aufirst%3DJ.%2BW.%26aulast%3DGramlich%26aufirst%3DT.%2BL.%26aulast%3DToddy%26aufirst%3DS.%2BM.%26aulast%3DShore%26aufirst%3DG.%2BI.%26aulast%3DOkuda%26aufirst%3DJ.%26aulast%3DFazio%26aufirst%3DV.%2BW.%26atitle%3DDoes%2520laparoscopic%2520vs%2520conventional%2520surgery%2520increase%2520exfoliated%2520cancer%2520cells%2520in%2520the%2520peritoneal%2520cavity%2520during%2520resection%2520of%2520colorectal%2520cancer%253F%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1998%26volume%3D41%26spage%3D971%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Averbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, P. H.</span><span> </span><span class="NLM_article-title">Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer</span> <span class="citation_source-journal">Ann. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1998&pages=347-354&author=W.+Yuauthor=I.+Whangauthor=I.+Suhauthor=A.+Averbachauthor=D.+Changauthor=P.+H.+Sugarbaker&title=Prospective+randomized+trial+of+early+postoperative+intraperitoneal+chemotherapy+as+an+adjuvant+to+resectable+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWhang%26aufirst%3DI.%26aulast%3DSuh%26aufirst%3DI.%26aulast%3DAverbach%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DD.%26aulast%3DSugarbaker%26aufirst%3DP.%2BH.%26atitle%3DProspective%2520randomized%2520trial%2520of%2520early%2520postoperative%2520intraperitoneal%2520chemotherapy%2520as%2520an%2520adjuvant%2520to%2520resectable%2520gastric%2520cancer%26jtitle%3DAnn.%2520Surg.%26date%3D1998%26volume%3D228%26spage%3D347%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Steinert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymond, M. A.</span><span> </span><span class="NLM_article-title">Tumor cell dissemination during laparoscopy: prevention and therapeutic opportunities</span> <span class="citation_source-journal">Dig. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1159%2F000067598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12499738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD38jjs1yrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2002&pages=464-472&author=R.+Steinertauthor=H.+Lippertauthor=M.+A.+Reymond&title=Tumor+cell+dissemination+during+laparoscopy%3A+prevention+and+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell dissemination during laparoscopy: prevention and therapeutic opportunities</span></div><div class="casAuthors">Steinert Ralf; Lippert Hans; Reymond Marc A</div><div class="citationInfo"><span class="NLM_cas:title">Digestive surgery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-72</span>
        ISSN:<span class="NLM_cas:issn">0253-4886</span>.
    </div><div class="casAbstract">Port-site recurrences (PSRs) are abdominal wall recurrences that occur in the subcutaneous tissue within a trocar site after cancer laparoscopy and are not associated with peritoneal carcinomatosis.  In order to develop PSRs, viable tumor cells must be liberated from the primary tumor, be transported to a wound, and find there a favorable environment for growth.  The short clinical delay in the occurrence of PSRs and their size suggest massive cell seeding into the abdominal wall.  Traumatic handling of the tumor, slipping of trocars, liquid projection, as well as poor extraction techniques can all cause implantation of malignant cells into the subcutaneous tissue.  Such contact can also occur postoperatively if the trocar channels remain open.  Some histologies (e.g. gallbladder adenocarcinoma), the presence of ascites and advanced tumor stage are risk factors for PSRs.  Further conditions--including the use of gas--might also play a limited role.  The first preventive measure is the correct indication for a laparoscopic approach.  Several techniques have been demonstrated to prevent PSRs in the animal model: (a) fixation of trocars to the abdominal wall; (b) prevention of leakage; (c) careful specimen handling; (d) reducing trauma to the abdominal wall; (e) specimen isolation before extraction from the abdominal cavity; (f) trocar-site irrigation with a cytotoxic solution, and (g) closure of peritoneum.  Further innovative therapies are currently under investigation.  In the clinical setting, correct indication, surgical expertise and application of prophylactic measures seem to be the best way to prevent the occurrence of PSRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2dp9pler65Be4jJGKT5N0fW6udTcc2eaTkuMprEa3zrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jjs1yrtQ%253D%253D&md5=75a6de41e6ffa0203f7d7a7107eb58c7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1159%2F000067598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000067598%26sid%3Dliteratum%253Aachs%26aulast%3DSteinert%26aufirst%3DR.%26aulast%3DLippert%26aufirst%3DH.%26aulast%3DReymond%26aufirst%3DM.%2BA.%26atitle%3DTumor%2520cell%2520dissemination%2520during%2520laparoscopy%253A%2520prevention%2520and%2520therapeutic%2520opportunities%26jtitle%3DDig.%2520Surg.%26date%3D2002%26volume%3D19%26spage%3D464%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Raa, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosterling, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kaaij, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Tol, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beelen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eijck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Sijp, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Egmond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeekel, J.</span><span> </span><span class="NLM_article-title">Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters</span> <span class="citation_source-journal">J. Surg. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1002%2Fjso.20273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=16231370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2Mrms1ertw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=124-129&author=S.+T.+Raaauthor=S.+J.+Oosterlingauthor=N.+P.+van+der+Kaaijauthor=M.+P.+van+den+Tolauthor=R.+H.+Beelenauthor=S.+Meijerauthor=C.+H.+van+Eijckauthor=J.+R.+van+der+Sijpauthor=M.+van+Egmondauthor=J.+Jeekel&title=Surgery+promotes+implantation+of+disseminated+tumor+cells%2C+but+does+not+increase+growth+of+tumor+cell+clusters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters</span></div><div class="casAuthors">Raa S Ten; Oosterling S J; van der Kaaij N P; van den Tol M P; Beelen R H J; Meijer S; van Eijck C H J; van der Sijp J R M; van Egmond M; Jeekel J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of surgical oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-9</span>
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    </div><div class="casAbstract">INTRODUCTION:  Local recurrence and peritoneal dissemination is common after intentionally curative resection of colorectal carcinoma.  It is not yet clear which mechanisms stimulate post-operative intra-abdominal tumor development.  Enhanced adhesion or growth of tumor cells and/or post-operative immuno suppression may influence tumor recurrence.  AIMS OF THE STUDY:  In the present study, we evaluated effects of local and remote surgery on intra-abdominal tumor development.  MATERIALS AND METHODS:  A standardized intra-abdominal trauma was inflicted by rubbing both uterus horns in laparotomy groups, while a dorsolateral thoracotomy was performed in thoracotomy groups (on day -1, 0, or +3).  To induce tumor development rats were injected intra-peritoneally with the coloncarcinoma cell line CC531s on day 0 and evaluated after 21 days.  RESULTS:  Rats undergoing laparotomy and injection on day 0 showed significantly higher tumorload than control rats (195 +/- 20 vs. 47 +/- 29, P < 0.001).  When a laparotomy was performed, the day before tumor inoculation even higher tumorload was seen (245 +/- 37 vs. 195 +/- 20, P < 0.01).  Strikingly, performing a thoracotomy on the day before or on the same day as tumor inoculation resulted in enhanced tumorload compared to controls as well (135 +/- 84 vs. 47 +/- 29; P < 0.001 and 88 +/- 38 vs. 47 +/- 29; P < 0.02, respectively).  Either laparotomy or thoracotomy 3 days after tumor cell inoculation did not affect growth of pre-existing tumor cell clusters.  CONCLUSIONS:  The (post) surgical intra-peritoneal microenvironment enhances successful implantation of spilled tumor cells, whereas growth of adhered tumor cell clusters is not affected.  The inflammatory response as a result of remote surgery promotes successful tumor development as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQnbV7OL59YTEwO064Z95rfW6udTcc2ebA4T05h9tQ7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mrms1ertw%253D%253D&md5=6bdf22e09a7808678e056b568a5afd8e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjso.20273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.20273%26sid%3Dliteratum%253Aachs%26aulast%3DRaa%26aufirst%3DS.%2BT.%26aulast%3DOosterling%26aufirst%3DS.%2BJ.%26aulast%3Dvan%2Bder%2BKaaij%26aufirst%3DN.%2BP.%26aulast%3Dvan%2Bden%2BTol%26aufirst%3DM.%2BP.%26aulast%3DBeelen%26aufirst%3DR.%2BH.%26aulast%3DMeijer%26aufirst%3DS.%26aulast%3Dvan%2BEijck%26aufirst%3DC.%2BH.%26aulast%3Dvan%2Bder%2BSijp%26aufirst%3DJ.%2BR.%26aulast%3Dvan%2BEgmond%26aufirst%3DM.%26aulast%3DJeekel%26aufirst%3DJ.%26atitle%3DSurgery%2520promotes%2520implantation%2520of%2520disseminated%2520tumor%2520cells%252C%2520but%2520does%2520not%2520increase%2520growth%2520of%2520tumor%2520cell%2520clusters%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D2005%26volume%3D92%26spage%3D124%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Takatsuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, T.</span><span> </span><span class="NLM_article-title">Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6065</span><span class="NLM_x">–</span> <span class="NLM_lpage">6070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6065-6070&author=H.+Takatsukiauthor=S.+Komatsuauthor=R.+Sanoauthor=Y.+Takadaauthor=T.+Tsuji&title=Adhesion+of+gastric+carcinoma+cells+to+peritoneum+mediated+by+alpha3beta1+integrin+%28VLA-3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakatsuki%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DS.%26aulast%3DSano%26aufirst%3DR.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DT.%26atitle%3DAdhesion%2520of%2520gastric%2520carcinoma%2520cells%2520to%2520peritoneum%2520mediated%2520by%2520alpha3beta1%2520integrin%2520%2528VLA-3%2529%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6065%26epage%3D6070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Weiss, L.</span><span> </span><span class="NLM_article-title">Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells</span> <span class="citation_source-journal">Cancer Treat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2F978-1-4613-1247-5_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=8849940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2s%252Fgt1GqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1996&pages=1-11&author=L.+Weiss&title=Metastatic+inefficiency%3A+intravascular+and+intraperitoneal+implantation+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells</span></div><div class="casAuthors">Weiss L</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment and research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>
        ISSN:<span class="NLM_cas:issn">0927-3042</span>.
    </div><div class="casAbstract">The term metastatic inefficiency reflects the fact that most of the cancer cells entering the metastatic process are killed; some of the evidence for this is reviewed in the case of renal and colorectal carcinomas.  Although much emphasis has been placed on the rapid intravascular death of cancer cells during hematogenous metastasis, much less is known about the inefficiency associated with peritoneal carcinomatosis, and up to the present no systematic and direct numerical studies have been reported of the relative metastatic inefficiencies associated with seeding of cancer cells by intraperitoneal, vascular, and lymphatic routes.  However, studies on people and laboratory animals indicate that most of the cancer cells released into the peritoneal cavity are killed.  Some of the mechanisms involved in killing constitute part of cellular defense operating through the release of toxic free radicals.  One of these, hydrogen peroxide, given by intraperitoneal injection, has been shown to retard the development of malignant ascites in mice previously given intraperitoneal injections of cancer cells.  It is suggested that local irrigation with hydrogen peroxide during surgery for abdominal tumors may be effective in inhibiting the development of peritoneal carcinomatosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCKwhEM8Ud0qcY7HFp97qMfW6udTcc2ebA4T05h9tQ7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252Fgt1GqsQ%253D%253D&md5=819a7ed0c96bc3386835940c8e19a13c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2F978-1-4613-1247-5_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4613-1247-5_1%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DL.%26atitle%3DMetastatic%2520inefficiency%253A%2520intravascular%2520and%2520intraperitoneal%2520implantation%2520of%2520cancer%2520cells%26jtitle%3DCancer%2520Treat.%2520Res.%26date%3D1996%26volume%3D82%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Scholler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden-Ledbetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, N.</span><span> </span><span class="NLM_article-title">Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1016%2Fj.canlet.2006.03.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=16677756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=2007&pages=130-136&author=N.+Schollerauthor=B.+Garvikauthor=M.+Hayden-Ledbetterauthor=T.+Klineauthor=N.+Urban&title=Development+of+a+CA125-mesothelin+cell+adhesion+assay+as+a+screening+tool+for+biologics+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery</span></div><div class="casAuthors">Scholler, Nathalie; Garvik, Barbara; Hayden-Ledbetter, Martha; Kline, Toni; Urban, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-136</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Preventing peritoneal implantation of ovarian carcinoma cells could prolong patient remission and survival.  CA125 is expressed on most ovarian cancer cells and was reported to be a ligand of mesothelin, a peritoneal protein.  The authors developed a cell adhesion assay with CA125-expresser ovarian cancer cells and human mesothelin-transfected cells and the authors confirmed that CA125 and mesothelin mediate cell attachment.  The authors also showed that this assay supplies a high-throughput screening system for reagents able to block CA125/mesothelin-dependent cell attachment with a sensitive quant. readout.  The authors finally demonstrated that a mesothelin chimeric protein and anti-CA125 antibodies block CA125/mesothelin-dependent cell attachment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbSxnFZWufXbVg90H21EOLACvtfcHk0liuA3xITb72qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eltw%253D%253D&md5=20ea5ee8c4031d9029cda57e027543ce</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.03.029%26sid%3Dliteratum%253Aachs%26aulast%3DScholler%26aufirst%3DN.%26aulast%3DGarvik%26aufirst%3DB.%26aulast%3DHayden-Ledbetter%26aufirst%3DM.%26aulast%3DKline%26aufirst%3DT.%26aulast%3DUrban%26aufirst%3DN.%26atitle%3DDevelopment%2520of%2520a%2520CA125-mesothelin%2520cell%2520adhesion%2520assay%2520as%2520a%2520screening%2520tool%2520for%2520biologics%2520discovery%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D247%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Scaife, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wills, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trowbridge, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichwald, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daynes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwada, S. K.</span><span> </span><span class="NLM_article-title">Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6870</span><span class="NLM_x">–</span> <span class="NLM_lpage">6878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6870-6878&author=C.+L.+Scaifeauthor=J.+Kuangauthor=J.+C.+Willsauthor=D.+B.+Trowbridgeauthor=P.+Grayauthor=B.+M.+Manningauthor=E.+J.+Eichwaldauthor=R.+A.+Daynesauthor=S.+K.+Kuwada&title=Nuclear+factor+kappaB+inhibitors+induce+adhesion-dependent+colon+cancer+apoptosis%3A+implications+for+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScaife%26aufirst%3DC.%2BL.%26aulast%3DKuang%26aufirst%3DJ.%26aulast%3DWills%26aufirst%3DJ.%2BC.%26aulast%3DTrowbridge%26aufirst%3DD.%2BB.%26aulast%3DGray%26aufirst%3DP.%26aulast%3DManning%26aufirst%3DB.%2BM.%26aulast%3DEichwald%26aufirst%3DE.%2BJ.%26aulast%3DDaynes%26aufirst%3DR.%2BA.%26aulast%3DKuwada%26aufirst%3DS.%2BK.%26atitle%3DNuclear%2520factor%2520kappaB%2520inhibitors%2520induce%2520adhesion-dependent%2520colon%2520cancer%2520apoptosis%253A%2520implications%2520for%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6870%26epage%3D6878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doxey, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwada, S. K.</span><span> </span><span class="NLM_article-title">Pharmacologic downregulation of c-FLIP(L) restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1494</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1002%2Fijc.26119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=21480219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2012&pages=1494-1503&author=Y.+Shenauthor=R.+Herdeauthor=B.+W.+Doxeyauthor=C.+Xuauthor=P.+D.+Grayauthor=S.+K.+Kuwada&title=Pharmacologic+downregulation+of+c-FLIP%28L%29+restores+juxtacrine+death+receptor-mediated+apoptosis+in+cancer+cells+in+a+peritoneal+carcinomatosis+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic downregulation of c-FLIPL restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model</span></div><div class="casAuthors">Shen, Yi; Herde, Ryan; Doxey, Brett W.; Xu, Changxin; Gray, Phillip D.; Kuwada, Scott K.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1494-1503</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Metastasis occurs when circulating cancer cells implant in normal secondary tissues.  Paradoxically, many cancer cells express death receptors while many normal tissues express the cognate death receptor ligands, suggesting that cancer cells possess mechanisms to inhibit death receptor signaling.  Pharmacol. restoration of juxtacrine-mediated death receptor signaling could prevent cancer cells from implanting in normal tissues such as the peritoneum.  The results showed that BAY 11-7085 significantly inhibited peritoneal carcinomatosis in mice following the introduction of colon and pancreatic cancer cell lines into the intra-abdominal cavity.  Treatment with BAY 11-7085 restored juxtacrine death receptor signaling during the adhesion of the cancer cells to mesothelial cells, which line the peritoneum.  BAY 11-7085 rapidly inhibited c-FLIPL expression in colon and pancreatic cancer cell lines during adhesion to mesothelial cells.  Pancreatic cancer cells sorted for high c-FLIPL expression formed peritoneal implants much more readily than cells with low c-FLIPL expression, and RNAi inhibition of c-FLIPL in colon cancer cells dramatically reduced peritoneal implantation.  This is a novel demonstration that the restoration of death receptor-mediated apoptotic signaling in cancer cells through the pharmacol. inhibition of c-FLIPL can inhibit tumor implantation in a clin. relevant model of peritoneal carcinomatosis, a fatal disease.  Pharmacol. inhibitors of FLIP hold promise as a way to curtail cancer cell colonization of secondary tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUURkASQMaz7Vg90H21EOLACvtfcHk0lhP9h16CxvIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsLs%253D&md5=63548151220976300f198e58a1d36bd9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fijc.26119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.26119%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DHerde%26aufirst%3DR.%26aulast%3DDoxey%26aufirst%3DB.%2BW.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DP.%2BD.%26aulast%3DKuwada%26aufirst%3DS.%2BK.%26atitle%3DPharmacologic%2520downregulation%2520of%2520c-FLIP%2528L%2529%2520restores%2520juxtacrine%2520death%2520receptor-mediated%2520apoptosis%2520in%2520cancer%2520cells%2520in%2520a%2520peritoneal%2520carcinomatosis%2520model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D130%26spage%3D1494%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Budd, R. C.</span><span> </span><span class="NLM_article-title">Death receptors couple to both cell proliferation and apoptosis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=437-441&author=R.+C.+Budd&title=Death+receptors+couple+to+both+cell+proliferation+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBudd%26aufirst%3DR.%2BC.%26atitle%3DDeath%2520receptors%2520couple%2520to%2520both%2520cell%2520proliferation%2520and%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D437%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Catalan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selgas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, A.</span><span> </span><span class="NLM_article-title">Regulation of apoptosis by lethal cytokines in human mesothelial cells</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1046%2Fj.1523-1755.2003.00062.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12787425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFeks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=321-330&author=M.+P.+Catalanauthor=D.+Subiraauthor=A.+Reyeroauthor=R.+Selgasauthor=A.+Ortiz-Gonzalezauthor=J.+Egidoauthor=A.+Ortiz&title=Regulation+of+apoptosis+by+lethal+cytokines+in+human+mesothelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of apoptosis by lethal cytokines in human mesothelial cells</span></div><div class="casAuthors">Catalan, Marina Penelope; Subira, Dolores; Reyero, Ana; Selgas, Rafael; Ortiz-Gonzalez, Arturo; Egido, Jesus; Ortiz, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">321-330</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Dysregulation of peritoneal cell death may contribute to the complications of peritoneal dialysis (PD).  Chronic peritoneal dialysis and acute peritonitis are both assocd. with loss of mesothelial cells.  In addn., acute peritonitis is characterized by sudden changes in the no. of peritoneal leukocytes.  However, the factors regulating peritoneal cell survival are poorly understood.  Peritoneal effluent cells and mesothelial cells cultured from peritoneal dialysis patients were studied.  Reverse transcriptase-polymerase chain reaction (RT-PCR) and flow cytometry were used to assess the expression of FasL and Fas mRNA and protein.  Western blot was used to assess FasL and tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL).  RT-PCR was used to study TRAIL and TRAIL receptor mRNA.  Apoptosis was quantified by flow cytometry of DNA content and confirmed by morphol.  Apoptotic cells, including apoptotic mesothelial cells, were present in the peritoneal effluent of stable peritoneal dialysis patients and patients with bacterial peritonitis.  The lethal cytokines FasL and TRAIL were expressed by peritoneal effluent cells, while cultured mesothelial cells expressed FasL, Fas, and TRAIL receptors.  Cultured mesothelial cells were sensitive to FasL-induced apoptosis.  IFN-γ increased the cell surface expression of Fas and the sensitivity of mesothelial cells to FasL-induced apoptosis.  In contrast to the effect of FasL, TNFα and TRAIL did not induce apoptosis in human mesothelial cells from peritoneal dialysis patients.  Lethal cytokines, such as FasL, may contribute to peritoneal cell turnover and the loss of mesothelium in peritoneal dialysis.  The role of other cytokines, such as TRAIL, remains undefined.  Approaches in limiting mesothelial cell injury that interferes with apoptosis should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrob54VO5dj3LVg90H21EOLACvtfcHk0lhP9h16CxvIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFeks7o%253D&md5=e3a0fd84eb7bb08abaef1ce253bf35f5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2003.00062.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2003.00062.x%26sid%3Dliteratum%253Aachs%26aulast%3DCatalan%26aufirst%3DM.%2BP.%26aulast%3DSubira%26aufirst%3DD.%26aulast%3DReyero%26aufirst%3DA.%26aulast%3DSelgas%26aufirst%3DR.%26aulast%3DOrtiz-Gonzalez%26aufirst%3DA.%26aulast%3DEgido%26aufirst%3DJ.%26aulast%3DOrtiz%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520apoptosis%2520by%2520lethal%2520cytokines%2520in%2520human%2520mesothelial%2520cells%26jtitle%3DKidney%2520Int.%26date%3D2003%26volume%3D64%26spage%3D321%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zificsak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theroff, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwada, S. K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of sulfonyl acrylonitriles as novel inhibitors to peritoneal carcinomatosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1850</span><span class="NLM_x">–</span> <span class="NLM_lpage">1853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1850-1853&author=C.+A.+Zificsakauthor=Y.+Shenauthor=J.+G.+Liskoauthor=J.+P.+Theroffauthor=X.+Laoauthor=O.+Bolltauthor=X.+Liauthor=B.+D.+Dorseyauthor=S.+K.+Kuwada&title=Synthesis+and+biological+evaluation+of+sulfonyl+acrylonitriles+as+novel+inhibitors+to+peritoneal+carcinomatosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZificsak%26aufirst%3DC.%2BA.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DTheroff%26aufirst%3DJ.%2BP.%26aulast%3DLao%26aufirst%3DX.%26aulast%3DBollt%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DKuwada%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520sulfonyl%2520acrylonitriles%2520as%2520novel%2520inhibitors%2520to%2520peritoneal%2520carcinomatosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1850%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Elokdah, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKean, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babiak, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinet, E. M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030219z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=681-695&author=H.+Elokdahauthor=T.+S.+Sulkowskiauthor=M.+Abou-Gharbiaauthor=J.+A.+Buteraauthor=S.+Y.+Chaiauthor=G.+R.+McFarlaneauthor=M.+L.+McKeanauthor=J.+L.+Babiakauthor=S.+J.+Adelmanauthor=E.+M.+Quinet&title=Design%2C+synthesis%2C+and+biological+evaluation+of+thio-containing+compounds+with+serum+HDL-cholesterol-elevating+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm030219z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030219z%26sid%3Dliteratum%253Aachs%26aulast%3DElokdah%26aufirst%3DH.%26aulast%3DSulkowski%26aufirst%3DT.%2BS.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DButera%26aufirst%3DJ.%2BA.%26aulast%3DChai%26aufirst%3DS.%2BY.%26aulast%3DMcFarlane%26aufirst%3DG.%2BR.%26aulast%3DMcKean%26aufirst%3DM.%2BL.%26aulast%3DBabiak%26aufirst%3DJ.%2BL.%26aulast%3DAdelman%26aufirst%3DS.%2BJ.%26aulast%3DQuinet%26aufirst%3DE.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520thio-containing%2520compounds%2520with%2520serum%2520HDL-cholesterol-elevating%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D681%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hashmi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyrauch, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bats, J. W.</span><span> </span><span class="NLM_article-title">Gold catalysis: mild conditions for the synthesis of oxazoles from <i>N</i>-propargylcarboxamides and mechanistic aspects</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4391</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0480067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4391-4394&author=A.+S.+Hashmiauthor=J.+P.+Weyrauchauthor=W.+Freyauthor=J.+W.+Bats&title=Gold+catalysis%3A+mild+conditions+for+the+synthesis+of+oxazoles+from+N-propargylcarboxamides+and+mechanistic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fol0480067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0480067%26sid%3Dliteratum%253Aachs%26aulast%3DHashmi%26aufirst%3DA.%2BS.%26aulast%3DWeyrauch%26aufirst%3DJ.%2BP.%26aulast%3DFrey%26aufirst%3DW.%26aulast%3DBats%26aufirst%3DJ.%2BW.%26atitle%3DGold%2520catalysis%253A%2520mild%2520conditions%2520for%2520the%2520synthesis%2520of%2520oxazoles%2520from%2520N-propargylcarboxamides%2520and%2520mechanistic%2520aspects%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4391%26epage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Talamas, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao-Ieong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vicente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaleb, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfeld, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span> </span><span class="NLM_article-title">De novo fragment design: a medicinal chemistry approach to fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3115</span><span class="NLM_x">–</span> <span class="NLM_lpage">3119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4002605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3115-3119&author=F.+X.+Talamasauthor=G.+Ao-Ieongauthor=K.+A.+Brameldauthor=E.+Chinauthor=J.+de+Vicenteauthor=J.+P.+Dunnauthor=M.+Ghateauthor=A.+M.+Giannettiauthor=S.+F.+Harrisauthor=S.+S.+Labadieauthor=V.+Levequeauthor=J.+Liauthor=A.+S.+Luiauthor=K.+L.+McCalebauthor=I.+Najeraauthor=R.+C.+Schoenfeldauthor=B.+Wangauthor=A.+Wong&title=De+novo+fragment+design%3A+a+medicinal+chemistry+approach+to+fragment-based+lead+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm4002605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002605%26sid%3Dliteratum%253Aachs%26aulast%3DTalamas%26aufirst%3DF.%2BX.%26aulast%3DAo-Ieong%26aufirst%3DG.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DChin%26aufirst%3DE.%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DJ.%2BP.%26aulast%3DGhate%26aufirst%3DM.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DLabadie%26aufirst%3DS.%2BS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLui%26aufirst%3DA.%2BS.%26aulast%3DMcCaleb%26aufirst%3DK.%2BL.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DA.%26atitle%3DDe%2520novo%2520fragment%2520design%253A%2520a%2520medicinal%2520chemistry%2520approach%2520to%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3115%26epage%3D3119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Johnstone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindelar, W. F.</span><span> </span><span class="NLM_article-title">Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial</span> <span class="citation_source-journal">Int. J. Radiat. Oncol. Biol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1016%2F0360-3016%2893%2990456-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=8244812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2c%252FmsVChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1993&pages=831-834&author=P.+A.+Johnstoneauthor=W.+F.+Sindelar&title=Patterns+of+disease+recurrence+following+definitive+therapy+of+adenocarcinoma+of+the+pancreas+using+surgery+and+adjuvant+radiotherapy%3A+correlations+of+a+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy:correlations of a clinical trial</span></div><div class="casAuthors">Johnstone P A; Sindelar W F</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation oncology, biology, physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">831-4</span>
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    </div><div class="casAbstract">PURPOSE:  Between 1980 and 1984, 26 patients with resectable adenocarcinoma of the pancreatic head were enrolled in a National Cancer Institute protocol evaluating intraoperative radiotherapy vs. standard therapy.  METHODS AND MATERIALS:  After complete excision of their lesions, patients were observed (Stage I), or randomized to intraoperative radiotherapy vs. external beam radiotherapy (Stages II-IV).  The intraoperative dose was 20 Gy in a single fraction using 9-20 MeV electrons.  The external beam radiotherapy schema involved daily 150-180 cGy fractions to 45-55 Gy in 5-6 weeks.  Chemotherapy was not used for primary disease but was administered off protocol for recurrent disease.  Median potential followup for the trial was > 9 years, with a median patient survival of 18 months.  Perioperative mortality was 27% (7 patients).  Of the remaining 19 patients, one remains alive and without evidence of disease 9 years post-therapy.  Twelve patients underwent autopsy and 2 required antemortem laparotomy; histopathologic evidence of disease recurrence was analyzed.  RESULTS:  Of 15 patients evaluable for intra-abdominal control, 7 (47%) suffered local recurrences and 7 (47%) failed regionally, with 5 patients (35%) failing in both areas.  Five patients (35%) developed peritoneal seeding.  Of 13 patients evaluable for systemic disease, 8 (62%) suffered distant failure.  There were no differences in outcome between intraoperative or external beam radiotherapy or observation in this subset of patients.  CONCLUSION:  This report is among the most rigorous descriptions of patterns of failure after resection of pancreatic cancer.  It appears clear that advances in local control of this disease are unlikely to translate into increased survival in the absence of improved systemic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTidEn3ZC8eeWBAiYWy6n3SfW6udTcc2ebnUo2cvgQ-Hrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FmsVChug%253D%253D&md5=dddfb74a699ce8d5da48dd08942cc74a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0360-3016%2893%2990456-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0360-3016%252893%252990456-6%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DP.%2BA.%26aulast%3DSindelar%26aufirst%3DW.%2BF.%26atitle%3DPatterns%2520of%2520disease%2520recurrence%2520following%2520definitive%2520therapy%2520of%2520adenocarcinoma%2520of%2520the%2520pancreas%2520using%2520surgery%2520and%2520adjuvant%2520radiotherapy%253A%2520correlations%2520of%2520a%2520clinical%2520trial%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%2520Biol.%2520Phys.%26date%3D1993%26volume%3D27%26spage%3D831%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fujiwara, K.</span><span> </span><span class="NLM_article-title">Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer</span> <span class="citation_source-journal">Gan To Kagaku Ryoho</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">Suppl 2</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3czptVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=Suppl+2&publication_year=2000&pages=354-358&author=K.+Fujiwara&title=Intraperitoneal+chemotherapy+and+intraperitoneal+washing+cytology+in+management+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer</span></div><div class="casAuthors">Fujiwara K</div><div class="citationInfo"><span class="NLM_cas:title">Gan to kagaku ryoho. Cancer & chemotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">354-8</span>
        ISSN:<span class="NLM_cas:issn">0385-0684</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyZu_Zs4r0-Htlzo9xastyfW6udTcc2eZdf8RWvPytd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czptVGmug%253D%253D&md5=00e01eaeb70a2caa3d3408a264014cfa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujiwara%26aufirst%3DK.%26atitle%3DIntraperitoneal%2520chemotherapy%2520and%2520intraperitoneal%2520washing%2520cytology%2520in%2520management%2520of%2520ovarian%2520cancer%26jtitle%3DGan%2520To%2520Kagaku%2520Ryoho%26date%3D2000%26volume%3DSuppl%25202%26spage%3D354%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kanellos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetriades, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zintzaras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandrali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantzoros, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betsis, D.</span><span> </span><span class="NLM_article-title">Incidence and prognostic value of positive peritoneal cytology in colorectal cancer</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs10350-004-6595-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12682550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3s7msVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=535-539&author=I.+Kanellosauthor=H.+Demetriadesauthor=E.+Zintzarasauthor=A.+Mandraliauthor=I.+Mantzorosauthor=D.+Betsis&title=Incidence+and+prognostic+value+of+positive+peritoneal+cytology+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence and prognostic value of positive peritoneal cytology in colorectal cancer</span></div><div class="casAuthors">Kanellos I; Demetriades H; Zintzaras E; Mandrali A; Mantzoros I; Betsis D</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">535-9</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  This study was conducted to investigate the incidence of free cancer cells in the peritoneal washings of patients who had undergone surgery for colorectal cancer and to evaluate its influence as a prognostic factor of the disease.  METHODS:  From 1990 to 1996, intraoperative washing cytology was performed in 110 patients who underwent surgery for colorectal cancer.  All patients had curative resections.  Immediately after the abdomen was opened and before exploration and mobilization of the tumor, 100 ml of saline was injected over the tumor site.  Washings were then aspirated and taken for cytologic examination.  RESULTS:  Twenty-two (20 percent) of 110 patients examined were found to have positive cytology for intraperitoneal free malignant cells.  The site of tumor in the colon or rectum, tumor size, nodal status, degree of differentiation, mucinous characteristics, and vascular or neural invasion were found not to affect the incidence of free cancer cells.  Conversely, tumor penetration was found to affect the incidence of positive cytology.  The degree of association among the stages of tumor penetration was indicated by the contingency coefficient, which was 0.42.  Patients with positive cytology had a significantly higher rate of local recurrence and peritoneal carcinomatosis (22.8 vs. 8 percent, P = 0.05) than patients with negative cytology.  Mortality rate was not found to be related to the presence of free cancer cells.  CONCLUSION:  Cytologic examination of peritoneal lavage at the time of surgery could be a useful prognostic indicator for local and peritoneal recurrence rate.  However, it was not found to be a predictor of survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5iupvSi8kMc25P7XSLhESfW6udTcc2eZdf8RWvPytd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7msVeitQ%253D%253D&md5=418cfe348dbf87150a2e10c0349a70b8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10350-004-6595-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10350-004-6595-0%26sid%3Dliteratum%253Aachs%26aulast%3DKanellos%26aufirst%3DI.%26aulast%3DDemetriades%26aufirst%3DH.%26aulast%3DZintzaras%26aufirst%3DE.%26aulast%3DMandrali%26aufirst%3DA.%26aulast%3DMantzoros%26aufirst%3DI.%26aulast%3DBetsis%26aufirst%3DD.%26atitle%3DIncidence%2520and%2520prognostic%2520value%2520of%2520positive%2520peritoneal%2520cytology%2520in%2520colorectal%2520cancer%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D2003%26volume%3D46%26spage%3D535%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nakatsuka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokohata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chijiiwa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span> </span><span class="NLM_article-title">Positive washing cytology in patients with pancreatic cancer indicates a contraindication of pancreatectomy</span> <span class="citation_source-journal">Int. J. Surg. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12774455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ltFehtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=311-317&author=A.+Nakatsukaauthor=K.+Yamaguchiauthor=S.+Shimizuauthor=K.+Yokohataauthor=T.+Morisakiauthor=K.+Chijiiwaauthor=M.+Tanaka&title=Positive+washing+cytology+in+patients+with+pancreatic+cancer+indicates+a+contraindication+of+pancreatectomy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Positive washing cytology in patients with pancreatic cancer indicates a contraindication of pancreatectomy</span></div><div class="casAuthors">Nakatsuka A; Yamaguchi K; Shimizu S; Yokohata K; Morisaki T; Chijiiwa K; Tanaka M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of surgical investigation</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-7</span>
        ISSN:<span class="NLM_cas:issn">1028-5229</span>.
    </div><div class="casAbstract">BACKGROUND:  Although peritoneal washing cytology has been widely used in the field of gynecology, it has not been performed so frequently in patients with pancreatic cancer.  Only a few papers have reported surgical implications of peritoneal washing cytology.  MATERIALS AND METHODS:  We reviewed results of peritoneal washing cytology performed immediately after laparotomy in 50 Japanese patients with pancreatic cancer.  The 50 patients were divided into two groups according to the results of cytology.  Clinicopathological findings were compared between these two groups.  RESULTS:  Cytology of peritoneal washing was positive in 13 (26%) of the 50 patients.  Nine of the 13 patients had no visible peritoneal dissemination.  There were no significant differences regarding the age, tumor size and serum level of the carcinoembryonic antigen.  Moderately to poorly differentiated adenocarcinoma and perineural invasion (ne3) and lymphatic permeation (ly3) of marked degree were more frequent in the positive group than in the negative group (p < 0.01).  The survival curve of the 37 patients with negative cytology was significantly better than that of the 13 with positive cytology (p < 0.01).  Four of 13 patients with positive cytology underwent a potentially curative resection but died within 12 months.  Three of these four patients died of peritonitis carcinomatosa with massive malignant ascites and one died of local recurrence.  CONCLUSIONS:  Positive peritoneal washing cytology is not rare in patients with pancreatic cancer and indicates a contraindication of pancreatectomy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0BQDWUhjo2hLDWw4HIq2sfW6udTcc2eZdf8RWvPytd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ltFehtQ%253D%253D&md5=5e03f8e96393311c898db44ac813a672</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakatsuka%26aufirst%3DA.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DYokohata%26aufirst%3DK.%26aulast%3DMorisaki%26aufirst%3DT.%26aulast%3DChijiiwa%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26atitle%3DPositive%2520washing%2520cytology%2520in%2520patients%2520with%2520pancreatic%2520cancer%2520indicates%2520a%2520contraindication%2520of%2520pancreatectomy%26jtitle%3DInt.%2520J.%2520Surg.%2520Invest.%26date%3D1999%26volume%3D1%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Santala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talvensaari-Mattila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauppila, A.</span><span> </span><span class="NLM_article-title">Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3097</span><span class="NLM_x">–</span> <span class="NLM_lpage">3103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12926169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVCntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3097-3103&author=M.+Santalaauthor=A.+Talvensaari-Mattilaauthor=A.+Kauppila&title=Peritoneal+cytology+and+preoperative+serum+CA+125+level+are+important+prognostic+indicators+of+overall+survival+in+advanced+endometrial+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer</span></div><div class="casAuthors">Santala, Markku; Talvensaari-Mattila, Anne; Kauppila, Antti</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3C</span>),
    <span class="NLM_cas:pages">3097-3103</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">The current study aimed to evaluate flow cytometry findings, peritoneal cytol. and preoperative CA125 level as prognostic factors of endometrial carcinoma.  A retrospective study of 44 patients with FIGO stage II-IV endometrial carcinoma who underwent abdominal hysterectomy, bilateral salpingo-oophorectomy and, all except three, pelvic lymph node dissection.  At operation, a peritoneal washing sample was taken for cytol. examn.  Flow cytometry was performed on fresh primary tumor samples.  Blood samples were obtained within 2 wk before surgery.  The median follow-up time was 54 mo.  In univariate anal., DNA ploidy, S-phase fraction, serum CA125 level and peritoneal cytol. findings correlated significantly with survival.  In multivariate anal., peritoneal cytol. (benign vs. malignant), grade (1 + 2 vs. 3) and preoperative serum CA125 concn. (≤ 25 U/mL vs. > 25 U/mL) remained significant independent predictors of overall survival DNA ploidy and S-phase fraction had a strong correlation with peritoneal cytol.  Malignant cytol. findings were more frequent in cases with DNA aneuploidy and S-phase fraction higher than 8%.  In addn. to histol. grade, peritoneal cytol. and preoperative serum CA125 level were also important independent prognostic indicators of outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDyAVx5Ug-0rVg90H21EOLACvtfcHk0liTzMI6BlA6NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVCntr0%253D&md5=0f910500bdb9fabc2cd92b8ec880e247</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantala%26aufirst%3DM.%26aulast%3DTalvensaari-Mattila%26aufirst%3DA.%26aulast%3DKauppila%26aufirst%3DA.%26atitle%3DPeritoneal%2520cytology%2520and%2520preoperative%2520serum%2520CA%2520125%2520level%2520are%2520important%2520prognostic%2520indicators%2520of%2520overall%2520survival%2520in%2520advanced%2520endometrial%2520cancer%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3097%26epage%3D3103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Terauchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, H.</span><span> </span><span class="NLM_article-title">Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm</span> <span class="citation_source-journal">Int. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs101470200054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12494251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Ohtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=356-360&author=F.+Terauchiauthor=T.+Moritakeauthor=Y.+Yamamotoauthor=H.+Ogura&title=Combination+chemotherapy+with+paclitaxel+and+intraperitoneal+cisplatin+for+ovarian+cancer+with+disseminated+lesions+in+the+peritoneum+and+the+diaphragm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm</span></div><div class="casAuthors">Terauchi, F.; Moritake, T.; Yamamoto, Y.; Ogura, H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-360</span>CODEN:
                <span class="NLM_cas:coden">IJCOF6</span>;
        ISSN:<span class="NLM_cas:issn">1341-9625</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Tokyo</span>)
        </div><div class="casAbstract">In ovarian cancer, the management of micrometastases disseminated in the peritoneal cavity is extremely important.  We performed i.v. paclitaxel (PAC) infusion combined with cisplatin (CDDP) i.p. infusion for progressive ovarian cancer.  Twelve patients with progressive epithelial ovarian cancer (FIGO IIIc), which was resected using an optimal method at primary surgery, except for disseminated lesions in the peritoneum and the diaphragm, were studied.  At primary surgery, a reservoir was placed in the peritoneal cavity.  If metastases were identified in the diaphragm, then another reservoir was also placed in the subdiaphragm (double reservoirs).  The basic regimen was set at 175 mg/m2 with divided doses of PAC and 75 mg/m2 CDDP by i.p. injection.  When a double reservoir was used, 30 mg/m2 of subdiaphragmatic CDDP and 45 mg/m2 of i.p. CDDP were administered.  The patients received five courses of this regimen.  The response to the therapy was evaluated with tumor markers, and by using cytodiagnoses on the peritoneal washing fluid collected from the reservoirs.  After five courses of the chemotherapy, the tumor marker levels and cytodiagnoses of all patients became neg.  With ref. to adverse effects, grade 3-4 neutropenia was detected in 2 patients (16.6%), peripheral neuropathy was detected in 4 patients (33.3%), and alopecia was detected in 11 patients (91.6%).  The median follow-up period was 29.2 mo and median progression-free survival was 25.6 mo.  Thus, the combination chemotherapy with i.v. PAC and i.p. CDDP was effective on ovarian cancer with disseminated lesions in the peritoneum and the diaphragm, having only mild adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo927SlQeW7rrVg90H21EOLACvtfcHk0lgQ0scSjS2BwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Ohtb0%253D&md5=1136127f97d3452cacb781d0422347ad</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs101470200054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs101470200054%26sid%3Dliteratum%253Aachs%26aulast%3DTerauchi%26aufirst%3DF.%26aulast%3DMoritake%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DOgura%26aufirst%3DH.%26atitle%3DCombination%2520chemotherapy%2520with%2520paclitaxel%2520and%2520intraperitoneal%2520cisplatin%2520for%2520ovarian%2520cancer%2520with%2520disseminated%2520lesions%2520in%2520the%2520peritoneum%2520and%2520the%2520diaphragm%26jtitle%3DInt.%2520J.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D7%26spage%3D356%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Yachida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosuge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirohashi, S.</span><span> </span><span class="NLM_article-title">Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer</span> <span class="citation_source-journal">Br. J. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1046%2Fj.1365-2168.2002.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=11972546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD383jsFehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2002&pages=573-578&author=S.+Yachidaauthor=N.+Fukushimaauthor=M.+Sakamotoauthor=Y.+Matsunoauthor=T.+Kosugeauthor=S.+Hirohashi&title=Implications+of+peritoneal+washing+cytology+in+patients+with+potentially+resectable+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer</span></div><div class="casAuthors">Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of surgery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">573-8</span>
        ISSN:<span class="NLM_cas:issn">0007-1323</span>.
    </div><div class="casAbstract">BACKGROUND:  The aim of this study was to assess the implications of positive peritoneal washing cytology for management of patients with potentially resectable pancreatic cancer.  METHODS:  Cytological examination of peritoneal washings was performed in 134 patients who underwent surgical resection for pancreatic adenocarcinoma.  The clinicopathological findings and the relationship between cytology results (including cytomorphology) and survival were investigated.  RESULTS:  One hundred and fourteen patients (85 per cent) had negative cytology results (group 1).  Excluding one patient with atypical cells, positive cytology results were obtained in 19 patients (14 per cent): 16 patients without macroscopic peritoneal metastases (group 2) and three patients with minimal macroscopic peritoneal metastases (group 3).  The patients in group 2 had significantly larger (P < 0.001) and more advanced (P = 0.022) tumours than those in group 1.  However, there were no significant differences in postoperative cumulative survival rates between groups 1 and 2 (P = 0.347).  Two patients in group 2 are long-term survivors (40 and 58 months).  In cytomorphological analyses, the presence of clusters with ragged edges and isolated carcinoma cells can be considered to indicate a high risk of peritoneal recurrence.  CONCLUSION:  Positive cytology does not directly predict peritoneal carcinomatosis and, while associated with advanced disease, does not contraindicate radical surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzmYewUgdhK4YPsCkJIw00fW6udTcc2eaRM4fEGHqV97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383jsFehsA%253D%253D&md5=8e82f79f2dfea64558dfef89ee9567f3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2168.2002.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2168.2002.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DYachida%26aufirst%3DS.%26aulast%3DFukushima%26aufirst%3DN.%26aulast%3DSakamoto%26aufirst%3DM.%26aulast%3DMatsuno%26aufirst%3DY.%26aulast%3DKosuge%26aufirst%3DT.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3DImplications%2520of%2520peritoneal%2520washing%2520cytology%2520in%2520patients%2520with%2520potentially%2520resectable%2520pancreatic%2520cancer%26jtitle%3DBr.%2520J.%2520Surg.%26date%3D2002%26volume%3D89%26spage%3D573%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Jorgensen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalak, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, D. R.</span><span> </span><span class="NLM_article-title">Is laparoscopy associated with a lower rate of postoperative adhesions than laparotomy? A comparative study in the rabbit</span> <span class="citation_source-journal">Aust. N. Z. J. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1111%2Fj.1445-2197.1995.tb00651.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=7741679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2M3mtVaksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1995&pages=342-344&author=J.+O.+Jorgensenauthor=N.+J.+Lalakauthor=D.+R.+Hunt&title=Is+laparoscopy+associated+with+a+lower+rate+of+postoperative+adhesions+than+laparotomy%3F+A+comparative+study+in+the+rabbit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Is laparoscopy associated with a lower rate of postoperative adhesions than laparotomy? A comparative study in the rabbit</span></div><div class="casAuthors">Jorgensen J O; Lalak N J; Hunt D R</div><div class="citationInfo"><span class="NLM_cas:title">The Australian and New Zealand journal of surgery</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">342-4</span>
        ISSN:<span class="NLM_cas:issn">0004-8682</span>.
    </div><div class="casAbstract">This trial set out to test the hypothesis that there is no difference in the incidence of intra-abdominal adhesions after a stereotyped intraperitoneal injury created via laparoscopy or laparotomy.  Twenty New Zealand White rabbits had a 2 x 2 cm area of peritoneum stripped off their caecum and adjacent parietal peritoneum, either by laparotomy or laparoscopy.  Outcome was assessed by the incidence of adhesions to the test site and the wound.  There was no difference in the rate of adhesions at the test site in the two groups.  The rate of adhesions to the wound was different in the two groups (70% laparotomy, 0% laparoscopy; P = 0.003).  In a rabbit model, comparing laparoscopy and laparotomy in a strictly controlled operative environment, a stereotyped intraperitoneal injury results in similar rates of postoperative adhesions.  Laparoscopy is, however, associated with a much lower incidence of wound adhesion.  The potential for postoperative adhesions is real after laparoscopic surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1HxZHxO9ZWEodMGTatQ7LfW6udTcc2eaRM4fEGHqV97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3mtVaksA%253D%253D&md5=fafcf4a1b82d24dfb2f0c5a2c0ac9602</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1445-2197.1995.tb00651.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1445-2197.1995.tb00651.x%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DJ.%2BO.%26aulast%3DLalak%26aufirst%3DN.%2BJ.%26aulast%3DHunt%26aufirst%3DD.%2BR.%26atitle%3DIs%2520laparoscopy%2520associated%2520with%2520a%2520lower%2520rate%2520of%2520postoperative%2520adhesions%2520than%2520laparotomy%253F%2520A%2520comparative%2520study%2520in%2520the%2520rabbit%26jtitle%3DAust.%2520N.%2520Z.%2520J.%2520Surg.%26date%3D1995%26volume%3D65%26spage%3D342%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, R. L.</span><span> </span><span class="NLM_article-title">Peritoneal irrigation with povidone–iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2FBF02236346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=10223750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK1M3jvValtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=319-326&author=S.+W.+Leeauthor=N.+R.+Gleasonauthor=M.+Besslerauthor=R.+L.+Whelan&title=Peritoneal+irrigation+with+povidone%E2%80%93iodine+solution+after+laparoscopic-assisted+splenectomy+significantly+decreases+port-tumor+recurrence+in+a+murine+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Peritoneal irrigation with povidone-iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model</span></div><div class="casAuthors">Lee S W; Gleason N R; Bessler M; Whelan R L</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-26</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  The development of port-wound tumor recurrences has raised questions regarding the safety of laparoscopic methods for the resection of malignancies.  The cause and the incidence of abdominal-wall tumor recurrences remain unknown.  It is also not clear how to avoid or lower the incidence of port-tumor recurrences.  The purpose of the current study was to determine the impact of abdominal irrigation with povidone-iodine on the port-wound tumor incidence in a murine model.  METHODS:  A splenic tumor model was used for this study.  To establish splenic tumors, female BALB/c mice (N = 48) were given subcapsular splenic injections of a 0.1 ml suspension containing 10(5) C-26 colon adenocarcinoma cells via a left-flank incision at the initial procedure.  Seven days later, the animals with isolated splenic tumors (100 percent) were randomly assigned to one of three groups: 1) control, 2) saline irrigation (saline), or 3) povidone-iodine irrigation.  All animals underwent laparoscopic mobilization of the spleen using a three-port technique, intra-abdominal crushing of the tumor, followed by an extracorporeal splenectomy via a subcostal incision.  No irrigation was performed for control group animals.  In the saline irrigation group, the subcostal incision was closed and pneumoperitoneum was re-established.  The abdominal cavity was irrigated with 5 ml of normal saline for 60 seconds before instrument removal.  In the povidone-iodine irrigation group, similar abdominal irrigation was performed, using 0.25 percent povidone-iodine.  Attempts were made to recover completely the irrigation for both irrigation groups.  Seven days after the splenectomy, animals were killed and inspected for abdominal-wall tumor implants.  RESULTS:  There were significantly more animals with at least one port-tumor recurrence in the control group than in the povidone-iodine group (P = 0.007).  Although not statistically significant, the number of animals with port-wound tumors was higher in the saline group than in the povidone-iodine group (P < 0.08).  There was no significant difference between the saline group and the control group.  When each port site was considered independently, the incidence of port-wound tumors (number of ports with tumors per total number of ports) was significantly lower in the povidone-iodine group than in both the control (P = 0.00001) and saline groups (P = 0.03).  The incidence of port-wound tumors was also significantly lower in the saline group compared with the control group incidence (P = 0.03).  CONCLUSIONS:  Abdominal irrigation with dilute povidone-iodine solution significantly reduced the number of animals with port-tumor recurrences.  Abdominal irrigation with saline was also effective in reducing the incidence of port-wound tumor formation when each port was considered separately.  However, povidone-iodine irrigation was much more effective than saline irrigation in preventing port-wound tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPLW2QA0YEELZpSb_XWfMrfW6udTcc2ebPdBDDfjNflbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3jvValtA%253D%253D&md5=41b94b8e3a5fdd82f0fb8f91399b4ede</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF02236346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02236346%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DGleason%26aufirst%3DN.%2BR.%26aulast%3DBessler%26aufirst%3DM.%26aulast%3DWhelan%26aufirst%3DR.%2BL.%26atitle%3DPeritoneal%2520irrigation%2520with%2520povidone%25E2%2580%2593iodine%2520solution%2520after%2520laparoscopic-assisted%2520splenectomy%2520significantly%2520decreases%2520port-tumor%2520recurrence%2520in%2520a%2520murine%2520model%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1999%26volume%3D42%26spage%3D319%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Micames, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jowell, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, K.</span><span> </span><span class="NLM_article-title">Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA</span> <span class="citation_source-journal">Gastrointest. Endosc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1016%2FS0016-5107%2803%2902009-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=14595302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3srhs1yitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=690-695&author=C.+Micamesauthor=P.+S.+Jowellauthor=R.+Whiteauthor=E.+Paulsonauthor=R.+Nelsonauthor=M.+Morseauthor=H.+Hurwitzauthor=T.+Pappasauthor=D.+Tylerauthor=K.+McGrath&title=Lower+frequency+of+peritoneal+carcinomatosis+in+patients+with+pancreatic+cancer+diagnosed+by+EUS-guided+FNA+vs.+percutaneous+FNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA</span></div><div class="casAuthors">Micames Carlos; Jowell Paul S; White Rebekah; Paulson Erik; Nelson Rendon; Morse Michael; Hurwitz Herbert; Pappas Theodore; Tyler Douglas; McGrath Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Gastrointestinal endoscopy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">690-5</span>
        ISSN:<span class="NLM_cas:issn">0016-5107</span>.
    </div><div class="casAbstract">BACKGROUND:  Studies have suggested an increased risk of peritoneal seeding in patients with pancreatic cancer diagnosed by percutaneous FNA.  EUS-FNA is an alternate method of diagnosis.  The aim of this study was to compare the frequency of peritoneal carcinomatosis as a treatment failure pattern in patients with pancreatic cancer diagnosed by EUS-FNA vs. percutaneous FNA.  METHODS:  Retrospective review of patients with non-metastatic pancreatic cancer identified 46 patients in whom the diagnosis was made by EUS-FNA and 43 with the diagnosis established by percutaneous FNA.  All had neoadjuvant chemoradiation.  Patients underwent restaging CT after completion of therapy, followed by attempted surgical resection if there was no evidence of disease progression.  RESULTS:  There were no significant differences in tumor characteristics between the two study groups.  In the EUS-FNA group, one patient had developed peritoneal carcinomatosis compared with 7 in the percutaneous FNA group (2.2% vs. 16.3%; p<0.025).  No patient with a potentially resectable tumor in the EUS-FNA group had developed peritoneal carcinomatosis.  CONCLUSIONS:  Peritoneal carcinomatosis may occur more frequently in patients who undergo percutaneous FNA compared with those who have EUS-FNA for the diagnosis of pancreatic cancer.  A concern for peritoneal seeding of pancreatic cancer via percutaneous FNA is warranted.  EUS-guided FNA is recommended as the method of choice for diagnosis in patients with potentially resectable pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXRWdwTw_aYAMthz5_Rx5rfW6udTcc2ebPdBDDfjNflbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srhs1yitQ%253D%253D&md5=5261f70fc94ff5580ab6c2f6d46c0186</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0016-5107%2803%2902009-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5107%252803%252902009-1%26sid%3Dliteratum%253Aachs%26aulast%3DMicames%26aufirst%3DC.%26aulast%3DJowell%26aufirst%3DP.%2BS.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DPaulson%26aufirst%3DE.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DMorse%26aufirst%3DM.%26aulast%3DHurwitz%26aufirst%3DH.%26aulast%3DPappas%26aufirst%3DT.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DMcGrath%26aufirst%3DK.%26atitle%3DLower%2520frequency%2520of%2520peritoneal%2520carcinomatosis%2520in%2520patients%2520with%2520pancreatic%2520cancer%2520diagnosed%2520by%2520EUS-guided%2520FNA%2520vs.%2520percutaneous%2520FNA%26jtitle%3DGastrointest.%2520Endosc.%26date%3D2003%26volume%3D58%26spage%3D690%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">P, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balshem, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litwin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. P.</span><span> </span><span class="NLM_article-title">Implications of fine-needle aspiration in patients with resectable pancreatic cancer</span> <span class="citation_source-journal">Am. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=9247432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2szptVGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=675-679&author=D.+E.+Johnsonauthor=T.+Pauthor=A.+M.+Balshemauthor=E.+Rossauthor=S.+Litwinauthor=B.+L.+Eisenbergauthor=J.+P.+Hoffman&title=Implications+of+fine-needle+aspiration+in+patients+with+resectable+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of fine-needle aspiration in patients with resectable pancreatic cancer</span></div><div class="casAuthors">Johnson D E; Pendurthi T K; Balshem A M; Ross E; Litwin S; Eisenberg B L; Hoffman J P</div><div class="citationInfo"><span class="NLM_cas:title">The American surgeon</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-9; discussion 679-80</span>
        ISSN:<span class="NLM_cas:issn">0003-1348</span>.
    </div><div class="casAbstract">A 9-year experience with fine-needle aspiration (FNA) in patients with resectable pancreatic adenocarcinoma was reviewed to determine whether this procedure is associated with positive peritoneal cytology, peritoneal recurrences, or decreased survival in patients who had pancreatic resection with curative intent.  Forty-one patients underwent pancreatic resection for primary pancreatic adenocarcinoma from July 1987 to February 1996.  Nine patients had open biopsies prior to definitive resection and were excluded from this study.  Of the remaining 32 patients, 21 (66%) had preoperative computed tomography-guided or fluoroscopically guided FNA biopsy of the pancreas for diagnosis.  FNA confirmed the diagnosis of adenocarcinoma in 17 of 21 patients (80%).  Fifteen of 21 FNA biopsies were performed in patients who went on to receive neoadjuvant chemoradiation.  Twenty-eight of 32 patients (87%) had peritoneal washings at the time of laparotomy.  Five patients had suspicious or positive washings (18%), and 23 patients had negative washings (82%).  Three of 18 patients (16.7%) who had both FNA and peritoneal washings and 2 of 10 patients (20%) who had no FNA but had peritoneal washings had positive or suspicious peritoneal cytology.  Eight of 32 patients ultimately failed in the peritoneum.  Six of 21 patients (28%) who had prior FNA and 2 of 11 (18%) who had no prior FNA failed in the peritoneum.  Although the number of patients is small, none of these differences proved to be statistically significant.  No difference in median survival was observed between the FNA and no FNA groups.  We conclude that FNA is a safe and useful tool to confirm the diagnosis of pancreatic cancer when patients are to be treated with neoadjuvant chemoradiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUYERZn_b7b75XHngOXiV_fW6udTcc2ebPdBDDfjNflbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szptVGktw%253D%253D&md5=bb495c2da4df85866f8ce3c54c7ce37d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DP%26aufirst%3DT.%26aulast%3DBalshem%26aufirst%3DA.%2BM.%26aulast%3DRoss%26aufirst%3DE.%26aulast%3DLitwin%26aufirst%3DS.%26aulast%3DEisenberg%26aufirst%3DB.%2BL.%26aulast%3DHoffman%26aufirst%3DJ.%2BP.%26atitle%3DImplications%2520of%2520fine-needle%2520aspiration%2520in%2520patients%2520with%2520resectable%2520pancreatic%2520cancer%26jtitle%3DAm.%2520Surg.%26date%3D1997%26volume%3D63%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hui-Yi Yang, Ya-Hong Yao, Ming Chen, Zhi-Hui Ren, <span class="NLM_string-name hlFld-ContribAuthor">Zheng-Hui Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Markovnikov Hydroaminocarbonylation of 1,1-Disubstituted and 1,1,2-Trisubstituted Alkenes for Formation of Amides with Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (19)
                                     , 7298-7305. <a href="https://doi.org/10.1021/jacs.1c03454" title="DOI URL">https://doi.org/10.1021/jacs.1c03454</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.1c03454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.1c03454%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DPalladium-Catalyzed%252BMarkovnikov%252BHydroaminocarbonylation%252Bof%252B1%25252C1-Disubstituted%252Band%252B1%25252C1%25252C2-Trisubstituted%252BAlkenes%252Bfor%252BFormation%252Bof%252BAmides%252Bwith%252BQuaternary%252BCarbon%26aulast%3DYang%26aufirst%3DHui-Yi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01042021%26date%3D10052021%26volume%3D143%26issue%3D19%26spage%3D7298%26epage%3D7305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tonghao Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Jie Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Directing-Group-Assisted C(sp2)–H Arylsulfonylation from Sulfur Dioxide. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (18)
                                     , 7094-7097. <a href="https://doi.org/10.1021/acs.orglett.0c02400" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02400%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDirecting-Group-Assisted%252BC%252528sp2%252529%2525E2%252580%252593H%252BArylsulfonylation%252Bfrom%252BSulfur%252BDioxide%26aulast%3DZhu%26aufirst%3DTonghao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19072020%26date%3D28082020%26volume%3D22%26issue%3D18%26spage%3D7094%26epage%3D7097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhenhua Liu, Lin Yang, Kaining Zhang, Wanjiao Chen, Tian Yu, Lianxiao Wang, Wen Gao, <span class="NLM_string-name hlFld-ContribAuthor">Bo Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Disulfonation of Terminal Alkynes with Sodium Arylsulfinates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     , 2081-2086. <a href="https://doi.org/10.1021/acs.orglett.0c00575" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c00575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c00575%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BDisulfonation%252Bof%252BTerminal%252BAlkynes%252Bwith%252BSodium%252BArylsulfinates%26aulast%3DLiu%26aufirst%3DZhenhua%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13022020%26date%3D26022020%26volume%3D22%26issue%3D5%26spage%3D2081%26epage%3D2086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qingjin Liang, Patrick J. Walsh, <span class="NLM_string-name hlFld-ContribAuthor">Tiezheng Jia</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Intermolecular Difunctionalization of Styrenes with Thiosulfonates and Arylboronic Acids via a Radical Relay Pathway. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 2633-2639. <a href="https://doi.org/10.1021/acscatal.9b04887" title="DOI URL">https://doi.org/10.1021/acscatal.9b04887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b04887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b04887%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCopper-Catalyzed%252BIntermolecular%252BDifunctionalization%252Bof%252BStyrenes%252Bwith%252BThiosulfonates%252Band%252BArylboronic%252BAcids%252Bvia%252Ba%252BRadical%252BRelay%252BPathway%26aulast%3DLiang%26aufirst%3DQingjin%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D11112019%26date%3D09122019%26date%3D07022020%26date%3D10122019%26volume%3D10%26issue%3D4%26spage%3D2633%26epage%3D2639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Fu</span>, <span class="hlFld-ContribAuthor ">Jia-Qi  Shang</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Yuehai  Shen</span>, <span class="hlFld-ContribAuthor ">Chuan-Zhu  Gao</span>, and <span class="hlFld-ContribAuthor ">Ya-Min  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Decarboxylative Disulfonylation of Alkynyl Carboxylic Acids with Sulfinic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 489-492. <a href="https://doi.org/10.1021/acs.orglett.7b03922" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03922%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCopper-Catalyzed%252BDecarboxylative%252BDisulfonylation%252Bof%252BAlkynyl%252BCarboxylic%252BAcids%252Bwith%252BSulfinic%252BAcids%26aulast%3DFu%26aufirst%3DHong%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D17122017%26date%3D09012018%26date%3D19012018%26volume%3D20%26issue%3D2%26spage%3D489%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kate  Lauder</span>, <span class="hlFld-ContribAuthor ">Anita  Toscani</span>, <span class="hlFld-ContribAuthor ">Nicolò  Scalacci</span>, and <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Reactivity of Propargylamines in Organic Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (24)
                                     , 14091-14200. <a href="https://doi.org/10.1021/acs.chemrev.7b00343" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00343%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSynthesis%252Band%252BReactivity%252Bof%252BPropargylamines%252Bin%252BOrganic%252BChemistry%26aulast%3DLauder%26aufirst%3DKate%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14062017%26date%3D22112017%26date%3D27122017%26volume%3D117%26issue%3D24%26spage%3D14091%26epage%3D14200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ismayil A.  Aliyev</span>, <span class="hlFld-ContribAuthor ">Boris A.  Trofimov</span>, <span class="hlFld-ContribAuthor ">Lyudmila A.  Oparina</span>. </span><span class="cited-content_cbyCitation_article-title">Some Areas of Application of Aromatic Thiols and Their Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 335-367. <a href="https://doi.org/10.1007/978-3-030-69621-4_7" title="DOI URL">https://doi.org/10.1007/978-3-030-69621-4_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-69621-4_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-69621-4_7%26sid%3Dliteratum%253Aachs%26atitle%3DSome%252BAreas%252Bof%252BApplication%252Bof%252BAromatic%252BThiols%252Band%252BTheir%252BDerivatives%26aulast%3DAliyev%26aufirst%3DIsmayil%2BA.%26date%3D2021%26date%3D2021%26spage%3D335%26epage%3D367%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAromatic%252BThiols%252Band%252BTheir%252BDerivatives%26aulast%3DAliyev%26aufirst%3DIsmayil%2BA.%26date%3D2021%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Kongshuang  Tang</span>, <span class="hlFld-ContribAuthor ">Zhaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Yongquan  Ning</span>. </span><span class="cited-content_cbyCitation_article-title">Disulfonation of terminal alkynes for 1,2-bisulfonylethenes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (86)
                                     , 13141-13144. <a href="https://doi.org/10.1039/D0CC05849A" title="DOI URL">https://doi.org/10.1039/D0CC05849A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC05849A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC05849A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DDisulfonation%252Bof%252Bterminal%252Balkynes%252Bfor%252B1%25252C2-bisulfonylethenes%26aulast%3DWang%26aufirst%3DYu%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D86%26spage%3D13141%26epage%3D13144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjian  Min</span>, <span class="hlFld-ContribAuthor ">Guozhe  Guo</span>, <span class="hlFld-ContribAuthor ">Caixia  Yang</span>, <span class="hlFld-ContribAuthor ">Congde  Huo</span>. </span><span class="cited-content_cbyCitation_article-title">Visible light promoted sulfonylation and sulfonylcarbonylation of alkenes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (25)
                                     , 152029. <a href="https://doi.org/10.1016/j.tetlet.2020.152029" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DVisible%252Blight%252Bpromoted%252Bsulfonylation%252Band%252Bsulfonylcarbonylation%252Bof%252Balkenes%26aulast%3DMin%26aufirst%3DWenjian%26date%3D2020%26volume%3D61%26issue%3D25%26spage%3D152029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju  Jannapu Reddy</span>, <span class="hlFld-ContribAuthor ">Md.  Waheed</span>, <span class="hlFld-ContribAuthor ">Gamidi  Rama Krishna</span>. </span><span class="cited-content_cbyCitation_article-title">Phenylboronic acid-catalyzed tandem construction of S–S and C–S bonds: a new method for the synthesis of benzyl disulfanylsulfone derivatives from
              S
              -benzyl thiosulfonates. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (17)
                                     , 3243-3248. <a href="https://doi.org/10.1039/D0OB00442A" title="DOI URL">https://doi.org/10.1039/D0OB00442A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00442A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00442A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPhenylboronic%252Bacid-catalyzed%252Btandem%252Bconstruction%252Bof%252BS%2525E2%252580%252593S%252Band%252BC%2525E2%252580%252593S%252Bbonds%25253A%252Ba%252Bnew%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bbenzyl%252Bdisulfanylsulfone%252Bderivatives%252Bfrom%252BS%252B-benzyl%252Bthiosulfonates%26aulast%3DJannapu%2BReddy%26aufirst%3DRaju%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D17%26spage%3D3243%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Yin</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Honghao  Sun</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 1068-1080. <a href="https://doi.org/10.1016/j.ejmech.2018.08.074" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.074%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bvinyl%252Bsulfone%252Bderivatives%252Bas%252Banti-tumor%252Bagents%252Bwith%252Bmicrotubule%252Bpolymerization%252Binhibitory%252Band%252Bvascular%252Bdisrupting%252Bactivities%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2018%26volume%3D157%26spage%3D1068%26epage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balakrishna  Aegurla</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Peddinti</span>. </span><span class="cited-content_cbyCitation_article-title">Metal‐Free Sulfonylation of α,β‐Conjugated Systems by Using Sulfonyl Hydrazides. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (5)
                                     , 946-954. <a href="https://doi.org/10.1002/ajoc.201700696" title="DOI URL">https://doi.org/10.1002/ajoc.201700696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201700696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201700696%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal%2525E2%252580%252590Free%252BSulfonylation%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2%2525E2%252580%252590Conjugated%252BSystems%252Bby%252BUsing%252BSulfonyl%252BHydrazides%26aulast%3DAegurla%26aufirst%3DBalakrishna%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D5%26spage%3D946%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Diercxsens</span>. </span><span class="cited-content_cbyCitation_article-title">2,2-Difluoroethylamine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-4. <a href="https://doi.org/10.1002/047084289X.rn02075" title="DOI URL">https://doi.org/10.1002/047084289X.rn02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn02075%26sid%3Dliteratum%253Aachs%26atitle%3D2%25252C2-Difluoroethylamine%26aulast%3DDiercxsens%26aufirst%3DNicolas%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D4%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander D.  Tereshchenko</span>, <span class="hlFld-ContribAuthor ">Julia S.  Myronchuk</span>, <span class="hlFld-ContribAuthor ">Lena D.  Leitchenko</span>, <span class="hlFld-ContribAuthor ">Irina V.  Knysh</span>, <span class="hlFld-ContribAuthor ">Ganna O.  Tokmakova</span>, <span class="hlFld-ContribAuthor ">Olena O.  Litsis</span>, <span class="hlFld-ContribAuthor ">Andrey  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Konstantin  Liubchak</span>, <span class="hlFld-ContribAuthor ">Pavel  Mykhailiuk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-oxadiazolyl/triazolyl morpholines: Novel scaffolds for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (6)
                                     , 750-757. <a href="https://doi.org/10.1016/j.tet.2016.12.052" title="DOI URL">https://doi.org/10.1016/j.tet.2016.12.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.12.052%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252B3-oxadiazolyl%25252Ftriazolyl%252Bmorpholines%25253A%252BNovel%252Bscaffolds%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DTereshchenko%26aufirst%3DAlexander%2BD.%26date%3D2017%26volume%3D73%26issue%3D6%26spage%3D750%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuhong  Xiao</span>, <span class="hlFld-ContribAuthor ">Jingxin  Tian</span>, <span class="hlFld-ContribAuthor ">Qiaoyan  Xing</span>, <span class="hlFld-ContribAuthor ">Huawen  Huang</span>, <span class="hlFld-ContribAuthor ">Guo-Jun  Deng</span>, <span class="hlFld-ContribAuthor ">Yuejin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Piperidine Promoted Direct Sulfenylation of 2-Naphthol with Aryl Thiols under Aqueous Conditions. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (1)
                                     , 428-431. <a href="https://doi.org/10.1002/slct.201601549" title="DOI URL">https://doi.org/10.1002/slct.201601549</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201601549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201601549%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DPiperidine%252BPromoted%252BDirect%252BSulfenylation%252Bof%252B2-Naphthol%252Bwith%252BAryl%252BThiols%252Bunder%252BAqueous%252BConditions%26aulast%3DXiao%26aufirst%3DFuhong%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D1%26spage%3D428%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Jun-Feng  Kou</span>, <span class="hlFld-ContribAuthor ">Zi-Zhuo  Zhao</span>, <span class="hlFld-ContribAuthor ">Kang-Qiang  Qiu</span>, <span class="hlFld-ContribAuthor ">Hui  Chao</span>. </span><span class="cited-content_cbyCitation_article-title">Anthraquinone-bridged diruthenium(
              ii
              ) complexes inhibit migration and invasion of human hepatocarcinoma MHCC97-H cells. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (6)
                                     , 1003-1012. <a href="https://doi.org/10.1039/C7QI00149E" title="DOI URL">https://doi.org/10.1039/C7QI00149E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QI00149E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QI00149E%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%2520Frontiers%26atitle%3DAnthraquinone-bridged%252Bdiruthenium%252528%252Bii%252B%252529%252Bcomplexes%252Binhibit%252Bmigration%252Band%252Binvasion%252Bof%252Bhuman%252Bhepatocarcinoma%252BMHCC97-H%252Bcells%26aulast%3DWang%26aufirst%3DJin-Quan%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D6%26spage%3D1003%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenshu  Dai</span>, <span class="hlFld-ContribAuthor ">Junqi  Wang</span>, <span class="hlFld-ContribAuthor ">Siqi  Deng</span>, <span class="hlFld-ContribAuthor ">Candong  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenhe  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiuhua  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-mediated sulfonylation of arylethynylene bromides with sodium arylsulfinates: synthesis of (E)-1,2-bis(arylsulfonyl)ethylenes and arylacetylenic sulfones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (57)
                                     , 36112-36116. <a href="https://doi.org/10.1039/C7RA07105A" title="DOI URL">https://doi.org/10.1039/C7RA07105A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA07105A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA07105A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAcid-mediated%252Bsulfonylation%252Bof%252Barylethynylene%252Bbromides%252Bwith%252Bsodium%252Barylsulfinates%25253A%252Bsynthesis%252Bof%252B%252528E%252529-1%25252C2-bis%252528arylsulfonyl%252529ethylenes%252Band%252Barylacetylenic%252Bsulfones%26aulast%3DDai%26aufirst%3DChenshu%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D57%26spage%3D36112%26epage%3D36116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Analogues of <b>1</b>. The diagram shows the strategies for modifiying the parent compound <b>1</b> to generate more effective antimetastatic drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Amide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt; (iv) Et<sub>3</sub>N, 43% (b) amine, EDCI, HOBT, rt, 22–67%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Heterocyclic Amide Isosteres<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RCSNHNH<sub>2</sub>, 3 equiv EDCI, DCM, rt, 11–19%, or (i) RCONHNH<sub>2</sub>, EDCI, HOBT, MeCN, rt, 4 h, (ii) dioxane, POCl<sub>3</sub>, 90 °C, 2 h, 72–76%; (b) MsOH, 1,4-dioxane, 90 °C, 24 h, 55% or AcOH, 70–105 °C, 1–3 d, 11–24%; (c) AuCl<sub>3</sub>, MeCN, 4 d, 30%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Cyclic Amide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 10–27%; (b) amine, EDCI, HOBT, MeCN or DCM, rt, 28–69%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0008.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenoxy Amide Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 32%; (b) amine, EDCI, HOBT, MeCN or DCM, rt, 38–79%; (c) MsOH, 1,4-dioxane, 90 °C, 11 h, 50%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Heteroaryl Analogues and a Negative Control<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuCOCH<sub>3</sub>, KOH, water, 100 °C, 3 h, 64%; (b) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 59%; (c) cyclohexylamine, Et<sub>3</sub>N, propylphosphonic anhydride, DMF, rt, 51%; (d) (i) PhLi, <i>n</i>-BuLi, −80 °C, (ii) SO<sub>2</sub>, −80 °C to rt, (iii) 2-chloroacrylonitrile, AcOH, MeOH, rt, (iv) Et<sub>3</sub>N, 15%; (e) 4-<i>t</i>-BuPhSH, Et<sub>3</sub>N, CHCl<sub>3</sub>, 97%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Apoptotic effects of test compounds. A2780 ovarian cancer cells were suspended and allowed to adhere in the presence of vehicle (DMSO) or test compound (5 μM in DMSO) for 4 h. The cells were then collected, lysed, and normalized for total protein concentration. The lysates were used to generate immunoblots of cleaved PARP and cleaved caspase 3 which are indicators of apoptosis. An immunoblot of actin served as a loading control. A sulfide analogue (<b>21</b>), which lacked potency in the coculture assay, was used as a negative control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>1</b> and analogues of <b>1</b> were tested for their ability to bind glutathione (GSH) in vitro (A) and in HT-29 cancer cells in vivo (B). In this assay, the sulfhydryl group of glutathione reacts with DTNB (5,5′-dithiobis-2-nitrobenzoic acid, Ellman’s reagent) and produces a yellow-colored 5-thio-2-nitrobenzoic acid (TNB). The mixed disulfide, GSTNB (between GSH and TNB) that is concomitantly produced, is reduced by glutathione reductase to recycle the GSH and produce more TNB. The rate of TNB production is directly proportional to the concentration of GSH in the sample. HT-29 cancer cells that stably expressed firefly luciferase were incubated with <b>1</b> and analogues of <b>1</b> with vehicle (H20) or 680 μM <i>N</i>-acetylcysteine (NAC) for 30 min. The HT-29 cells were then transiently suspended and cocultured on mesothelial cell monolayers for 5 h. The surviving HT-29 cells were detected by luciferase activity in a luminometer (C). Results are expressed as the mean light output and error bars represent standard errors of the mean. HT-29 cells, that stably expressed firefly luciferase, were treated with buthionine sulfoximine (BSO) for 24 h. The cells were lysed and levels of cellular GSH determined (D) as in <b>3A</b>,<b>B</b> above. The effect of 24- h preincubation of BSO on cancer cell viability was tested using the coculture model (E) as in <b>3C</b>. Structures of compounds <b>22</b> and <b>23</b> are shown (F).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/medium/jm-2014-01437v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>1</b> and test compounds inhibit peritoneal carcinomatosis by of ovarian cancer cells. The mice were pretreated intraperitoneally (IP) with 5 mg/kg active analogue or vehicle. Four hours later, 1.5 × 10<sup>6</sup> A2780-luciferase or 2 × 10<sup>6</sup> SKOV3-luciferase ovarian cancer cells were injected into each mouse IP. The treatment with vehicle or 5 mg/kg active analogue was continued three times a week for 14 days total. The intraperitoneal tumor implants were detected and quantified using a bioluminescence imager following IP D-luciferin administration. The graphs show abdominal bioluminescent output of the mice inoculated with A2780-luc cells (A) or SKOV-3-luc (B) cells. The columns represent the average tumor burden (bioluminescence) for the mice in each treatment arm and the error bars, the standard error of the means. (C,D) Imaging data for A2780-luc cells when treated with vehicle or benzoxazole <b>6b</b> on day 14 respectively. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-3/jm501437v/20150206/images/large/jm-2014-01437v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501437v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Vogel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalthoff, H.</span><span> </span><span class="NLM_article-title">Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas</span> <span class="citation_source-journal">Virchow’s Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">439</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs004280100476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=11561750" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2001&pages=109-117&author=I.+Vogelauthor=H.+Kalthoff&title=Disseminated+tumour+cells.+Their+detection+and+significance+for+prognosis+of+gastrointestinal+and+pancreatic+carcinomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs004280100476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004280100476%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DI.%26aulast%3DKalthoff%26aufirst%3DH.%26atitle%3DDisseminated%2520tumour%2520cells.%2520Their%2520detection%2520and%2520significance%2520for%2520prognosis%2520of%2520gastrointestinal%2520and%2520pancreatic%2520carcinomas%26jtitle%3DVirchow%25E2%2580%2599s%2520Arch.%26date%3D2001%26volume%3D439%26spage%3D109%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vogel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalthoff, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne-Bruns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, B.</span><span> </span><span class="NLM_article-title">Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma</span> <span class="citation_source-journal">Pancreatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=79-88&author=I.+Vogelauthor=H.+Kalthoffauthor=D.+Henne-Brunsauthor=B.+Kremer&title=Detection+and+prognostic+impact+of+disseminated+tumor+cells+in+pancreatic+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DI.%26aulast%3DKalthoff%26aufirst%3DH.%26aulast%3DHenne-Bruns%26aufirst%3DD.%26aulast%3DKremer%26aufirst%3DB.%26atitle%3DDetection%2520and%2520prognostic%2520impact%2520of%2520disseminated%2520tumor%2520cells%2520in%2520pancreatic%2520carcinoma%26jtitle%3DPancreatology%26date%3D2002%26volume%3D2%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pannu, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montz, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fishman, E. K.</span><span> </span><span class="NLM_article-title">Multidetector CT of peritoneal carcinomatosis from ovarian cancer</span> <span class="citation_source-journal">Radiographics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=687-701&author=H.+K.+Pannuauthor=R.+E.+Bristowauthor=F.+J.+Montzauthor=E.+K.+Fishman&title=Multidetector+CT+of+peritoneal+carcinomatosis+from+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPannu%26aufirst%3DH.%2BK.%26aulast%3DBristow%26aufirst%3DR.%2BE.%26aulast%3DMontz%26aufirst%3DF.%2BJ.%26aulast%3DFishman%26aufirst%3DE.%2BK.%26atitle%3DMultidetector%2520CT%2520of%2520peritoneal%2520carcinomatosis%2520from%2520ovarian%2520cancer%26jtitle%3DRadiographics%26date%3D2003%26volume%3D23%26spage%3D687%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span> </span><span class="NLM_article-title">The characteristics of disseminated tumor cells in pancreatic cancer: a black box needs to be explored</span> <span class="citation_source-journal">Pancreatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><div class="note"><p class="first last">(discussion 324)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=316-324&author=D.+Suauthor=K.+Yamaguchiauthor=M.+Tanaka&title=The+characteristics+of+disseminated+tumor+cells+in+pancreatic+cancer%3A+a+black+box+needs+to+be+explored"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26atitle%3DThe%2520characteristics%2520of%2520disseminated%2520tumor%2520cells%2520in%2520pancreatic%2520cancer%253A%2520a%2520black%2520box%2520needs%2520to%2520be%2520explored%26jtitle%3DPancreatology%26date%3D2005%26volume%3D5%26spage%3D316%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Munoz-Casares, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rufian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lizarraga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Iglesias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciria, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muntane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrios, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Melero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Moreno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Bayon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bretcha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega-Perez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Portilla, A.</span><span> </span><span class="NLM_article-title">Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals</span> <span class="citation_source-journal">Clin. Transl. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs12094-007-0118-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=17974526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2snltVKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=652-662&author=F.+C.+Munoz-Casaresauthor=S.+Rufianauthor=M.+J.+Rubioauthor=E.+Lizarragaauthor=C.+Diaz-Iglesiasauthor=E.+Arandaauthor=R.+Ciriaauthor=J.+Muntaneauthor=P.+Barriosauthor=J.+Torres-Meleroauthor=S.+Gonzalez-Morenoauthor=L.+Gonzalez-Bayonauthor=B.+Campsauthor=P.+Bretchaauthor=J.+Farreauthor=G.+Ortega-Perezauthor=A.+Gomez-Portilla&title=Treatment+of+peritoneal+carcinomatosis+from+ovarian+cancer.+Present%2C+future+directions+and+proposals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals</span></div><div class="casAuthors">Munoz-Casares F C; Rufian S; Rubio M J; Lizarraga E; Diaz-Iglesias C; Aranda E; Ciria R; Muntane J; Barrios P; Torres-Melero J; Gonzalez-Moreno S; Gonzalez-Bayon L; Camps B; Bretcha P; Farre J; Ortega-Perez G; Gomez-Portilla A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">652-62</span>
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    </div><div class="casAbstract">Peritoneal carcinomatosis, considered years ago as a final stage of unresectable cancer, can now be managed with curative intention by means of a radical cytoreductive surgical procedure with associated peritonectomy and intraperitoneal chemotherapy, as described by Sugarbaker.  Malignant neoplasms such as mesothelioma and pseudomyxoma peritonei, ovarian and colon cancer nowadays are experiencing some new therapeutical approaches.  Higher survival rates can be reached in ovarian cancer, which is commonly diagnosed in the presence of peritoneal carcinomatosis, using an optimal cytoreductive radical surgery with intraperitoneal chemotherapy.  An actualised review of the treatment of advanced ovarian cancer and a proposal of a national multicentre protocol for the treatment of peritoneal carcinomatosis from ovarian cancer has been performed by a group of Spanish surgeons and oncologists dedicated to a therapeutical approach to this pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrveJCkX-B3gaK-_ZudimnfW6udTcc2eZcg29EYSVcWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snltVKruw%253D%253D&md5=2fce405d19580857f70c1548cdefa22a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs12094-007-0118-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-007-0118-0%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Casares%26aufirst%3DF.%2BC.%26aulast%3DRufian%26aufirst%3DS.%26aulast%3DRubio%26aufirst%3DM.%2BJ.%26aulast%3DLizarraga%26aufirst%3DE.%26aulast%3DDiaz-Iglesias%26aufirst%3DC.%26aulast%3DAranda%26aufirst%3DE.%26aulast%3DCiria%26aufirst%3DR.%26aulast%3DMuntane%26aufirst%3DJ.%26aulast%3DBarrios%26aufirst%3DP.%26aulast%3DTorres-Melero%26aufirst%3DJ.%26aulast%3DGonzalez-Moreno%26aufirst%3DS.%26aulast%3DGonzalez-Bayon%26aufirst%3DL.%26aulast%3DCamps%26aufirst%3DB.%26aulast%3DBretcha%26aufirst%3DP.%26aulast%3DFarre%26aufirst%3DJ.%26aulast%3DOrtega-Perez%26aufirst%3DG.%26aulast%3DGomez-Portilla%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520peritoneal%2520carcinomatosis%2520from%2520ovarian%2520cancer.%2520Present%252C%2520future%2520directions%2520and%2520proposals%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2007%26volume%3D9%26spage%3D652%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Davidson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trope, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih Ie, M.</span><span> </span><span class="NLM_article-title">New determinates of disease progression and outcome in metastatic ovarian carcinoma</span> <span class="citation_source-journal">Histol. Histopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=20886439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmvVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=1591-1609&author=B.+Davidsonauthor=R.+Reichauthor=C.+G.+Tropeauthor=T.+L.+Wangauthor=M.+Shih+Ie&title=New+determinates+of+disease+progression+and+outcome+in+metastatic+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New determinates of disease progression and outcome in metastatic ovarian carcinoma</span></div><div class="casAuthors">Davidson Ben; Reich Reuven; Trope Claes G; Wang Tian-Li; Shih Ie-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Histology and histopathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1591-609</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ovarian cancer is the most lethal gynecologic malignancy.  This is attributed to frequent presentation at late stage, when the tumor has metastasized, as well as to development of chemotherapy resistance along tumor progression.  Patients with advanced-stage ovarian carcinoma have widespread intraperitoneal metastases, including the formation of malignant serous effusions within the peritoneal cavity.  Pleural effusions constitute the most frequent site of distant metastasis (FIGO stage IV disease).  Unlike the majority of solid tumors, particularly at the primary site, cancer cells in effusions are not amenable to surgical removal, and failure in their eradication is one of the main causes of treatment failure.  Our research in recent years has demonstrated that a large number of cancer-associated molecules are differentially expressed in effusions compared to primary carcinomas and solid metastases.  We have additionally observed that expression of several of these molecules differs between primary diagnosis (pre-chemotherapy) and disease recurrence (post-chemotherapy) specimens, and that they are significantly associated with response to chemotherapy and patient survival.  These observations are thought to be related to disease progression, as well as to the unique microenvironment of effusions, and may have impact on the selection of targeted therapy in this cancer.  This review discusses our recent observations with respect to the biology of ovarian carcinoma cells in effusions, and focuses on the clinical role of tumor-associated molecules at this anatomic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSn0Rujn_TlTIFEOhA_Im3cfW6udTcc2eZcg29EYSVcWbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmvVeksw%253D%253D&md5=53a1d9975daf9a7837ba7d8b47cdfb63</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DB.%26aulast%3DReich%26aufirst%3DR.%26aulast%3DTrope%26aufirst%3DC.%2BG.%26aulast%3DWang%26aufirst%3DT.%2BL.%26aulast%3DShih%2BIe%26aufirst%3DM.%26atitle%3DNew%2520determinates%2520of%2520disease%2520progression%2520and%2520outcome%2520in%2520metastatic%2520ovarian%2520carcinoma%26jtitle%3DHistol.%2520Histopathol.%26date%3D2010%26volume%3D25%26spage%3D1591%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span>Cancer Facts and Figures 2013; <span class="NLM_publisher-name">American Cancer Society</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cancer+Facts+and+Figures+2013%3B+American+Cancer+Society%3A+Atlanta%2C+GA%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Facts%2520and%2520Figures%25202013%26pub%3DAmerican%2520Cancer%2520Society%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fader, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. G.</span><span> </span><span class="NLM_article-title">Role of surgery in ovarian carcinoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2873</span><span class="NLM_x">–</span> <span class="NLM_lpage">2883</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1200%2FJCO.2007.11.0932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=17617518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2svgtVWlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=2873-2883&author=A.+N.+Faderauthor=P.+G.+Rose&title=Role+of+surgery+in+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of surgery in ovarian carcinoma</span></div><div class="casAuthors">Fader Amanda Nickles; Rose Peter G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2873-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Surgery plays a critical role in the optimal management of all stages of ovarian carcinoma.  In apparent early-stage ovarian cancer, a comprehensive surgical evaluation allows stratification of patients into low- and high-risk categories.  Low-risk patients may be candidates for fertility-sparing surgery and can safely avoid chemotherapy and be observed.  Treatment of patients with high-risk early- or advanced-stage ovarian cancer usually requires a combined modality approach.  Although it is well known that epithelial ovarian cancer is moderately chemosensitive, what distinguishes it most from other metastatic solid tumors is that surgical cytoreduction of tumor volume is highly correlated with prolongation of patient survival.  Procedures such as radical pelvic surgery, bowel resection, and aggressive upper abdominal surgery are commonly required to achieve optimal cytoreduction.  Women who develop recurrent disease may be eligible for a secondary cytoreductive surgery or may require a surgical intervention to palliate disease-related symptoms.  For women at high risk of ovarian cancer, prophylactic bilateral salpingo-oophorectomy significantly reduces the incidence of this disease.  The purpose of this article is to provide a comprehensive review of the surgical management of ovarian carcinoma.  The roles of primary, interval, and secondary cytoreductive surgeries; second-look procedures; and palliative surgery are reviewed.  The indications for fertility-sparing and minimally invasive surgery as well as the current guidelines for prophylactic surgery in high-risk mutation carriers are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9J6wI5hl9NEewzGPswiWOfW6udTcc2ebwLaOx5jziVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svgtVWlug%253D%253D&md5=1d4a459c16b08893e60440537603896c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.11.0932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.11.0932%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DA.%2BN.%26aulast%3DRose%26aufirst%3DP.%2BG.%26atitle%3DRole%2520of%2520surgery%2520in%2520ovarian%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D2873%26epage%3D2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Horng, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. H.</span><span> </span><span class="NLM_article-title">Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery</span> <span class="citation_source-journal">Eur. J. Gynaecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=17375705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ns1ShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=43-44&author=H.+C.+Horngauthor=C.+C.+Yuanauthor=C.+R.+Laiauthor=P.+H.+Wang&title=Presumed+Stage+IA+primary+epithelial+ovarian+carcinoma%3A+the+role+of+complete+staging+surgery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Presumed Stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery</span></div><div class="casAuthors">Horng H C; Yuan C C; Lai C R; Wang P H</div><div class="citationInfo"><span class="NLM_cas:title">European journal of gynaecological oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-4</span>
        ISSN:<span class="NLM_cas:issn">0392-2936</span>.
    </div><div class="casAbstract">PURPOSE:  Proper staging is warranted in any patient with primary epithelial ovarian carcinoma (PEOC), but sometimes it cannot always be performed.  The prognosis of patients with and without complete staging surgery is to be determined.  METHODS:  We retrospectively evaluated 61 patients with presumed Stage IA PEOC between January 1970 and December 1993.  Inclusion criteria were: being referred patients; no ascites; an intact ovarian tumor without extra-spillage or rupture before, during or after operation; conventional regular exploratory laparotomy without urgency; more than a 5-year follow-up, except for recurrent diseases; a detailed pathology review; and no other systemic disease.  Tumors of lower malignant potential (LMP) and cystectomy for removing tumor were excluded.  Of the 61 patients, 17 patients received a close observation (Group A), and the others (44 patients) received a re-exploratory laparotomy to complete the staging surgery (Group B).  RESULTS:  The mean follow-up time was 7.4 years, ranging between 5.4 and 11.1 years, in Group A, and 8.1 years, ranging from 5.6 to 12.7 years, in Group B.  Two patients (11.8%) in Group A and seven patients (15.9%) in Group B suffered from recurrence.  Two patients finally died of disease, and both were in Group B.  CONCLUSIONS:  Based on the observation in this study that the recurrence rate of the two groups was not statistically different, close follow-up for patients with presumed Stage IA EOC, but without complete surgical staging surgery, might be acceptable when these patients are treated with postoperative adjuvant chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCX15baGk9HX6HPRus0rAafW6udTcc2ebwLaOx5jziVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ns1ShsQ%253D%253D&md5=909174e7d9b30ec18ff46ad85dd52c28</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorng%26aufirst%3DH.%2BC.%26aulast%3DYuan%26aufirst%3DC.%2BC.%26aulast%3DLai%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DP.%2BH.%26atitle%3DPresumed%2520Stage%2520IA%2520primary%2520epithelial%2520ovarian%2520carcinoma%253A%2520the%2520role%2520of%2520complete%2520staging%2520surgery%26jtitle%3DEur.%2520J.%2520Gynaecol.%2520Oncol.%26date%3D2007%26volume%3D28%26spage%3D43%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hase, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuranaga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsunomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, H.</span><span> </span><span class="NLM_article-title">Intraperitoneal exfoliated cancer cells in patients with colorectal cancer</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2FBF02239435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=9749497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK1cvhvF2htA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1134-1140&author=K.+Haseauthor=H.+Uenoauthor=N.+Kuranagaauthor=K.+Utsunomiyaauthor=S.+Kanabeauthor=H.+Mochizuki&title=Intraperitoneal+exfoliated+cancer+cells+in+patients+with+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Intraperitoneal exfoliated cancer cells in patients with colorectal cancer</span></div><div class="casAuthors">Hase K; Ueno H; Kuranaga N; Utsunomiya K; Kanabe S; Mochizuki H</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1134-40</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  The aims of this study were to evaluate potential predictors of exfoliated free cancer cells in the peritoneal cavity and to assess intraoperative peritoneal lavage cytology as a prognostic indicator in patients with colorectal cancer.  METHODS:  From 1985 to 1987, intraoperative peritoneal lavage cytology was performed in 140 patients with colorectal cancer.  Among them, 88 patients underwent curative resection and 52 patients had noncurative surgery.  Cytology was examined twice, i.e., immediately after opening the peritoneal cavity (precytology) and just before closing the abdomen (postcytology).  One hundred milliliters of saline was poured into the peritoneal cavity and it was retrieved by suction after irrigation.  Cytologic examination was performed after staining with Papanicolaou, Giemsa, periodic acid-Schiff, and Alcian blue stains.  RESULTS:  Among the 140 patients examined, the incidence of positive cytology in the prelavage was 15 percent, and that in the postlavage was 9 percent, although it was 16 percent in either lavage.  Among patients with curative resection, 10 percent had positive cytology.  Seven characteristics were identified as features of tumors which are prone to exfoliate cells into the peritoneal cavity: 1) macroscopic peritoneal dissemination, 2) liver metastasis, 3) more than 20 ml of ascites, 4) ulcerated tumors without definite borders, 5) invasion of the serosal surface or beyond, 6) semiannular or annular shape, and 7) moderate or marked lymphatic invasion.  In patients undergoing curative surgery, among these features, circumferential involvement was the only one correlated closely with positive cytology (P < 0.02).  Positive cytology was associated with a worse outcome.  In patients who were resected curatively, the postcytology had a stronger influence on local recurrence than the precytology; the local recurrence rate in patients with positive postcytology was higher than in those with negative postcytology, regardless of the precytology.  All patients with cancer cells in the peritoneal cavity at the end of surgery had recurrence.  CONCLUSIONS:  Seven characteristics were identified as risk factors for exfoliation of cancer cells into the peritoneal cavity in patients with colorectal cancer.  These findings may be helpful for the choice of laparoscopic surgery in this era of increasing port-site metastases after laparoscopic procedure.  The results of peritoneal lavage cytology at the end of surgery were correlated with the long-term postoperative outcome of colorectal cancer.  Thus, meticulous follow-up and possibly adjuvant chemotherapy may be beneficial for patients with free cancer cells in lavage fluid, even after curative surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwuZghxOeO7-RS7coPn-RtfW6udTcc2ebwLaOx5jziVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvhvF2htA%253D%253D&md5=6807a9faaf6b85bfd97d7b7b1d9a4e90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF02239435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02239435%26sid%3Dliteratum%253Aachs%26aulast%3DHase%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DKuranaga%26aufirst%3DN.%26aulast%3DUtsunomiya%26aufirst%3DK.%26aulast%3DKanabe%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DH.%26atitle%3DIntraperitoneal%2520exfoliated%2520cancer%2520cells%2520in%2520patients%2520with%2520colorectal%2520cancer%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1998%26volume%3D41%26spage%3D1134%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milsom, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toddy, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, V. W.</span><span> </span><span class="NLM_article-title">Does laparoscopic vs conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer?</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2FBF02237382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=9715151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK1czotVyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=971-978&author=S.+H.+Kimauthor=J.+W.+Milsomauthor=T.+L.+Gramlichauthor=S.+M.+Toddyauthor=G.+I.+Shoreauthor=J.+Okudaauthor=V.+W.+Fazio&title=Does+laparoscopic+vs+conventional+surgery+increase+exfoliated+cancer+cells+in+the+peritoneal+cavity+during+resection+of+colorectal+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer?</span></div><div class="casAuthors">Kim S H; Milsom J W; Gramlich T L; Toddy S M; Shore G I; Okuda J; Fazio V W</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">971-8</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  Traumatic manipulation of cancer specimens during laparoscopic colectomy may increase exfoliation of malignant cells into the peritoneal cavity, causing an early occurrence of peritoneal carcinomatosis or port-sites recurrence.  Because of this concern, the routine use of intraperitoneal chemotherapy after laparoscopic colectomy for cancer was suggested recently.  We assessed if laparoscopic vs. conventional surgery increases exfoliated malignant cells in the peritoneal cavity during resection of colorectal cancer.  METHODS:  In a prospective, randomized fashion, 38 colorectal cancer patients undergoing an elective, curative operation were assigned to either a conventional or laparoscopic procedure between June 1996 and May 1997.  In either group (n = 19), after the abdominal cavity was entered, saline was instilled into the peritoneal cavity, and the fluid was collected (Specimen 1).  During surgery, all irrigating fluids were collected (Specimen 2).  Both specimens were assessed for malignancy using four techniques: filtration process (ThinPrep), smear, cell block, and immunochemistry using Ber-EP4.  The change in the amount of tumor cells in both specimens was compared between surgical groups.  A pilot study was performed to validate the proposed cytologic method.  RESULTS:  In the pilot study of 20 consecutive patients with colorectal cancer, postresectional peritoneal cytology was positive in six patients, including two Stage II (T3, N0, M0) patients.  The pilot study also validated that our semiquantitative scoring system can be reliably used to assess the amount of free peritoneal cancer cells.  In the main study, 16 right colectomies, 3 extended right colectomies, 17 proctosigmoidectomies, and 1 left colectomy were performed.  The T and N stages were T1 (n = 13, T2 (n = 5), T3 (n = 8), T4 (n = 11); N0 (n =22), N1 (n = 8), N2 (n = 7).  Malignant cells were not detected in any Specimens 1 or, more importantly, in Specimens 2 in either surgical group.  CONCLUSION:  When performed according to strict oncologic surgical principles, laparoscopic techniques in curative colorectal cancer surgery did not have an increased risk of intraperitoneal cancer cell spillage, compared with conventional techniques.  We hope that these results can decrease some of the concerns about tumor cell spillage and seeding during laparoscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCbkMSz9JPKTDnmmyUf5qOfW6udTcc2ebliMP818Dp9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czotVyrsQ%253D%253D&md5=55afe715c931b7af029fe837ce503c5f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2FBF02237382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02237382%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DMilsom%26aufirst%3DJ.%2BW.%26aulast%3DGramlich%26aufirst%3DT.%2BL.%26aulast%3DToddy%26aufirst%3DS.%2BM.%26aulast%3DShore%26aufirst%3DG.%2BI.%26aulast%3DOkuda%26aufirst%3DJ.%26aulast%3DFazio%26aufirst%3DV.%2BW.%26atitle%3DDoes%2520laparoscopic%2520vs%2520conventional%2520surgery%2520increase%2520exfoliated%2520cancer%2520cells%2520in%2520the%2520peritoneal%2520cavity%2520during%2520resection%2520of%2520colorectal%2520cancer%253F%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1998%26volume%3D41%26spage%3D971%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Averbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, P. H.</span><span> </span><span class="NLM_article-title">Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer</span> <span class="citation_source-journal">Ann. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=1998&pages=347-354&author=W.+Yuauthor=I.+Whangauthor=I.+Suhauthor=A.+Averbachauthor=D.+Changauthor=P.+H.+Sugarbaker&title=Prospective+randomized+trial+of+early+postoperative+intraperitoneal+chemotherapy+as+an+adjuvant+to+resectable+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWhang%26aufirst%3DI.%26aulast%3DSuh%26aufirst%3DI.%26aulast%3DAverbach%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DD.%26aulast%3DSugarbaker%26aufirst%3DP.%2BH.%26atitle%3DProspective%2520randomized%2520trial%2520of%2520early%2520postoperative%2520intraperitoneal%2520chemotherapy%2520as%2520an%2520adjuvant%2520to%2520resectable%2520gastric%2520cancer%26jtitle%3DAnn.%2520Surg.%26date%3D1998%26volume%3D228%26spage%3D347%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Steinert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymond, M. A.</span><span> </span><span class="NLM_article-title">Tumor cell dissemination during laparoscopy: prevention and therapeutic opportunities</span> <span class="citation_source-journal">Dig. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1159%2F000067598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12499738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD38jjs1yrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2002&pages=464-472&author=R.+Steinertauthor=H.+Lippertauthor=M.+A.+Reymond&title=Tumor+cell+dissemination+during+laparoscopy%3A+prevention+and+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor cell dissemination during laparoscopy: prevention and therapeutic opportunities</span></div><div class="casAuthors">Steinert Ralf; Lippert Hans; Reymond Marc A</div><div class="citationInfo"><span class="NLM_cas:title">Digestive surgery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-72</span>
        ISSN:<span class="NLM_cas:issn">0253-4886</span>.
    </div><div class="casAbstract">Port-site recurrences (PSRs) are abdominal wall recurrences that occur in the subcutaneous tissue within a trocar site after cancer laparoscopy and are not associated with peritoneal carcinomatosis.  In order to develop PSRs, viable tumor cells must be liberated from the primary tumor, be transported to a wound, and find there a favorable environment for growth.  The short clinical delay in the occurrence of PSRs and their size suggest massive cell seeding into the abdominal wall.  Traumatic handling of the tumor, slipping of trocars, liquid projection, as well as poor extraction techniques can all cause implantation of malignant cells into the subcutaneous tissue.  Such contact can also occur postoperatively if the trocar channels remain open.  Some histologies (e.g. gallbladder adenocarcinoma), the presence of ascites and advanced tumor stage are risk factors for PSRs.  Further conditions--including the use of gas--might also play a limited role.  The first preventive measure is the correct indication for a laparoscopic approach.  Several techniques have been demonstrated to prevent PSRs in the animal model: (a) fixation of trocars to the abdominal wall; (b) prevention of leakage; (c) careful specimen handling; (d) reducing trauma to the abdominal wall; (e) specimen isolation before extraction from the abdominal cavity; (f) trocar-site irrigation with a cytotoxic solution, and (g) closure of peritoneum.  Further innovative therapies are currently under investigation.  In the clinical setting, correct indication, surgical expertise and application of prophylactic measures seem to be the best way to prevent the occurrence of PSRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2dp9pler65Be4jJGKT5N0fW6udTcc2ebliMP818Dp9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jjs1yrtQ%253D%253D&md5=75a6de41e6ffa0203f7d7a7107eb58c7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1159%2F000067598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000067598%26sid%3Dliteratum%253Aachs%26aulast%3DSteinert%26aufirst%3DR.%26aulast%3DLippert%26aufirst%3DH.%26aulast%3DReymond%26aufirst%3DM.%2BA.%26atitle%3DTumor%2520cell%2520dissemination%2520during%2520laparoscopy%253A%2520prevention%2520and%2520therapeutic%2520opportunities%26jtitle%3DDig.%2520Surg.%26date%3D2002%26volume%3D19%26spage%3D464%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Raa, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oosterling, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kaaij, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Tol, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beelen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eijck, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Sijp, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Egmond, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeekel, J.</span><span> </span><span class="NLM_article-title">Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters</span> <span class="citation_source-journal">J. Surg. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1002%2Fjso.20273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=16231370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD2Mrms1ertw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2005&pages=124-129&author=S.+T.+Raaauthor=S.+J.+Oosterlingauthor=N.+P.+van+der+Kaaijauthor=M.+P.+van+den+Tolauthor=R.+H.+Beelenauthor=S.+Meijerauthor=C.+H.+van+Eijckauthor=J.+R.+van+der+Sijpauthor=M.+van+Egmondauthor=J.+Jeekel&title=Surgery+promotes+implantation+of+disseminated+tumor+cells%2C+but+does+not+increase+growth+of+tumor+cell+clusters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Surgery promotes implantation of disseminated tumor cells, but does not increase growth of tumor cell clusters</span></div><div class="casAuthors">Raa S Ten; Oosterling S J; van der Kaaij N P; van den Tol M P; Beelen R H J; Meijer S; van Eijck C H J; van der Sijp J R M; van Egmond M; Jeekel J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of surgical oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-9</span>
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    </div><div class="casAbstract">INTRODUCTION:  Local recurrence and peritoneal dissemination is common after intentionally curative resection of colorectal carcinoma.  It is not yet clear which mechanisms stimulate post-operative intra-abdominal tumor development.  Enhanced adhesion or growth of tumor cells and/or post-operative immuno suppression may influence tumor recurrence.  AIMS OF THE STUDY:  In the present study, we evaluated effects of local and remote surgery on intra-abdominal tumor development.  MATERIALS AND METHODS:  A standardized intra-abdominal trauma was inflicted by rubbing both uterus horns in laparotomy groups, while a dorsolateral thoracotomy was performed in thoracotomy groups (on day -1, 0, or +3).  To induce tumor development rats were injected intra-peritoneally with the coloncarcinoma cell line CC531s on day 0 and evaluated after 21 days.  RESULTS:  Rats undergoing laparotomy and injection on day 0 showed significantly higher tumorload than control rats (195 +/- 20 vs. 47 +/- 29, P < 0.001).  When a laparotomy was performed, the day before tumor inoculation even higher tumorload was seen (245 +/- 37 vs. 195 +/- 20, P < 0.01).  Strikingly, performing a thoracotomy on the day before or on the same day as tumor inoculation resulted in enhanced tumorload compared to controls as well (135 +/- 84 vs. 47 +/- 29; P < 0.001 and 88 +/- 38 vs. 47 +/- 29; P < 0.02, respectively).  Either laparotomy or thoracotomy 3 days after tumor cell inoculation did not affect growth of pre-existing tumor cell clusters.  CONCLUSIONS:  The (post) surgical intra-peritoneal microenvironment enhances successful implantation of spilled tumor cells, whereas growth of adhered tumor cell clusters is not affected.  The inflammatory response as a result of remote surgery promotes successful tumor development as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQnbV7OL59YTEwO064Z95rfW6udTcc2ebliMP818Dp9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mrms1ertw%253D%253D&md5=6bdf22e09a7808678e056b568a5afd8e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjso.20273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.20273%26sid%3Dliteratum%253Aachs%26aulast%3DRaa%26aufirst%3DS.%2BT.%26aulast%3DOosterling%26aufirst%3DS.%2BJ.%26aulast%3Dvan%2Bder%2BKaaij%26aufirst%3DN.%2BP.%26aulast%3Dvan%2Bden%2BTol%26aufirst%3DM.%2BP.%26aulast%3DBeelen%26aufirst%3DR.%2BH.%26aulast%3DMeijer%26aufirst%3DS.%26aulast%3Dvan%2BEijck%26aufirst%3DC.%2BH.%26aulast%3Dvan%2Bder%2BSijp%26aufirst%3DJ.%2BR.%26aulast%3Dvan%2BEgmond%26aufirst%3DM.%26aulast%3DJeekel%26aufirst%3DJ.%26atitle%3DSurgery%2520promotes%2520implantation%2520of%2520disseminated%2520tumor%2520cells%252C%2520but%2520does%2520not%2520increase%2520growth%2520of%2520tumor%2520cell%2520clusters%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D2005%26volume%3D92%26spage%3D124%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Takatsuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, T.</span><span> </span><span class="NLM_article-title">Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">6065</span><span class="NLM_x">–</span> <span class="NLM_lpage">6070</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6065-6070&author=H.+Takatsukiauthor=S.+Komatsuauthor=R.+Sanoauthor=Y.+Takadaauthor=T.+Tsuji&title=Adhesion+of+gastric+carcinoma+cells+to+peritoneum+mediated+by+alpha3beta1+integrin+%28VLA-3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakatsuki%26aufirst%3DH.%26aulast%3DKomatsu%26aufirst%3DS.%26aulast%3DSano%26aufirst%3DR.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DT.%26atitle%3DAdhesion%2520of%2520gastric%2520carcinoma%2520cells%2520to%2520peritoneum%2520mediated%2520by%2520alpha3beta1%2520integrin%2520%2528VLA-3%2529%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6065%26epage%3D6070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Weiss, L.</span><span> </span><span class="NLM_article-title">Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells</span> <span class="citation_source-journal">Cancer Treat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2F978-1-4613-1247-5_1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=8849940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2s%252Fgt1GqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1996&pages=1-11&author=L.+Weiss&title=Metastatic+inefficiency%3A+intravascular+and+intraperitoneal+implantation+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells</span></div><div class="casAuthors">Weiss L</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment and research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-11</span>
        ISSN:<span class="NLM_cas:issn">0927-3042</span>.
    </div><div class="casAbstract">The term metastatic inefficiency reflects the fact that most of the cancer cells entering the metastatic process are killed; some of the evidence for this is reviewed in the case of renal and colorectal carcinomas.  Although much emphasis has been placed on the rapid intravascular death of cancer cells during hematogenous metastasis, much less is known about the inefficiency associated with peritoneal carcinomatosis, and up to the present no systematic and direct numerical studies have been reported of the relative metastatic inefficiencies associated with seeding of cancer cells by intraperitoneal, vascular, and lymphatic routes.  However, studies on people and laboratory animals indicate that most of the cancer cells released into the peritoneal cavity are killed.  Some of the mechanisms involved in killing constitute part of cellular defense operating through the release of toxic free radicals.  One of these, hydrogen peroxide, given by intraperitoneal injection, has been shown to retard the development of malignant ascites in mice previously given intraperitoneal injections of cancer cells.  It is suggested that local irrigation with hydrogen peroxide during surgery for abdominal tumors may be effective in inhibiting the development of peritoneal carcinomatosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCKwhEM8Ud0qcY7HFp97qMfW6udTcc2eabBUL3TYu3Wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252Fgt1GqsQ%253D%253D&md5=819a7ed0c96bc3386835940c8e19a13c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2F978-1-4613-1247-5_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4613-1247-5_1%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DL.%26atitle%3DMetastatic%2520inefficiency%253A%2520intravascular%2520and%2520intraperitoneal%2520implantation%2520of%2520cancer%2520cells%26jtitle%3DCancer%2520Treat.%2520Res.%26date%3D1996%26volume%3D82%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Scholler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden-Ledbetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kline, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, N.</span><span> </span><span class="NLM_article-title">Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1016%2Fj.canlet.2006.03.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=16677756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1eltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=2007&pages=130-136&author=N.+Schollerauthor=B.+Garvikauthor=M.+Hayden-Ledbetterauthor=T.+Klineauthor=N.+Urban&title=Development+of+a+CA125-mesothelin+cell+adhesion+assay+as+a+screening+tool+for+biologics+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery</span></div><div class="casAuthors">Scholler, Nathalie; Garvik, Barbara; Hayden-Ledbetter, Martha; Kline, Toni; Urban, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130-136</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Preventing peritoneal implantation of ovarian carcinoma cells could prolong patient remission and survival.  CA125 is expressed on most ovarian cancer cells and was reported to be a ligand of mesothelin, a peritoneal protein.  The authors developed a cell adhesion assay with CA125-expresser ovarian cancer cells and human mesothelin-transfected cells and the authors confirmed that CA125 and mesothelin mediate cell attachment.  The authors also showed that this assay supplies a high-throughput screening system for reagents able to block CA125/mesothelin-dependent cell attachment with a sensitive quant. readout.  The authors finally demonstrated that a mesothelin chimeric protein and anti-CA125 antibodies block CA125/mesothelin-dependent cell attachment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbSxnFZWufXbVg90H21EOLACvtfcHk0lj_tO5UAF2Cng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1eltw%253D%253D&md5=20ea5ee8c4031d9029cda57e027543ce</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.03.029%26sid%3Dliteratum%253Aachs%26aulast%3DScholler%26aufirst%3DN.%26aulast%3DGarvik%26aufirst%3DB.%26aulast%3DHayden-Ledbetter%26aufirst%3DM.%26aulast%3DKline%26aufirst%3DT.%26aulast%3DUrban%26aufirst%3DN.%26atitle%3DDevelopment%2520of%2520a%2520CA125-mesothelin%2520cell%2520adhesion%2520assay%2520as%2520a%2520screening%2520tool%2520for%2520biologics%2520discovery%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D247%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Scaife, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wills, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trowbridge, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichwald, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daynes, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwada, S. K.</span><span> </span><span class="NLM_article-title">Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">6870</span><span class="NLM_x">–</span> <span class="NLM_lpage">6878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=6870-6878&author=C.+L.+Scaifeauthor=J.+Kuangauthor=J.+C.+Willsauthor=D.+B.+Trowbridgeauthor=P.+Grayauthor=B.+M.+Manningauthor=E.+J.+Eichwaldauthor=R.+A.+Daynesauthor=S.+K.+Kuwada&title=Nuclear+factor+kappaB+inhibitors+induce+adhesion-dependent+colon+cancer+apoptosis%3A+implications+for+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScaife%26aufirst%3DC.%2BL.%26aulast%3DKuang%26aufirst%3DJ.%26aulast%3DWills%26aufirst%3DJ.%2BC.%26aulast%3DTrowbridge%26aufirst%3DD.%2BB.%26aulast%3DGray%26aufirst%3DP.%26aulast%3DManning%26aufirst%3DB.%2BM.%26aulast%3DEichwald%26aufirst%3DE.%2BJ.%26aulast%3DDaynes%26aufirst%3DR.%2BA.%26aulast%3DKuwada%26aufirst%3DS.%2BK.%26atitle%3DNuclear%2520factor%2520kappaB%2520inhibitors%2520induce%2520adhesion-dependent%2520colon%2520cancer%2520apoptosis%253A%2520implications%2520for%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D6870%26epage%3D6878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doxey, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwada, S. K.</span><span> </span><span class="NLM_article-title">Pharmacologic downregulation of c-FLIP(L) restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1494</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1002%2Fijc.26119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=21480219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2012&pages=1494-1503&author=Y.+Shenauthor=R.+Herdeauthor=B.+W.+Doxeyauthor=C.+Xuauthor=P.+D.+Grayauthor=S.+K.+Kuwada&title=Pharmacologic+downregulation+of+c-FLIP%28L%29+restores+juxtacrine+death+receptor-mediated+apoptosis+in+cancer+cells+in+a+peritoneal+carcinomatosis+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic downregulation of c-FLIPL restores juxtacrine death receptor-mediated apoptosis in cancer cells in a peritoneal carcinomatosis model</span></div><div class="casAuthors">Shen, Yi; Herde, Ryan; Doxey, Brett W.; Xu, Changxin; Gray, Phillip D.; Kuwada, Scott K.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1494-1503</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Metastasis occurs when circulating cancer cells implant in normal secondary tissues.  Paradoxically, many cancer cells express death receptors while many normal tissues express the cognate death receptor ligands, suggesting that cancer cells possess mechanisms to inhibit death receptor signaling.  Pharmacol. restoration of juxtacrine-mediated death receptor signaling could prevent cancer cells from implanting in normal tissues such as the peritoneum.  The results showed that BAY 11-7085 significantly inhibited peritoneal carcinomatosis in mice following the introduction of colon and pancreatic cancer cell lines into the intra-abdominal cavity.  Treatment with BAY 11-7085 restored juxtacrine death receptor signaling during the adhesion of the cancer cells to mesothelial cells, which line the peritoneum.  BAY 11-7085 rapidly inhibited c-FLIPL expression in colon and pancreatic cancer cell lines during adhesion to mesothelial cells.  Pancreatic cancer cells sorted for high c-FLIPL expression formed peritoneal implants much more readily than cells with low c-FLIPL expression, and RNAi inhibition of c-FLIPL in colon cancer cells dramatically reduced peritoneal implantation.  This is a novel demonstration that the restoration of death receptor-mediated apoptotic signaling in cancer cells through the pharmacol. inhibition of c-FLIPL can inhibit tumor implantation in a clin. relevant model of peritoneal carcinomatosis, a fatal disease.  Pharmacol. inhibitors of FLIP hold promise as a way to curtail cancer cell colonization of secondary tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUURkASQMaz7Vg90H21EOLACvtfcHk0lgcnKjifqYfFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsLs%253D&md5=63548151220976300f198e58a1d36bd9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fijc.26119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.26119%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DY.%26aulast%3DHerde%26aufirst%3DR.%26aulast%3DDoxey%26aufirst%3DB.%2BW.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DP.%2BD.%26aulast%3DKuwada%26aufirst%3DS.%2BK.%26atitle%3DPharmacologic%2520downregulation%2520of%2520c-FLIP%2528L%2529%2520restores%2520juxtacrine%2520death%2520receptor-mediated%2520apoptosis%2520in%2520cancer%2520cells%2520in%2520a%2520peritoneal%2520carcinomatosis%2520model%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2012%26volume%3D130%26spage%3D1494%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Budd, R. C.</span><span> </span><span class="NLM_article-title">Death receptors couple to both cell proliferation and apoptosis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=437-441&author=R.+C.+Budd&title=Death+receptors+couple+to+both+cell+proliferation+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBudd%26aufirst%3DR.%2BC.%26atitle%3DDeath%2520receptors%2520couple%2520to%2520both%2520cell%2520proliferation%2520and%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D437%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Catalan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selgas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, A.</span><span> </span><span class="NLM_article-title">Regulation of apoptosis by lethal cytokines in human mesothelial cells</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1046%2Fj.1523-1755.2003.00062.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12787425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFeks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=321-330&author=M.+P.+Catalanauthor=D.+Subiraauthor=A.+Reyeroauthor=R.+Selgasauthor=A.+Ortiz-Gonzalezauthor=J.+Egidoauthor=A.+Ortiz&title=Regulation+of+apoptosis+by+lethal+cytokines+in+human+mesothelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of apoptosis by lethal cytokines in human mesothelial cells</span></div><div class="casAuthors">Catalan, Marina Penelope; Subira, Dolores; Reyero, Ana; Selgas, Rafael; Ortiz-Gonzalez, Arturo; Egido, Jesus; Ortiz, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">321-330</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Dysregulation of peritoneal cell death may contribute to the complications of peritoneal dialysis (PD).  Chronic peritoneal dialysis and acute peritonitis are both assocd. with loss of mesothelial cells.  In addn., acute peritonitis is characterized by sudden changes in the no. of peritoneal leukocytes.  However, the factors regulating peritoneal cell survival are poorly understood.  Peritoneal effluent cells and mesothelial cells cultured from peritoneal dialysis patients were studied.  Reverse transcriptase-polymerase chain reaction (RT-PCR) and flow cytometry were used to assess the expression of FasL and Fas mRNA and protein.  Western blot was used to assess FasL and tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL).  RT-PCR was used to study TRAIL and TRAIL receptor mRNA.  Apoptosis was quantified by flow cytometry of DNA content and confirmed by morphol.  Apoptotic cells, including apoptotic mesothelial cells, were present in the peritoneal effluent of stable peritoneal dialysis patients and patients with bacterial peritonitis.  The lethal cytokines FasL and TRAIL were expressed by peritoneal effluent cells, while cultured mesothelial cells expressed FasL, Fas, and TRAIL receptors.  Cultured mesothelial cells were sensitive to FasL-induced apoptosis.  IFN-γ increased the cell surface expression of Fas and the sensitivity of mesothelial cells to FasL-induced apoptosis.  In contrast to the effect of FasL, TNFα and TRAIL did not induce apoptosis in human mesothelial cells from peritoneal dialysis patients.  Lethal cytokines, such as FasL, may contribute to peritoneal cell turnover and the loss of mesothelium in peritoneal dialysis.  The role of other cytokines, such as TRAIL, remains undefined.  Approaches in limiting mesothelial cell injury that interferes with apoptosis should be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrob54VO5dj3LVg90H21EOLACvtfcHk0lgcnKjifqYfFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFeks7o%253D&md5=e3a0fd84eb7bb08abaef1ce253bf35f5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2003.00062.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2003.00062.x%26sid%3Dliteratum%253Aachs%26aulast%3DCatalan%26aufirst%3DM.%2BP.%26aulast%3DSubira%26aufirst%3DD.%26aulast%3DReyero%26aufirst%3DA.%26aulast%3DSelgas%26aufirst%3DR.%26aulast%3DOrtiz-Gonzalez%26aufirst%3DA.%26aulast%3DEgido%26aufirst%3DJ.%26aulast%3DOrtiz%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520apoptosis%2520by%2520lethal%2520cytokines%2520in%2520human%2520mesothelial%2520cells%26jtitle%3DKidney%2520Int.%26date%3D2003%26volume%3D64%26spage%3D321%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zificsak, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theroff, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwada, S. K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of sulfonyl acrylonitriles as novel inhibitors to peritoneal carcinomatosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1850</span><span class="NLM_x">–</span> <span class="NLM_lpage">1853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1850-1853&author=C.+A.+Zificsakauthor=Y.+Shenauthor=J.+G.+Liskoauthor=J.+P.+Theroffauthor=X.+Laoauthor=O.+Bolltauthor=X.+Liauthor=B.+D.+Dorseyauthor=S.+K.+Kuwada&title=Synthesis+and+biological+evaluation+of+sulfonyl+acrylonitriles+as+novel+inhibitors+to+peritoneal+carcinomatosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZificsak%26aufirst%3DC.%2BA.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DTheroff%26aufirst%3DJ.%2BP.%26aulast%3DLao%26aufirst%3DX.%26aulast%3DBollt%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26aulast%3DKuwada%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520sulfonyl%2520acrylonitriles%2520as%2520novel%2520inhibitors%2520to%2520peritoneal%2520carcinomatosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1850%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Elokdah, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarlane, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKean, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babiak, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinet, E. M.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030219z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=681-695&author=H.+Elokdahauthor=T.+S.+Sulkowskiauthor=M.+Abou-Gharbiaauthor=J.+A.+Buteraauthor=S.+Y.+Chaiauthor=G.+R.+McFarlaneauthor=M.+L.+McKeanauthor=J.+L.+Babiakauthor=S.+J.+Adelmanauthor=E.+M.+Quinet&title=Design%2C+synthesis%2C+and+biological+evaluation+of+thio-containing+compounds+with+serum+HDL-cholesterol-elevating+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm030219z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030219z%26sid%3Dliteratum%253Aachs%26aulast%3DElokdah%26aufirst%3DH.%26aulast%3DSulkowski%26aufirst%3DT.%2BS.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DButera%26aufirst%3DJ.%2BA.%26aulast%3DChai%26aufirst%3DS.%2BY.%26aulast%3DMcFarlane%26aufirst%3DG.%2BR.%26aulast%3DMcKean%26aufirst%3DM.%2BL.%26aulast%3DBabiak%26aufirst%3DJ.%2BL.%26aulast%3DAdelman%26aufirst%3DS.%2BJ.%26aulast%3DQuinet%26aufirst%3DE.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520thio-containing%2520compounds%2520with%2520serum%2520HDL-cholesterol-elevating%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D681%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hashmi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyrauch, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bats, J. W.</span><span> </span><span class="NLM_article-title">Gold catalysis: mild conditions for the synthesis of oxazoles from <i>N</i>-propargylcarboxamides and mechanistic aspects</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4391</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0480067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4391-4394&author=A.+S.+Hashmiauthor=J.+P.+Weyrauchauthor=W.+Freyauthor=J.+W.+Bats&title=Gold+catalysis%3A+mild+conditions+for+the+synthesis+of+oxazoles+from+N-propargylcarboxamides+and+mechanistic+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fol0480067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0480067%26sid%3Dliteratum%253Aachs%26aulast%3DHashmi%26aufirst%3DA.%2BS.%26aulast%3DWeyrauch%26aufirst%3DJ.%2BP.%26aulast%3DFrey%26aufirst%3DW.%26aulast%3DBats%26aufirst%3DJ.%2BW.%26atitle%3DGold%2520catalysis%253A%2520mild%2520conditions%2520for%2520the%2520synthesis%2520of%2520oxazoles%2520from%2520N-propargylcarboxamides%2520and%2520mechanistic%2520aspects%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4391%26epage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Talamas, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao-Ieong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brameld, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vicente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lui, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCaleb, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfeld, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, A.</span><span> </span><span class="NLM_article-title">De novo fragment design: a medicinal chemistry approach to fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3115</span><span class="NLM_x">–</span> <span class="NLM_lpage">3119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4002605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3115-3119&author=F.+X.+Talamasauthor=G.+Ao-Ieongauthor=K.+A.+Brameldauthor=E.+Chinauthor=J.+de+Vicenteauthor=J.+P.+Dunnauthor=M.+Ghateauthor=A.+M.+Giannettiauthor=S.+F.+Harrisauthor=S.+S.+Labadieauthor=V.+Levequeauthor=J.+Liauthor=A.+S.+Luiauthor=K.+L.+McCalebauthor=I.+Najeraauthor=R.+C.+Schoenfeldauthor=B.+Wangauthor=A.+Wong&title=De+novo+fragment+design%3A+a+medicinal+chemistry+approach+to+fragment-based+lead+generation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm4002605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002605%26sid%3Dliteratum%253Aachs%26aulast%3DTalamas%26aufirst%3DF.%2BX.%26aulast%3DAo-Ieong%26aufirst%3DG.%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DChin%26aufirst%3DE.%26aulast%3Dde%2BVicente%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DJ.%2BP.%26aulast%3DGhate%26aufirst%3DM.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DLabadie%26aufirst%3DS.%2BS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLui%26aufirst%3DA.%2BS.%26aulast%3DMcCaleb%26aufirst%3DK.%2BL.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DA.%26atitle%3DDe%2520novo%2520fragment%2520design%253A%2520a%2520medicinal%2520chemistry%2520approach%2520to%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3115%26epage%3D3119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Johnstone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindelar, W. F.</span><span> </span><span class="NLM_article-title">Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial</span> <span class="citation_source-journal">Int. J. Radiat. Oncol. Biol. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1016%2F0360-3016%2893%2990456-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=8244812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2c%252FmsVChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1993&pages=831-834&author=P.+A.+Johnstoneauthor=W.+F.+Sindelar&title=Patterns+of+disease+recurrence+following+definitive+therapy+of+adenocarcinoma+of+the+pancreas+using+surgery+and+adjuvant+radiotherapy%3A+correlations+of+a+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy:correlations of a clinical trial</span></div><div class="casAuthors">Johnstone P A; Sindelar W F</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation oncology, biology, physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">831-4</span>
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    </div><div class="casAbstract">PURPOSE:  Between 1980 and 1984, 26 patients with resectable adenocarcinoma of the pancreatic head were enrolled in a National Cancer Institute protocol evaluating intraoperative radiotherapy vs. standard therapy.  METHODS AND MATERIALS:  After complete excision of their lesions, patients were observed (Stage I), or randomized to intraoperative radiotherapy vs. external beam radiotherapy (Stages II-IV).  The intraoperative dose was 20 Gy in a single fraction using 9-20 MeV electrons.  The external beam radiotherapy schema involved daily 150-180 cGy fractions to 45-55 Gy in 5-6 weeks.  Chemotherapy was not used for primary disease but was administered off protocol for recurrent disease.  Median potential followup for the trial was > 9 years, with a median patient survival of 18 months.  Perioperative mortality was 27% (7 patients).  Of the remaining 19 patients, one remains alive and without evidence of disease 9 years post-therapy.  Twelve patients underwent autopsy and 2 required antemortem laparotomy; histopathologic evidence of disease recurrence was analyzed.  RESULTS:  Of 15 patients evaluable for intra-abdominal control, 7 (47%) suffered local recurrences and 7 (47%) failed regionally, with 5 patients (35%) failing in both areas.  Five patients (35%) developed peritoneal seeding.  Of 13 patients evaluable for systemic disease, 8 (62%) suffered distant failure.  There were no differences in outcome between intraoperative or external beam radiotherapy or observation in this subset of patients.  CONCLUSION:  This report is among the most rigorous descriptions of patterns of failure after resection of pancreatic cancer.  It appears clear that advances in local control of this disease are unlikely to translate into increased survival in the absence of improved systemic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTidEn3ZC8eeWBAiYWy6n3SfW6udTcc2eb2GADD_ohY8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FmsVChug%253D%253D&md5=dddfb74a699ce8d5da48dd08942cc74a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0360-3016%2893%2990456-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0360-3016%252893%252990456-6%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DP.%2BA.%26aulast%3DSindelar%26aufirst%3DW.%2BF.%26atitle%3DPatterns%2520of%2520disease%2520recurrence%2520following%2520definitive%2520therapy%2520of%2520adenocarcinoma%2520of%2520the%2520pancreas%2520using%2520surgery%2520and%2520adjuvant%2520radiotherapy%253A%2520correlations%2520of%2520a%2520clinical%2520trial%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%2520Biol.%2520Phys.%26date%3D1993%26volume%3D27%26spage%3D831%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fujiwara, K.</span><span> </span><span class="NLM_article-title">Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer</span> <span class="citation_source-journal">Gan To Kagaku Ryoho</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">Suppl 2</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3czptVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=Suppl+2&publication_year=2000&pages=354-358&author=K.+Fujiwara&title=Intraperitoneal+chemotherapy+and+intraperitoneal+washing+cytology+in+management+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Intraperitoneal chemotherapy and intraperitoneal washing cytology in management of ovarian cancer</span></div><div class="casAuthors">Fujiwara K</div><div class="citationInfo"><span class="NLM_cas:title">Gan to kagaku ryoho. Cancer & chemotherapy</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27 Suppl 2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">354-8</span>
        ISSN:<span class="NLM_cas:issn">0385-0684</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTyZu_Zs4r0-Htlzo9xastyfW6udTcc2eZHPWlEP5HWk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3czptVGmug%253D%253D&md5=00e01eaeb70a2caa3d3408a264014cfa</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujiwara%26aufirst%3DK.%26atitle%3DIntraperitoneal%2520chemotherapy%2520and%2520intraperitoneal%2520washing%2520cytology%2520in%2520management%2520of%2520ovarian%2520cancer%26jtitle%3DGan%2520To%2520Kagaku%2520Ryoho%26date%3D2000%26volume%3DSuppl%25202%26spage%3D354%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kanellos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetriades, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zintzaras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandrali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantzoros, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betsis, D.</span><span> </span><span class="NLM_article-title">Incidence and prognostic value of positive peritoneal cytology in colorectal cancer</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs10350-004-6595-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12682550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3s7msVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=535-539&author=I.+Kanellosauthor=H.+Demetriadesauthor=E.+Zintzarasauthor=A.+Mandraliauthor=I.+Mantzorosauthor=D.+Betsis&title=Incidence+and+prognostic+value+of+positive+peritoneal+cytology+in+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Incidence and prognostic value of positive peritoneal cytology in colorectal cancer</span></div><div class="casAuthors">Kanellos I; Demetriades H; Zintzaras E; Mandrali A; Mantzoros I; Betsis D</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">535-9</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  This study was conducted to investigate the incidence of free cancer cells in the peritoneal washings of patients who had undergone surgery for colorectal cancer and to evaluate its influence as a prognostic factor of the disease.  METHODS:  From 1990 to 1996, intraoperative washing cytology was performed in 110 patients who underwent surgery for colorectal cancer.  All patients had curative resections.  Immediately after the abdomen was opened and before exploration and mobilization of the tumor, 100 ml of saline was injected over the tumor site.  Washings were then aspirated and taken for cytologic examination.  RESULTS:  Twenty-two (20 percent) of 110 patients examined were found to have positive cytology for intraperitoneal free malignant cells.  The site of tumor in the colon or rectum, tumor size, nodal status, degree of differentiation, mucinous characteristics, and vascular or neural invasion were found not to affect the incidence of free cancer cells.  Conversely, tumor penetration was found to affect the incidence of positive cytology.  The degree of association among the stages of tumor penetration was indicated by the contingency coefficient, which was 0.42.  Patients with positive cytology had a significantly higher rate of local recurrence and peritoneal carcinomatosis (22.8 vs. 8 percent, P = 0.05) than patients with negative cytology.  Mortality rate was not found to be related to the presence of free cancer cells.  CONCLUSION:  Cytologic examination of peritoneal lavage at the time of surgery could be a useful prognostic indicator for local and peritoneal recurrence rate.  However, it was not found to be a predictor of survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5iupvSi8kMc25P7XSLhESfW6udTcc2eZHPWlEP5HWk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7msVeitQ%253D%253D&md5=418cfe348dbf87150a2e10c0349a70b8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs10350-004-6595-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10350-004-6595-0%26sid%3Dliteratum%253Aachs%26aulast%3DKanellos%26aufirst%3DI.%26aulast%3DDemetriades%26aufirst%3DH.%26aulast%3DZintzaras%26aufirst%3DE.%26aulast%3DMandrali%26aufirst%3DA.%26aulast%3DMantzoros%26aufirst%3DI.%26aulast%3DBetsis%26aufirst%3DD.%26atitle%3DIncidence%2520and%2520prognostic%2520value%2520of%2520positive%2520peritoneal%2520cytology%2520in%2520colorectal%2520cancer%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D2003%26volume%3D46%26spage%3D535%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nakatsuka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokohata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chijiiwa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span> </span><span class="NLM_article-title">Positive washing cytology in patients with pancreatic cancer indicates a contraindication of pancreatectomy</span> <span class="citation_source-journal">Int. J. Surg. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12774455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ltFehtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=311-317&author=A.+Nakatsukaauthor=K.+Yamaguchiauthor=S.+Shimizuauthor=K.+Yokohataauthor=T.+Morisakiauthor=K.+Chijiiwaauthor=M.+Tanaka&title=Positive+washing+cytology+in+patients+with+pancreatic+cancer+indicates+a+contraindication+of+pancreatectomy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Positive washing cytology in patients with pancreatic cancer indicates a contraindication of pancreatectomy</span></div><div class="casAuthors">Nakatsuka A; Yamaguchi K; Shimizu S; Yokohata K; Morisaki T; Chijiiwa K; Tanaka M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of surgical investigation</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-7</span>
        ISSN:<span class="NLM_cas:issn">1028-5229</span>.
    </div><div class="casAbstract">BACKGROUND:  Although peritoneal washing cytology has been widely used in the field of gynecology, it has not been performed so frequently in patients with pancreatic cancer.  Only a few papers have reported surgical implications of peritoneal washing cytology.  MATERIALS AND METHODS:  We reviewed results of peritoneal washing cytology performed immediately after laparotomy in 50 Japanese patients with pancreatic cancer.  The 50 patients were divided into two groups according to the results of cytology.  Clinicopathological findings were compared between these two groups.  RESULTS:  Cytology of peritoneal washing was positive in 13 (26%) of the 50 patients.  Nine of the 13 patients had no visible peritoneal dissemination.  There were no significant differences regarding the age, tumor size and serum level of the carcinoembryonic antigen.  Moderately to poorly differentiated adenocarcinoma and perineural invasion (ne3) and lymphatic permeation (ly3) of marked degree were more frequent in the positive group than in the negative group (p < 0.01).  The survival curve of the 37 patients with negative cytology was significantly better than that of the 13 with positive cytology (p < 0.01).  Four of 13 patients with positive cytology underwent a potentially curative resection but died within 12 months.  Three of these four patients died of peritonitis carcinomatosa with massive malignant ascites and one died of local recurrence.  CONCLUSIONS:  Positive peritoneal washing cytology is not rare in patients with pancreatic cancer and indicates a contraindication of pancreatectomy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0BQDWUhjo2hLDWw4HIq2sfW6udTcc2eZHPWlEP5HWk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ltFehtQ%253D%253D&md5=5e03f8e96393311c898db44ac813a672</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakatsuka%26aufirst%3DA.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DYokohata%26aufirst%3DK.%26aulast%3DMorisaki%26aufirst%3DT.%26aulast%3DChijiiwa%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DM.%26atitle%3DPositive%2520washing%2520cytology%2520in%2520patients%2520with%2520pancreatic%2520cancer%2520indicates%2520a%2520contraindication%2520of%2520pancreatectomy%26jtitle%3DInt.%2520J.%2520Surg.%2520Invest.%26date%3D1999%26volume%3D1%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Santala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talvensaari-Mattila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauppila, A.</span><span> </span><span class="NLM_article-title">Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3097</span><span class="NLM_x">–</span> <span class="NLM_lpage">3103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12926169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVCntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3097-3103&author=M.+Santalaauthor=A.+Talvensaari-Mattilaauthor=A.+Kauppila&title=Peritoneal+cytology+and+preoperative+serum+CA+125+level+are+important+prognostic+indicators+of+overall+survival+in+advanced+endometrial+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer</span></div><div class="casAuthors">Santala, Markku; Talvensaari-Mattila, Anne; Kauppila, Antti</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3C</span>),
    <span class="NLM_cas:pages">3097-3103</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">The current study aimed to evaluate flow cytometry findings, peritoneal cytol. and preoperative CA125 level as prognostic factors of endometrial carcinoma.  A retrospective study of 44 patients with FIGO stage II-IV endometrial carcinoma who underwent abdominal hysterectomy, bilateral salpingo-oophorectomy and, all except three, pelvic lymph node dissection.  At operation, a peritoneal washing sample was taken for cytol. examn.  Flow cytometry was performed on fresh primary tumor samples.  Blood samples were obtained within 2 wk before surgery.  The median follow-up time was 54 mo.  In univariate anal., DNA ploidy, S-phase fraction, serum CA125 level and peritoneal cytol. findings correlated significantly with survival.  In multivariate anal., peritoneal cytol. (benign vs. malignant), grade (1 + 2 vs. 3) and preoperative serum CA125 concn. (≤ 25 U/mL vs. > 25 U/mL) remained significant independent predictors of overall survival DNA ploidy and S-phase fraction had a strong correlation with peritoneal cytol.  Malignant cytol. findings were more frequent in cases with DNA aneuploidy and S-phase fraction higher than 8%.  In addn. to histol. grade, peritoneal cytol. and preoperative serum CA125 level were also important independent prognostic indicators of outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDyAVx5Ug-0rVg90H21EOLACvtfcHk0liCChyRfJaaNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVCntr0%253D&md5=0f910500bdb9fabc2cd92b8ec880e247</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantala%26aufirst%3DM.%26aulast%3DTalvensaari-Mattila%26aufirst%3DA.%26aulast%3DKauppila%26aufirst%3DA.%26atitle%3DPeritoneal%2520cytology%2520and%2520preoperative%2520serum%2520CA%2520125%2520level%2520are%2520important%2520prognostic%2520indicators%2520of%2520overall%2520survival%2520in%2520advanced%2520endometrial%2520cancer%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3097%26epage%3D3103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Terauchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, H.</span><span> </span><span class="NLM_article-title">Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm</span> <span class="citation_source-journal">Int. J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2Fs101470200054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=12494251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Ohtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=356-360&author=F.+Terauchiauthor=T.+Moritakeauthor=Y.+Yamamotoauthor=H.+Ogura&title=Combination+chemotherapy+with+paclitaxel+and+intraperitoneal+cisplatin+for+ovarian+cancer+with+disseminated+lesions+in+the+peritoneum+and+the+diaphragm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm</span></div><div class="casAuthors">Terauchi, F.; Moritake, T.; Yamamoto, Y.; Ogura, H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">356-360</span>CODEN:
                <span class="NLM_cas:coden">IJCOF6</span>;
        ISSN:<span class="NLM_cas:issn">1341-9625</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag Tokyo</span>)
        </div><div class="casAbstract">In ovarian cancer, the management of micrometastases disseminated in the peritoneal cavity is extremely important.  We performed i.v. paclitaxel (PAC) infusion combined with cisplatin (CDDP) i.p. infusion for progressive ovarian cancer.  Twelve patients with progressive epithelial ovarian cancer (FIGO IIIc), which was resected using an optimal method at primary surgery, except for disseminated lesions in the peritoneum and the diaphragm, were studied.  At primary surgery, a reservoir was placed in the peritoneal cavity.  If metastases were identified in the diaphragm, then another reservoir was also placed in the subdiaphragm (double reservoirs).  The basic regimen was set at 175 mg/m2 with divided doses of PAC and 75 mg/m2 CDDP by i.p. injection.  When a double reservoir was used, 30 mg/m2 of subdiaphragmatic CDDP and 45 mg/m2 of i.p. CDDP were administered.  The patients received five courses of this regimen.  The response to the therapy was evaluated with tumor markers, and by using cytodiagnoses on the peritoneal washing fluid collected from the reservoirs.  After five courses of the chemotherapy, the tumor marker levels and cytodiagnoses of all patients became neg.  With ref. to adverse effects, grade 3-4 neutropenia was detected in 2 patients (16.6%), peripheral neuropathy was detected in 4 patients (33.3%), and alopecia was detected in 11 patients (91.6%).  The median follow-up period was 29.2 mo and median progression-free survival was 25.6 mo.  Thus, the combination chemotherapy with i.v. PAC and i.p. CDDP was effective on ovarian cancer with disseminated lesions in the peritoneum and the diaphragm, having only mild adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo927SlQeW7rrVg90H21EOLACvtfcHk0lhFjPpwSvVPPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Ohtb0%253D&md5=1136127f97d3452cacb781d0422347ad</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs101470200054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs101470200054%26sid%3Dliteratum%253Aachs%26aulast%3DTerauchi%26aufirst%3DF.%26aulast%3DMoritake%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DOgura%26aufirst%3DH.%26atitle%3DCombination%2520chemotherapy%2520with%2520paclitaxel%2520and%2520intraperitoneal%2520cisplatin%2520for%2520ovarian%2520cancer%2520with%2520disseminated%2520lesions%2520in%2520the%2520peritoneum%2520and%2520the%2520diaphragm%26jtitle%3DInt.%2520J.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D7%26spage%3D356%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Yachida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosuge, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirohashi, S.</span><span> </span><span class="NLM_article-title">Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer</span> <span class="citation_source-journal">Br. J. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1046%2Fj.1365-2168.2002.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=11972546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD383jsFehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2002&pages=573-578&author=S.+Yachidaauthor=N.+Fukushimaauthor=M.+Sakamotoauthor=Y.+Matsunoauthor=T.+Kosugeauthor=S.+Hirohashi&title=Implications+of+peritoneal+washing+cytology+in+patients+with+potentially+resectable+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of peritoneal washing cytology in patients with potentially resectable pancreatic cancer</span></div><div class="casAuthors">Yachida S; Fukushima N; Sakamoto M; Matsuno Y; Kosuge T; Hirohashi S</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of surgery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">573-8</span>
        ISSN:<span class="NLM_cas:issn">0007-1323</span>.
    </div><div class="casAbstract">BACKGROUND:  The aim of this study was to assess the implications of positive peritoneal washing cytology for management of patients with potentially resectable pancreatic cancer.  METHODS:  Cytological examination of peritoneal washings was performed in 134 patients who underwent surgical resection for pancreatic adenocarcinoma.  The clinicopathological findings and the relationship between cytology results (including cytomorphology) and survival were investigated.  RESULTS:  One hundred and fourteen patients (85 per cent) had negative cytology results (group 1).  Excluding one patient with atypical cells, positive cytology results were obtained in 19 patients (14 per cent): 16 patients without macroscopic peritoneal metastases (group 2) and three patients with minimal macroscopic peritoneal metastases (group 3).  The patients in group 2 had significantly larger (P < 0.001) and more advanced (P = 0.022) tumours than those in group 1.  However, there were no significant differences in postoperative cumulative survival rates between groups 1 and 2 (P = 0.347).  Two patients in group 2 are long-term survivors (40 and 58 months).  In cytomorphological analyses, the presence of clusters with ragged edges and isolated carcinoma cells can be considered to indicate a high risk of peritoneal recurrence.  CONCLUSION:  Positive cytology does not directly predict peritoneal carcinomatosis and, while associated with advanced disease, does not contraindicate radical surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzmYewUgdhK4YPsCkJIw00fW6udTcc2eYzUW9ATrNPGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383jsFehsA%253D%253D&md5=8e82f79f2dfea64558dfef89ee9567f3</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2168.2002.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2168.2002.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DYachida%26aufirst%3DS.%26aulast%3DFukushima%26aufirst%3DN.%26aulast%3DSakamoto%26aufirst%3DM.%26aulast%3DMatsuno%26aufirst%3DY.%26aulast%3DKosuge%26aufirst%3DT.%26aulast%3DHirohashi%26aufirst%3DS.%26atitle%3DImplications%2520of%2520peritoneal%2520washing%2520cytology%2520in%2520patients%2520with%2520potentially%2520resectable%2520pancreatic%2520cancer%26jtitle%3DBr.%2520J.%2520Surg.%26date%3D2002%26volume%3D89%26spage%3D573%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Jorgensen, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalak, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, D. R.</span><span> </span><span class="NLM_article-title">Is laparoscopy associated with a lower rate of postoperative adhesions than laparotomy? A comparative study in the rabbit</span> <span class="citation_source-journal">Aust. N. Z. J. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1111%2Fj.1445-2197.1995.tb00651.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=7741679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2M3mtVaksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1995&pages=342-344&author=J.+O.+Jorgensenauthor=N.+J.+Lalakauthor=D.+R.+Hunt&title=Is+laparoscopy+associated+with+a+lower+rate+of+postoperative+adhesions+than+laparotomy%3F+A+comparative+study+in+the+rabbit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Is laparoscopy associated with a lower rate of postoperative adhesions than laparotomy? A comparative study in the rabbit</span></div><div class="casAuthors">Jorgensen J O; Lalak N J; Hunt D R</div><div class="citationInfo"><span class="NLM_cas:title">The Australian and New Zealand journal of surgery</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">342-4</span>
        ISSN:<span class="NLM_cas:issn">0004-8682</span>.
    </div><div class="casAbstract">This trial set out to test the hypothesis that there is no difference in the incidence of intra-abdominal adhesions after a stereotyped intraperitoneal injury created via laparoscopy or laparotomy.  Twenty New Zealand White rabbits had a 2 x 2 cm area of peritoneum stripped off their caecum and adjacent parietal peritoneum, either by laparotomy or laparoscopy.  Outcome was assessed by the incidence of adhesions to the test site and the wound.  There was no difference in the rate of adhesions at the test site in the two groups.  The rate of adhesions to the wound was different in the two groups (70% laparotomy, 0% laparoscopy; P = 0.003).  In a rabbit model, comparing laparoscopy and laparotomy in a strictly controlled operative environment, a stereotyped intraperitoneal injury results in similar rates of postoperative adhesions.  Laparoscopy is, however, associated with a much lower incidence of wound adhesion.  The potential for postoperative adhesions is real after laparoscopic surgery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1HxZHxO9ZWEodMGTatQ7LfW6udTcc2eYzUW9ATrNPGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3mtVaksA%253D%253D&md5=fafcf4a1b82d24dfb2f0c5a2c0ac9602</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fj.1445-2197.1995.tb00651.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1445-2197.1995.tb00651.x%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DJ.%2BO.%26aulast%3DLalak%26aufirst%3DN.%2BJ.%26aulast%3DHunt%26aufirst%3DD.%2BR.%26atitle%3DIs%2520laparoscopy%2520associated%2520with%2520a%2520lower%2520rate%2520of%2520postoperative%2520adhesions%2520than%2520laparotomy%253F%2520A%2520comparative%2520study%2520in%2520the%2520rabbit%26jtitle%3DAust.%2520N.%2520Z.%2520J.%2520Surg.%26date%3D1995%26volume%3D65%26spage%3D342%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, R. L.</span><span> </span><span class="NLM_article-title">Peritoneal irrigation with povidone–iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1007%2FBF02236346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=10223750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK1M3jvValtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=319-326&author=S.+W.+Leeauthor=N.+R.+Gleasonauthor=M.+Besslerauthor=R.+L.+Whelan&title=Peritoneal+irrigation+with+povidone%E2%80%93iodine+solution+after+laparoscopic-assisted+splenectomy+significantly+decreases+port-tumor+recurrence+in+a+murine+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Peritoneal irrigation with povidone-iodine solution after laparoscopic-assisted splenectomy significantly decreases port-tumor recurrence in a murine model</span></div><div class="casAuthors">Lee S W; Gleason N R; Bessler M; Whelan R L</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-26</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  The development of port-wound tumor recurrences has raised questions regarding the safety of laparoscopic methods for the resection of malignancies.  The cause and the incidence of abdominal-wall tumor recurrences remain unknown.  It is also not clear how to avoid or lower the incidence of port-tumor recurrences.  The purpose of the current study was to determine the impact of abdominal irrigation with povidone-iodine on the port-wound tumor incidence in a murine model.  METHODS:  A splenic tumor model was used for this study.  To establish splenic tumors, female BALB/c mice (N = 48) were given subcapsular splenic injections of a 0.1 ml suspension containing 10(5) C-26 colon adenocarcinoma cells via a left-flank incision at the initial procedure.  Seven days later, the animals with isolated splenic tumors (100 percent) were randomly assigned to one of three groups: 1) control, 2) saline irrigation (saline), or 3) povidone-iodine irrigation.  All animals underwent laparoscopic mobilization of the spleen using a three-port technique, intra-abdominal crushing of the tumor, followed by an extracorporeal splenectomy via a subcostal incision.  No irrigation was performed for control group animals.  In the saline irrigation group, the subcostal incision was closed and pneumoperitoneum was re-established.  The abdominal cavity was irrigated with 5 ml of normal saline for 60 seconds before instrument removal.  In the povidone-iodine irrigation group, similar abdominal irrigation was performed, using 0.25 percent povidone-iodine.  Attempts were made to recover completely the irrigation for both irrigation groups.  Seven days after the splenectomy, animals were killed and inspected for abdominal-wall tumor implants.  RESULTS:  There were significantly more animals with at least one port-tumor recurrence in the control group than in the povidone-iodine group (P = 0.007).  Although not statistically significant, the number of animals with port-wound tumors was higher in the saline group than in the povidone-iodine group (P < 0.08).  There was no significant difference between the saline group and the control group.  When each port site was considered independently, the incidence of port-wound tumors (number of ports with tumors per total number of ports) was significantly lower in the povidone-iodine group than in both the control (P = 0.00001) and saline groups (P = 0.03).  The incidence of port-wound tumors was also significantly lower in the saline group compared with the control group incidence (P = 0.03).  CONCLUSIONS:  Abdominal irrigation with dilute povidone-iodine solution significantly reduced the number of animals with port-tumor recurrences.  Abdominal irrigation with saline was also effective in reducing the incidence of port-wound tumor formation when each port was considered separately.  However, povidone-iodine irrigation was much more effective than saline irrigation in preventing port-wound tumor formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPLW2QA0YEELZpSb_XWfMrfW6udTcc2eYzUW9ATrNPGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3jvValtA%253D%253D&md5=41b94b8e3a5fdd82f0fb8f91399b4ede</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2FBF02236346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02236346%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DGleason%26aufirst%3DN.%2BR.%26aulast%3DBessler%26aufirst%3DM.%26aulast%3DWhelan%26aufirst%3DR.%2BL.%26atitle%3DPeritoneal%2520irrigation%2520with%2520povidone%25E2%2580%2593iodine%2520solution%2520after%2520laparoscopic-assisted%2520splenectomy%2520significantly%2520decreases%2520port-tumor%2520recurrence%2520in%2520a%2520murine%2520model%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1999%26volume%3D42%26spage%3D319%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Micames, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jowell, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pappas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, K.</span><span> </span><span class="NLM_article-title">Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA</span> <span class="citation_source-journal">Gastrointest. Endosc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm501437v&amp;key=10.1016%2FS0016-5107%2803%2902009-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=14595302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADC%252BD3srhs1yitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2003&pages=690-695&author=C.+Micamesauthor=P.+S.+Jowellauthor=R.+Whiteauthor=E.+Paulsonauthor=R.+Nelsonauthor=M.+Morseauthor=H.+Hurwitzauthor=T.+Pappasauthor=D.+Tylerauthor=K.+McGrath&title=Lower+frequency+of+peritoneal+carcinomatosis+in+patients+with+pancreatic+cancer+diagnosed+by+EUS-guided+FNA+vs.+percutaneous+FNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA</span></div><div class="casAuthors">Micames Carlos; Jowell Paul S; White Rebekah; Paulson Erik; Nelson Rendon; Morse Michael; Hurwitz Herbert; Pappas Theodore; Tyler Douglas; McGrath Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Gastrointestinal endoscopy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">690-5</span>
        ISSN:<span class="NLM_cas:issn">0016-5107</span>.
    </div><div class="casAbstract">BACKGROUND:  Studies have suggested an increased risk of peritoneal seeding in patients with pancreatic cancer diagnosed by percutaneous FNA.  EUS-FNA is an alternate method of diagnosis.  The aim of this study was to compare the frequency of peritoneal carcinomatosis as a treatment failure pattern in patients with pancreatic cancer diagnosed by EUS-FNA vs. percutaneous FNA.  METHODS:  Retrospective review of patients with non-metastatic pancreatic cancer identified 46 patients in whom the diagnosis was made by EUS-FNA and 43 with the diagnosis established by percutaneous FNA.  All had neoadjuvant chemoradiation.  Patients underwent restaging CT after completion of therapy, followed by attempted surgical resection if there was no evidence of disease progression.  RESULTS:  There were no significant differences in tumor characteristics between the two study groups.  In the EUS-FNA group, one patient had developed peritoneal carcinomatosis compared with 7 in the percutaneous FNA group (2.2% vs. 16.3%; p<0.025).  No patient with a potentially resectable tumor in the EUS-FNA group had developed peritoneal carcinomatosis.  CONCLUSIONS:  Peritoneal carcinomatosis may occur more frequently in patients who undergo percutaneous FNA compared with those who have EUS-FNA for the diagnosis of pancreatic cancer.  A concern for peritoneal seeding of pancreatic cancer via percutaneous FNA is warranted.  EUS-guided FNA is recommended as the method of choice for diagnosis in patients with potentially resectable pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSXRWdwTw_aYAMthz5_Rx5rfW6udTcc2ebz8akXDH2u1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srhs1yitQ%253D%253D&md5=5261f70fc94ff5580ab6c2f6d46c0186</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0016-5107%2803%2902009-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5107%252803%252902009-1%26sid%3Dliteratum%253Aachs%26aulast%3DMicames%26aufirst%3DC.%26aulast%3DJowell%26aufirst%3DP.%2BS.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DPaulson%26aufirst%3DE.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DMorse%26aufirst%3DM.%26aulast%3DHurwitz%26aufirst%3DH.%26aulast%3DPappas%26aufirst%3DT.%26aulast%3DTyler%26aufirst%3DD.%26aulast%3DMcGrath%26aufirst%3DK.%26atitle%3DLower%2520frequency%2520of%2520peritoneal%2520carcinomatosis%2520in%2520patients%2520with%2520pancreatic%2520cancer%2520diagnosed%2520by%2520EUS-guided%2520FNA%2520vs.%2520percutaneous%2520FNA%26jtitle%3DGastrointest.%2520Endosc.%26date%3D2003%26volume%3D58%26spage%3D690%26epage%3D695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Johnson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">P, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balshem, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litwin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. P.</span><span> </span><span class="NLM_article-title">Implications of fine-needle aspiration in patients with resectable pancreatic cancer</span> <span class="citation_source-journal">Am. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501437v&amp;key=9247432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501437v&amp;key=1%3ACAS%3A280%3ADyaK2szptVGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1997&pages=675-679&author=D.+E.+Johnsonauthor=T.+Pauthor=A.+M.+Balshemauthor=E.+Rossauthor=S.+Litwinauthor=B.+L.+Eisenbergauthor=J.+P.+Hoffman&title=Implications+of+fine-needle+aspiration+in+patients+with+resectable+pancreatic+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of fine-needle aspiration in patients with resectable pancreatic cancer</span></div><div class="casAuthors">Johnson D E; Pendurthi T K; Balshem A M; Ross E; Litwin S; Eisenberg B L; Hoffman J P</div><div class="citationInfo"><span class="NLM_cas:title">The American surgeon</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">675-9; discussion 679-80</span>
        ISSN:<span class="NLM_cas:issn">0003-1348</span>.
    </div><div class="casAbstract">A 9-year experience with fine-needle aspiration (FNA) in patients with resectable pancreatic adenocarcinoma was reviewed to determine whether this procedure is associated with positive peritoneal cytology, peritoneal recurrences, or decreased survival in patients who had pancreatic resection with curative intent.  Forty-one patients underwent pancreatic resection for primary pancreatic adenocarcinoma from July 1987 to February 1996.  Nine patients had open biopsies prior to definitive resection and were excluded from this study.  Of the remaining 32 patients, 21 (66%) had preoperative computed tomography-guided or fluoroscopically guided FNA biopsy of the pancreas for diagnosis.  FNA confirmed the diagnosis of adenocarcinoma in 17 of 21 patients (80%).  Fifteen of 21 FNA biopsies were performed in patients who went on to receive neoadjuvant chemoradiation.  Twenty-eight of 32 patients (87%) had peritoneal washings at the time of laparotomy.  Five patients had suspicious or positive washings (18%), and 23 patients had negative washings (82%).  Three of 18 patients (16.7%) who had both FNA and peritoneal washings and 2 of 10 patients (20%) who had no FNA but had peritoneal washings had positive or suspicious peritoneal cytology.  Eight of 32 patients ultimately failed in the peritoneum.  Six of 21 patients (28%) who had prior FNA and 2 of 11 (18%) who had no prior FNA failed in the peritoneum.  Although the number of patients is small, none of these differences proved to be statistically significant.  No difference in median survival was observed between the FNA and no FNA groups.  We conclude that FNA is a safe and useful tool to confirm the diagnosis of pancreatic cancer when patients are to be treated with neoadjuvant chemoradiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUYERZn_b7b75XHngOXiV_fW6udTcc2ebz8akXDH2u1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szptVGktw%253D%253D&md5=bb495c2da4df85866f8ce3c54c7ce37d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BE.%26aulast%3DP%26aufirst%3DT.%26aulast%3DBalshem%26aufirst%3DA.%2BM.%26aulast%3DRoss%26aufirst%3DE.%26aulast%3DLitwin%26aufirst%3DS.%26aulast%3DEisenberg%26aufirst%3DB.%2BL.%26aulast%3DHoffman%26aufirst%3DJ.%2BP.%26atitle%3DImplications%2520of%2520fine-needle%2520aspiration%2520in%2520patients%2520with%2520resectable%2520pancreatic%2520cancer%26jtitle%3DAm.%2520Surg.%26date%3D1997%26volume%3D63%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501437v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501437v%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-3" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501437v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799d7055ef93d82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
